EP3518881A1 - Improved conditioning hair treatment product with washout protection - Google Patents
Improved conditioning hair treatment product with washout protectionInfo
- Publication number
- EP3518881A1 EP3518881A1 EP17742246.6A EP17742246A EP3518881A1 EP 3518881 A1 EP3518881 A1 EP 3518881A1 EP 17742246 A EP17742246 A EP 17742246A EP 3518881 A1 EP3518881 A1 EP 3518881A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- weight
- hair treatment
- hair
- composition according
- treatment composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 160
- 238000011282 treatment Methods 0.000 title claims abstract description 106
- 230000003750 conditioning effect Effects 0.000 title description 7
- -1 amine salt Chemical class 0.000 claims abstract description 86
- 239000003531 protein hydrolysate Substances 0.000 claims abstract description 31
- 108010009736 Protein Hydrolysates Proteins 0.000 claims abstract description 20
- 108010076876 Keratins Proteins 0.000 claims abstract description 11
- 102000011782 Keratins Human genes 0.000 claims abstract description 11
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims description 130
- 239000003795 chemical substances by application Substances 0.000 claims description 42
- 150000001413 amino acids Chemical group 0.000 claims description 27
- 108010038807 Oligopeptides Proteins 0.000 claims description 26
- 102000015636 Oligopeptides Human genes 0.000 claims description 26
- 125000002091 cationic group Chemical group 0.000 claims description 21
- 229920000642 polymer Polymers 0.000 claims description 19
- UZVUJVFQFNHRSY-OUTKXMMCSA-J tetrasodium;(2s)-2-[bis(carboxylatomethyl)amino]pentanedioate Chemical class [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC[C@@H](C([O-])=O)N(CC([O-])=O)CC([O-])=O UZVUJVFQFNHRSY-OUTKXMMCSA-J 0.000 claims description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims description 12
- 239000001913 cellulose Substances 0.000 claims description 12
- 229920002678 cellulose Polymers 0.000 claims description 12
- 239000008139 complexing agent Substances 0.000 claims description 11
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 10
- 125000003277 amino group Chemical group 0.000 claims description 9
- GYBINGQBXROMRS-UHFFFAOYSA-J tetrasodium;2-(1,2-dicarboxylatoethylamino)butanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC(C([O-])=O)NC(C([O-])=O)CC([O-])=O GYBINGQBXROMRS-UHFFFAOYSA-J 0.000 claims description 9
- 235000021307 Triticum Nutrition 0.000 claims description 8
- 150000001299 aldehydes Chemical class 0.000 claims description 8
- 239000002280 amphoteric surfactant Substances 0.000 claims description 8
- BSABBBMNWQWLLU-UHFFFAOYSA-N lactaldehyde Chemical compound CC(O)C=O BSABBBMNWQWLLU-UHFFFAOYSA-N 0.000 claims description 8
- LQPLDXQVILYOOL-UHFFFAOYSA-I pentasodium;2-[bis[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC(=O)[O-])CCN(CC([O-])=O)CC([O-])=O LQPLDXQVILYOOL-UHFFFAOYSA-I 0.000 claims description 8
- QPCDCPDFJACHGM-UHFFFAOYSA-K pentetate(3-) Chemical compound OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O QPCDCPDFJACHGM-UHFFFAOYSA-K 0.000 claims description 8
- 229920006395 saturated elastomer Polymers 0.000 claims description 8
- 229940080258 tetrasodium iminodisuccinate Drugs 0.000 claims description 8
- QKUACYKHLMFAGS-UHFFFAOYSA-N 2-hydroxyoctanal Chemical compound CCCCCCC(O)C=O QKUACYKHLMFAGS-UHFFFAOYSA-N 0.000 claims description 7
- 239000003093 cationic surfactant Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 102000008186 Collagen Human genes 0.000 claims description 6
- 108010035532 Collagen Proteins 0.000 claims description 6
- 244000303965 Cyamopsis psoralioides Species 0.000 claims description 6
- 229920001436 collagen Polymers 0.000 claims description 6
- SURMYNZXHKLDFO-UHFFFAOYSA-N 2-bromopropanedial Chemical compound O=CC(Br)C=O SURMYNZXHKLDFO-UHFFFAOYSA-N 0.000 claims description 5
- BRZMRZVKWQWYPJ-UHFFFAOYSA-N 2-hydroxy caproaldehyde Chemical compound CCCCC(O)C=O BRZMRZVKWQWYPJ-UHFFFAOYSA-N 0.000 claims description 5
- 244000144725 Amygdalus communis Species 0.000 claims description 5
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 claims description 5
- 235000020224 almond Nutrition 0.000 claims description 5
- 229920006317 cationic polymer Polymers 0.000 claims description 5
- 150000001768 cations Chemical class 0.000 claims description 5
- 125000004122 cyclic group Chemical group 0.000 claims description 5
- DSGGHBUAHUMMHN-UHFFFAOYSA-N 2-(2-hydroxyethoxy)acetaldehyde Chemical compound OCCOCC=O DSGGHBUAHUMMHN-UHFFFAOYSA-N 0.000 claims description 4
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 claims description 4
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 244000068988 Glycine max Species 0.000 claims description 4
- 244000179886 Moringa oleifera Species 0.000 claims description 4
- 235000011347 Moringa oleifera Nutrition 0.000 claims description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 4
- 244000061456 Solanum tuberosum Species 0.000 claims description 4
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 claims description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 3
- 102000016942 Elastin Human genes 0.000 claims description 3
- 108010014258 Elastin Proteins 0.000 claims description 3
- 102000014171 Milk Proteins Human genes 0.000 claims description 3
- 108010011756 Milk Proteins Proteins 0.000 claims description 3
- 235000010582 Pisum sativum Nutrition 0.000 claims description 3
- 240000004713 Pisum sativum Species 0.000 claims description 3
- 229920002549 elastin Polymers 0.000 claims description 3
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 claims description 3
- 125000003010 ionic group Chemical group 0.000 claims description 3
- 235000021239 milk protein Nutrition 0.000 claims description 3
- VKZRWSNIWNFCIQ-WDSKDSINSA-N (2s)-2-[2-[[(1s)-1,2-dicarboxyethyl]amino]ethylamino]butanedioic acid Chemical compound OC(=O)C[C@@H](C(O)=O)NCCN[C@H](C(O)=O)CC(O)=O VKZRWSNIWNFCIQ-WDSKDSINSA-N 0.000 claims description 2
- KRVUEZAOJJVWLW-UHFFFAOYSA-N C(CCC(=O)O)(=O)O.C(CCC(=O)O)(=O)O.C(CN)N.[Na].[Na].[Na].[Na] Chemical compound C(CCC(=O)O)(=O)O.C(CCC(=O)O)(=O)O.C(CN)N.[Na].[Na].[Na].[Na] KRVUEZAOJJVWLW-UHFFFAOYSA-N 0.000 claims description 2
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 claims description 2
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 claims description 2
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 claims description 2
- 229910052727 yttrium Inorganic materials 0.000 claims description 2
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 239000000047 product Substances 0.000 abstract description 20
- 230000002787 reinforcement Effects 0.000 abstract description 2
- 229920001296 polysiloxane Polymers 0.000 description 40
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 23
- 239000003921 oil Substances 0.000 description 23
- 235000019198 oils Nutrition 0.000 description 23
- 229940049920 malate Drugs 0.000 description 22
- 229940024606 amino acid Drugs 0.000 description 17
- 235000001014 amino acid Nutrition 0.000 description 17
- 150000003839 salts Chemical class 0.000 description 16
- 239000000284 extract Substances 0.000 description 14
- 239000004094 surface-active agent Substances 0.000 description 14
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 13
- 239000002253 acid Substances 0.000 description 13
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 239000002453 shampoo Substances 0.000 description 11
- 235000015112 vegetable and seed oil Nutrition 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000004480 active ingredient Substances 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 125000000217 alkyl group Chemical group 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 241000209140 Triticum Species 0.000 description 7
- 150000007513 acids Chemical class 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- PQHYOGIRXOKOEJ-UHFFFAOYSA-N 2-(1,2-dicarboxyethylamino)butanedioic acid Chemical compound OC(=O)CC(C(O)=O)NC(C(O)=O)CC(O)=O PQHYOGIRXOKOEJ-UHFFFAOYSA-N 0.000 description 6
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 6
- 229910003849 O-Si Inorganic materials 0.000 description 6
- 229910003872 O—Si Inorganic materials 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 6
- 229960005069 calcium Drugs 0.000 description 6
- 235000001465 calcium Nutrition 0.000 description 6
- 150000001805 chlorine compounds Chemical class 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 229940044170 formate Drugs 0.000 description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 6
- 229940080260 iminodisuccinate Drugs 0.000 description 6
- 229910052749 magnesium Inorganic materials 0.000 description 6
- 239000011777 magnesium Substances 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 229940095064 tartrate Drugs 0.000 description 6
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical compound OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 239000010478 argan oil Substances 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 238000004043 dyeing Methods 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 229940119170 jojoba wax Drugs 0.000 description 5
- 229940091250 magnesium supplement Drugs 0.000 description 5
- 239000004006 olive oil Substances 0.000 description 5
- 235000008390 olive oil Nutrition 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000001944 prunus armeniaca kernel oil Substances 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 229940061605 tetrasodium glutamate diacetate Drugs 0.000 description 5
- 239000008158 vegetable oil Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- 235000019489 Almond oil Nutrition 0.000 description 4
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 4
- 240000001592 Amaranthus caudatus Species 0.000 description 4
- 244000144730 Amygdalus persica Species 0.000 description 4
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- 235000013162 Cocos nucifera Nutrition 0.000 description 4
- 244000060011 Cocos nucifera Species 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- BUZMZDDKFCSKOT-CIUDSAMLSA-N Glu-Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O BUZMZDDKFCSKOT-CIUDSAMLSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- 235000006040 Prunus persica var persica Nutrition 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 4
- 241001135917 Vitellaria paradoxa Species 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 239000008168 almond oil Substances 0.000 description 4
- 239000004178 amaranth Substances 0.000 description 4
- 235000012735 amaranth Nutrition 0.000 description 4
- 239000003945 anionic surfactant Substances 0.000 description 4
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 4
- 235000019868 cocoa butter Nutrition 0.000 description 4
- 229940110456 cocoa butter Drugs 0.000 description 4
- 230000003766 combability Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 229940001447 lactate Drugs 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 229940057910 shea butter Drugs 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- 235000004936 Bromus mango Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 235000014826 Mangifera indica Nutrition 0.000 description 3
- 240000007228 Mangifera indica Species 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- NQRYJNQNLNOLGT-UHFFFAOYSA-O Piperidinium(1+) Chemical compound C1CC[NH2+]CC1 NQRYJNQNLNOLGT-UHFFFAOYSA-O 0.000 description 3
- 229910008329 Si-V Inorganic materials 0.000 description 3
- 229910006768 Si—V Inorganic materials 0.000 description 3
- 235000009184 Spondias indica Nutrition 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 235000009108 Urtica dioica Nutrition 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 235000014121 butter Nutrition 0.000 description 3
- 150000007942 carboxylates Chemical group 0.000 description 3
- 150000001735 carboxylic acids Chemical class 0.000 description 3
- 229940106189 ceramide Drugs 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 3
- 239000000118 hair dye Substances 0.000 description 3
- 230000003806 hair structure Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229960000310 isoleucine Drugs 0.000 description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- XYTOINHYAJCBFG-UHFFFAOYSA-N octanoate;trimethylazanium Chemical compound C[NH+](C)C.CCCCCCCC([O-])=O XYTOINHYAJCBFG-UHFFFAOYSA-N 0.000 description 3
- 229940101267 panthenol Drugs 0.000 description 3
- 235000020957 pantothenol Nutrition 0.000 description 3
- 239000011619 pantothenol Substances 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 3
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 3
- 239000012178 vegetable wax Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000002888 zwitterionic surfactant Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- GGFDFNHQSGONII-UHFFFAOYSA-M (3-docosanoyloxy-2-hydroxypropyl)-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)C[N+](C)(C)C GGFDFNHQSGONII-UHFFFAOYSA-M 0.000 description 2
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 2
- OWEGWHBOCFMBLP-UHFFFAOYSA-N 1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one Chemical compound C1=CN=CN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 OWEGWHBOCFMBLP-UHFFFAOYSA-N 0.000 description 2
- XFRVVPUIAFSTFO-UHFFFAOYSA-N 1-Tridecanol Chemical compound CCCCCCCCCCCCCO XFRVVPUIAFSTFO-UHFFFAOYSA-N 0.000 description 2
- AZLWQVJVINEILY-UHFFFAOYSA-N 2-(2-dodecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCOCCOCCO AZLWQVJVINEILY-UHFFFAOYSA-N 0.000 description 2
- OYINQIKIQCNQOX-UHFFFAOYSA-M 2-hydroxybutyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCC(O)C[N+](C)(C)C OYINQIKIQCNQOX-UHFFFAOYSA-M 0.000 description 2
- GUQMDNQYMMRJPY-UHFFFAOYSA-N 4,4-dimethyl-1,3-oxazolidine Chemical compound CC1(C)COCN1 GUQMDNQYMMRJPY-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 description 2
- 244000144927 Aloe barbadensis Species 0.000 description 2
- 239000001715 Ammonium malate Substances 0.000 description 2
- 240000005528 Arctium lappa Species 0.000 description 2
- 235000003130 Arctium lappa Nutrition 0.000 description 2
- 235000008078 Arctium minus Nutrition 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- 241000222666 Boerhavia diffusa Species 0.000 description 2
- UFOJJMNTDMGSIL-UHFFFAOYSA-N CCCCCC(O)=O.CCO.N Chemical compound CCCCCC(O)=O.CCO.N UFOJJMNTDMGSIL-UHFFFAOYSA-N 0.000 description 2
- 240000003538 Chamaemelum nobile Species 0.000 description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 240000004530 Echinacea purpurea Species 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 2
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 2
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 241000208680 Hamamelis mollis Species 0.000 description 2
- 235000019487 Hazelnut oil Nutrition 0.000 description 2
- 241001456088 Hesperocnide Species 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 241001072282 Limnanthes Species 0.000 description 2
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 2
- 240000000912 Macadamia tetraphylla Species 0.000 description 2
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 240000000982 Malva neglecta Species 0.000 description 2
- 235000000060 Malva neglecta Nutrition 0.000 description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 244000183331 Nephelium lappaceum Species 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 235000002725 Olea europaea Nutrition 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 244000082204 Phyllostachys viridis Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 235000019774 Rice Bran oil Nutrition 0.000 description 2
- 235000019485 Safflower oil Nutrition 0.000 description 2
- 240000003935 Sclerocarya birrea Species 0.000 description 2
- 235000001836 Sclerocarya caffra Nutrition 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 240000007313 Tilia cordata Species 0.000 description 2
- 206010044625 Trichorrhexis Diseases 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 235000019498 Walnut oil Nutrition 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 2
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 2
- 235000019292 ammonium malate Nutrition 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 239000008163 avocado oil Substances 0.000 description 2
- 235000021302 avocado oil Nutrition 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 229940070718 behentrimonium Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 235000019445 benzyl alcohol Nutrition 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000000828 canola oil Substances 0.000 description 2
- 235000019519 canola oil Nutrition 0.000 description 2
- 150000001783 ceramides Chemical class 0.000 description 2
- 229940081733 cetearyl alcohol Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 229960003344 climbazole Drugs 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 239000003581 cosmetic carrier Substances 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 150000001991 dicarboxylic acids Chemical class 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 235000014134 echinacea Nutrition 0.000 description 2
- 235000008524 evening primrose extract Nutrition 0.000 description 2
- 239000010475 evening primrose oil Substances 0.000 description 2
- 229940089020 evening primrose oil Drugs 0.000 description 2
- 238000005562 fading Methods 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 229940100608 glycol distearate Drugs 0.000 description 2
- 239000008169 grapeseed oil Substances 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 230000037308 hair color Effects 0.000 description 2
- 239000010468 hazelnut oil Substances 0.000 description 2
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- QNVRIHYSUZMSGM-UHFFFAOYSA-N hexan-2-ol Chemical compound CCCCC(C)O QNVRIHYSUZMSGM-UHFFFAOYSA-N 0.000 description 2
- 239000002563 ionic surfactant Substances 0.000 description 2
- 229940100491 laureth-2 Drugs 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 2
- 239000011654 magnesium acetate Substances 0.000 description 2
- 229940069446 magnesium acetate Drugs 0.000 description 2
- 235000011285 magnesium acetate Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- WYAXWRDZCAVSMG-UHFFFAOYSA-N nonanoate propylazanium Chemical compound CCC[NH3+].CCCCCCCCC([O-])=O WYAXWRDZCAVSMG-UHFFFAOYSA-N 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- VSUZBPXFSJFOIB-UHFFFAOYSA-N oxalate;tripropylazanium Chemical compound [O-]C(=O)C([O-])=O.CCC[NH+](CCC)CCC.CCC[NH+](CCC)CCC VSUZBPXFSJFOIB-UHFFFAOYSA-N 0.000 description 2
- 239000003346 palm kernel oil Substances 0.000 description 2
- 235000019865 palm kernel oil Nutrition 0.000 description 2
- 229940086539 peg-7 glyceryl cocoate Drugs 0.000 description 2
- JYVLIDXNZAXMDK-UHFFFAOYSA-N pentan-2-ol Chemical compound CCCC(C)O JYVLIDXNZAXMDK-UHFFFAOYSA-N 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 2
- 229940081510 piroctone olamine Drugs 0.000 description 2
- 229920002553 poly(2-methacrylolyloxyethyltrimethylammonium chloride) polymer Polymers 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- 239000008171 pumpkin seed oil Substances 0.000 description 2
- 235000007861 rambutan Nutrition 0.000 description 2
- 239000008165 rice bran oil Substances 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 229920005573 silicon-containing polymer Polymers 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 229940057950 sodium laureth sulfate Drugs 0.000 description 2
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 239000010677 tea tree oil Substances 0.000 description 2
- 229940111630 tea tree oil Drugs 0.000 description 2
- 239000010496 thistle oil Substances 0.000 description 2
- 235000015961 tonic Nutrition 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- ZMANZCXQSJIPKH-UHFFFAOYSA-O triethylammonium ion Chemical compound CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 description 2
- RKBCYCFRFCNLTO-UHFFFAOYSA-N triisopropylamine Chemical compound CC(C)N(C(C)C)C(C)C RKBCYCFRFCNLTO-UHFFFAOYSA-N 0.000 description 2
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 239000008170 walnut oil Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000010497 wheat germ oil Substances 0.000 description 2
- 229940118846 witch hazel Drugs 0.000 description 2
- 229940043810 zinc pyrithione Drugs 0.000 description 2
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- MEJYDZQQVZJMPP-ULAWRXDQSA-N (3s,3ar,6r,6ar)-3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound CO[C@H]1CO[C@@H]2[C@H](OC)CO[C@@H]21 MEJYDZQQVZJMPP-ULAWRXDQSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical group C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- 229940083957 1,2-butanediol Drugs 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 1
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical class OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- GGEMQIQNOIHENV-UHFFFAOYSA-N 2,3-dihydroxybutanedioate 4,4-dimethyl-1,3-oxazolidin-3-ium Chemical compound CC1(C)COC[NH2+]1.CC1(C)COC[NH2+]1.OC(C(O)C([O-])=O)C([O-])=O GGEMQIQNOIHENV-UHFFFAOYSA-N 0.000 description 1
- MYGNPJQOMHTCEG-UHFFFAOYSA-N 2,3-dihydroxybutanedioate di(propan-2-yl)azanium Chemical compound CC(C)[NH2+]C(C)C.CC(C)[NH2+]C(C)C.OC(C(O)C([O-])=O)C([O-])=O MYGNPJQOMHTCEG-UHFFFAOYSA-N 0.000 description 1
- ODGQNMFDAUCRNM-UHFFFAOYSA-N 2,3-dihydroxybutanedioate diphenylazanium Chemical compound OC(C(O)C([O-])=O)C([O-])=O.[NH2+](c1ccccc1)c1ccccc1.[NH2+](c1ccccc1)c1ccccc1 ODGQNMFDAUCRNM-UHFFFAOYSA-N 0.000 description 1
- FPMAYJXPEORXLC-UHFFFAOYSA-N 2,3-dihydroxybutanedioate dipropylazanium Chemical compound CCC[NH2+]CCC.CCC[NH2+]CCC.OC(C(O)C([O-])=O)C([O-])=O FPMAYJXPEORXLC-UHFFFAOYSA-N 0.000 description 1
- ULEFVEYOYMUIPX-UHFFFAOYSA-N 2,3-dihydroxybutanedioate phenylazanium Chemical compound NC1=CC=CC=C1.C(=O)(O)C(O)C(O)C(=O)O.NC1=CC=CC=C1 ULEFVEYOYMUIPX-UHFFFAOYSA-N 0.000 description 1
- MOUOCMSNPLHGRA-UHFFFAOYSA-N 2,3-dihydroxybutanedioate propan-2-ylazanium Chemical compound CC(C)[NH3+].CC(C)[NH3+].OC(C(O)C([O-])=O)C([O-])=O MOUOCMSNPLHGRA-UHFFFAOYSA-N 0.000 description 1
- GKCTZRVVAQPGMJ-UHFFFAOYSA-N 2,3-dihydroxybutanedioate propylazanium Chemical compound C(=O)([O-])C(O)C(O)C(=O)[O-].C(CC)[NH3+].C(CC)[NH3+] GKCTZRVVAQPGMJ-UHFFFAOYSA-N 0.000 description 1
- VNYRBBLFKIBHED-UHFFFAOYSA-N 2,3-dihydroxybutanedioate tri(propan-2-yl)azanium Chemical compound CC(C)[NH+](C(C)C)C(C)C.CC(C)[NH+](C(C)C)C(C)C.OC(C(O)C([O-])=O)C([O-])=O VNYRBBLFKIBHED-UHFFFAOYSA-N 0.000 description 1
- ZTEPZVKTASMQAJ-UHFFFAOYSA-N 2,3-dihydroxybutanedioate triphenylazanium Chemical compound OC(C(O)C([O-])=O)C([O-])=O.c1ccc(cc1)[NH+](c1ccccc1)c1ccccc1.c1ccc(cc1)[NH+](c1ccccc1)c1ccccc1 ZTEPZVKTASMQAJ-UHFFFAOYSA-N 0.000 description 1
- UYHPFQSFPHWAPY-UHFFFAOYSA-N 2,3-dihydroxybutanedioate;ethylazanium Chemical compound CC[NH3+].CC[NH3+].[O-]C(=O)C(O)C(O)C([O-])=O UYHPFQSFPHWAPY-UHFFFAOYSA-N 0.000 description 1
- MMMIIRUNFBTGKB-UHFFFAOYSA-N 2,3-dihydroxybutanedioate;morpholin-4-ium Chemical compound C1COCCN1.C1COCCN1.OC(=O)C(O)C(O)C(O)=O MMMIIRUNFBTGKB-UHFFFAOYSA-N 0.000 description 1
- XKZLUOXDKKCKSP-UHFFFAOYSA-N 2,3-dihydroxybutanedioate;piperidin-1-ium Chemical compound C1CCNCC1.C1CCNCC1.OC(=O)C(O)C(O)C(O)=O XKZLUOXDKKCKSP-UHFFFAOYSA-N 0.000 description 1
- VTFPRJUXVTZNLZ-UHFFFAOYSA-N 2,3-dihydroxybutanedioate;triethylazanium Chemical compound CC[NH+](CC)CC.CC[NH+](CC)CC.[O-]C(=O)C(O)C(O)C([O-])=O VTFPRJUXVTZNLZ-UHFFFAOYSA-N 0.000 description 1
- HJHCYVXFIMHXIB-UHFFFAOYSA-N 2,3-dihydroxybutanedioate;tripropylazanium Chemical compound CCC[NH+](CCC)CCC.CCC[NH+](CCC)CCC.[O-]C(=O)C(O)C(O)C([O-])=O HJHCYVXFIMHXIB-UHFFFAOYSA-N 0.000 description 1
- DFCRNFJCOHZUKM-UHFFFAOYSA-N 2,3-dihydroxybutanedioic acid;methanamine Chemical compound [NH3+]C.[NH3+]C.[O-]C(=O)C(O)C(O)C([O-])=O DFCRNFJCOHZUKM-UHFFFAOYSA-N 0.000 description 1
- SGMXEWPRYYCNFS-UHFFFAOYSA-N 2,3-dihydroxybutanedioic acid;n,n-dimethylmethanamine Chemical compound CN(C)C.CN(C)C.OC(=O)C(O)C(O)C(O)=O SGMXEWPRYYCNFS-UHFFFAOYSA-N 0.000 description 1
- DWNXZDZAYNCLNK-UHFFFAOYSA-N 2,3-dihydroxybutanedioic acid;n-methylmethanamine Chemical compound C[NH2+]C.C[NH2+]C.[O-]C(=O)C(O)C(O)C([O-])=O DWNXZDZAYNCLNK-UHFFFAOYSA-N 0.000 description 1
- SCOUYYCCBDRYLF-UHFFFAOYSA-N 2-(2-hydroxyethylamino)ethanol;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OCCNCCO.OC(=O)CC(O)(C(O)=O)CC(O)=O SCOUYYCCBDRYLF-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- QNVRIHYSUZMSGM-LURJTMIESA-N 2-Hexanol Natural products CCCC[C@H](C)O QNVRIHYSUZMSGM-LURJTMIESA-N 0.000 description 1
- HBETWZFHOXOAPB-UHFFFAOYSA-N 2-hydroxyacetate methylazanium Chemical compound C(CO)(=O)[O-].C[NH3+] HBETWZFHOXOAPB-UHFFFAOYSA-N 0.000 description 1
- RIUDGYLEEGUDAZ-UHFFFAOYSA-N 2-hydroxyacetate;morpholin-4-ium Chemical compound OCC(O)=O.C1COCCN1 RIUDGYLEEGUDAZ-UHFFFAOYSA-N 0.000 description 1
- WNLDRUOKRQLOOX-UHFFFAOYSA-N 2-hydroxyacetic acid;piperidine Chemical compound OCC(O)=O.C1CCNCC1 WNLDRUOKRQLOOX-UHFFFAOYSA-N 0.000 description 1
- VKIGAWAEXPTIOL-UHFFFAOYSA-N 2-hydroxyhexanenitrile Chemical compound CCCCC(O)C#N VKIGAWAEXPTIOL-UHFFFAOYSA-N 0.000 description 1
- XCUPOZKRJPLPGW-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylate morpholin-4-ium Chemical compound C1COCC[NH2+]1.C1COCC[NH2+]1.C1COCC[NH2+]1.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O XCUPOZKRJPLPGW-UHFFFAOYSA-N 0.000 description 1
- QZACEZLWLWYFKY-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylate phenylazanium Chemical compound NC1=CC=CC=C1.NC1=CC=CC=C1.NC1=CC=CC=C1.OC(=O)CC(O)(C(O)=O)CC(O)=O QZACEZLWLWYFKY-UHFFFAOYSA-N 0.000 description 1
- MXQKLLPTLXAWLY-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylate propan-2-ylazanium Chemical compound C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].C(C)(C)[NH3+].C(C)(C)[NH3+].C(C)(C)[NH3+] MXQKLLPTLXAWLY-UHFFFAOYSA-N 0.000 description 1
- IGYGMKPQDMIYOO-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylate tri(propan-2-yl)azanium Chemical compound C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].C(C)(C)[NH+](C(C)C)C(C)C.C(C)(C)[NH+](C(C)C)C(C)C.C(C)(C)[NH+](C(C)C)C(C)C IGYGMKPQDMIYOO-UHFFFAOYSA-N 0.000 description 1
- NNCMOUXUQISLRG-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylate triphenylazanium Chemical compound C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].C1(=CC=CC=C1)[NH+](C1=CC=CC=C1)C1=CC=CC=C1.C1(=CC=CC=C1)[NH+](C1=CC=CC=C1)C1=CC=CC=C1.C1(=CC=CC=C1)[NH+](C1=CC=CC=C1)C1=CC=CC=C1 NNCMOUXUQISLRG-UHFFFAOYSA-N 0.000 description 1
- GCOIOQSCBOBGCJ-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylate;piperidin-1-ium Chemical compound C1CC[NH2+]CC1.C1CC[NH2+]CC1.C1CC[NH2+]CC1.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O GCOIOQSCBOBGCJ-UHFFFAOYSA-N 0.000 description 1
- ARLXEFZGGCEDPT-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylate;trimethylazanium Chemical compound C[NH+](C)C.C[NH+](C)C.C[NH+](C)C.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O ARLXEFZGGCEDPT-UHFFFAOYSA-N 0.000 description 1
- AQVXBLREZAWABD-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;n-methylmethanamine Chemical compound CNC.CNC.CNC.OC(=O)CC(O)(C(O)=O)CC(O)=O AQVXBLREZAWABD-UHFFFAOYSA-N 0.000 description 1
- WUCUNIUUNXXCAG-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;propan-1-amine Chemical compound CCCN.CCCN.CCCN.OC(=O)CC(O)(C(O)=O)CC(O)=O WUCUNIUUNXXCAG-UHFFFAOYSA-N 0.000 description 1
- XEUJBESOSKIRKW-UHFFFAOYSA-N 2-hydroxypropanoate propan-2-ylazanium Chemical compound C(C(O)C)(=O)O.C(C)(C)N XEUJBESOSKIRKW-UHFFFAOYSA-N 0.000 description 1
- XWWHZZWRFGUJLD-UHFFFAOYSA-N 2-hydroxypropanoate propylazanium Chemical compound CCCN.CC(O)C(O)=O XWWHZZWRFGUJLD-UHFFFAOYSA-N 0.000 description 1
- PDBLEFGYTFKEJY-UHFFFAOYSA-N 2-hydroxypropanoate tri(propan-2-yl)azanium Chemical compound CC(O)C([O-])=O.CC(C)[NH+](C(C)C)C(C)C PDBLEFGYTFKEJY-UHFFFAOYSA-N 0.000 description 1
- ZBFPVSCXPVZZQT-UHFFFAOYSA-N 2-hydroxypropanoate triphenylazanium Chemical compound CC(O)C([O-])=O.c1ccc(cc1)[NH+](c1ccccc1)c1ccccc1 ZBFPVSCXPVZZQT-UHFFFAOYSA-N 0.000 description 1
- CVBHIXYCICBDES-UHFFFAOYSA-N 2-hydroxypropanoate tripropylazanium Chemical compound CC(O)C([O-])=O.CCC[NH+](CCC)CCC CVBHIXYCICBDES-UHFFFAOYSA-N 0.000 description 1
- QGCDCQXHCJKJHS-UHFFFAOYSA-N 2-hydroxypropanoate;morpholin-4-ium Chemical compound CC(O)C([O-])=O.C1COCC[NH2+]1 QGCDCQXHCJKJHS-UHFFFAOYSA-N 0.000 description 1
- RVUKSVFTVSAIGS-UHFFFAOYSA-N 2-hydroxypropanoate;trimethylazanium Chemical compound C[NH+](C)C.CC(O)C([O-])=O RVUKSVFTVSAIGS-UHFFFAOYSA-N 0.000 description 1
- RJQQOKKINHMXIM-UHFFFAOYSA-N 2-hydroxypropanoate;tris(2-hydroxyethyl)azanium Chemical compound CC(O)C(O)=O.OCCN(CCO)CCO RJQQOKKINHMXIM-UHFFFAOYSA-N 0.000 description 1
- CXHQOGGKSNSIEE-UHFFFAOYSA-N 2-hydroxypropanoic acid;methanamine Chemical compound NC.CC(O)C(O)=O CXHQOGGKSNSIEE-UHFFFAOYSA-N 0.000 description 1
- LJINUHNXFYXJSU-UHFFFAOYSA-N 2-hydroxypropanoic acid;n-methylmethanamine Chemical compound C[NH2+]C.CC(O)C([O-])=O LJINUHNXFYXJSU-UHFFFAOYSA-N 0.000 description 1
- LBTNMWYMGJVEPT-UHFFFAOYSA-N 2-hydroxypropanoic acid;n-propan-2-ylpropan-2-amine Chemical compound CC(O)C(O)=O.CC(C)NC(C)C LBTNMWYMGJVEPT-UHFFFAOYSA-N 0.000 description 1
- AEEFFCVOBJCHAK-UHFFFAOYSA-N 2-hydroxypropanoic acid;piperidine Chemical compound CC(O)C(O)=O.C1CCNCC1 AEEFFCVOBJCHAK-UHFFFAOYSA-N 0.000 description 1
- HWKRAUXFMLQKLS-UHFFFAOYSA-N 2-oxidanylidenepropanoic acid Chemical compound CC(=O)C(O)=O.CC(=O)C(O)=O HWKRAUXFMLQKLS-UHFFFAOYSA-N 0.000 description 1
- AGNTUZCMJBTHOG-UHFFFAOYSA-N 3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]propane-1,2-diol Chemical compound OCC(O)COCC(O)COCC(O)CO AGNTUZCMJBTHOG-UHFFFAOYSA-N 0.000 description 1
- AACHVWXCVWWMSI-UHFFFAOYSA-N 3-hydroxypropyl(trimethyl)azanium Chemical compound C[N+](C)(C)CCCO AACHVWXCVWWMSI-UHFFFAOYSA-N 0.000 description 1
- VWXSYFIOKNSOOC-UHFFFAOYSA-N 4,4-dimethyl-1,3-oxazolidine 2-hydroxyacetic acid Chemical compound OCC(O)=O.CC1(C)COCN1 VWXSYFIOKNSOOC-UHFFFAOYSA-N 0.000 description 1
- CKWJXBLKXCXXKT-UHFFFAOYSA-N 4,4-dimethyl-1,3-oxazolidine 2-hydroxypropanoic acid Chemical compound CC(O)C(O)=O.CC1(C)COCN1 CKWJXBLKXCXXKT-UHFFFAOYSA-N 0.000 description 1
- DMXMMKLLLMFUJO-UHFFFAOYSA-N 4,4-dimethyl-1,3-oxazolidine formic acid Chemical compound OC=O.CC1(C)COCN1 DMXMMKLLLMFUJO-UHFFFAOYSA-N 0.000 description 1
- LOWYXEWCIHDGNQ-UHFFFAOYSA-N 4,4-dimethyl-1,3-oxazolidine hexanoic acid Chemical compound CC1(C)COCN1.CCCCCC(O)=O LOWYXEWCIHDGNQ-UHFFFAOYSA-N 0.000 description 1
- IXRVMBFENDDPDD-UHFFFAOYSA-N 4,4-dimethyl-1,3-oxazolidine nonanoic acid Chemical compound CC1(C)COCN1.CCCCCCCCC(O)=O IXRVMBFENDDPDD-UHFFFAOYSA-N 0.000 description 1
- NCAHZQDPIRYQEW-UHFFFAOYSA-N 4,4-dimethyl-1,3-oxazolidine octanoic acid Chemical compound CC1(C)COCN1.CCCCCCCC(O)=O NCAHZQDPIRYQEW-UHFFFAOYSA-N 0.000 description 1
- FOWKBBKDUPBEJR-UHFFFAOYSA-N 4,4-dimethyl-1,3-oxazolidine pentanoic acid Chemical compound CCCCC(O)=O.CC1(C)COCN1 FOWKBBKDUPBEJR-UHFFFAOYSA-N 0.000 description 1
- CAEFRMJUIGUKDT-UHFFFAOYSA-N 4,4-dimethyl-1,3-oxazolidine propanoic acid Chemical compound CCC(O)=O.CC1(C)COCN1 CAEFRMJUIGUKDT-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000208874 Althaea officinalis Species 0.000 description 1
- 235000006576 Althaea officinalis Nutrition 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- BYDTYLXAVAIMEA-UHFFFAOYSA-N C(C(=O)[O-])(=O)[O-].C(C)(C)[NH+](C(C)C)C(C)C.C(C(=O)O)(=O)[O-].C(C)(C)[NH2+]C(C)C.C(C(=O)O)(=O)O.C(C)(C)[NH3+] Chemical compound C(C(=O)[O-])(=O)[O-].C(C)(C)[NH+](C(C)C)C(C)C.C(C(=O)O)(=O)[O-].C(C)(C)[NH2+]C(C)C.C(C(=O)O)(=O)O.C(C)(C)[NH3+] BYDTYLXAVAIMEA-UHFFFAOYSA-N 0.000 description 1
- GYLBBSMXSOUDNY-UHFFFAOYSA-N C(C(=O)[O-])(=O)[O-].C1(=CC=CC=C1)[NH2+]C1=CC=CC=C1.C(C(=O)O)(=O)O.C1(=CC=CC=C1)[NH3+] Chemical compound C(C(=O)[O-])(=O)[O-].C1(=CC=CC=C1)[NH2+]C1=CC=CC=C1.C(C(=O)O)(=O)O.C1(=CC=CC=C1)[NH3+] GYLBBSMXSOUDNY-UHFFFAOYSA-N 0.000 description 1
- IZLITWVJCHDTNH-UHFFFAOYSA-L C(C(=O)[O-])(=O)[O-].C[N+]1(COCC1)C.C[N+]1(COCC1)C Chemical compound C(C(=O)[O-])(=O)[O-].C[N+]1(COCC1)C.C[N+]1(COCC1)C IZLITWVJCHDTNH-UHFFFAOYSA-L 0.000 description 1
- AJHVISIGTGGHBJ-UHFFFAOYSA-N C(C(=O)[O-])(=O)[O-].[NH4+].C(C)O.C(C)O.C(C(=O)[O-])(=O)[O-].[NH4+].[NH4+].[NH4+] Chemical compound C(C(=O)[O-])(=O)[O-].[NH4+].C(C)O.C(C)O.C(C(=O)[O-])(=O)[O-].[NH4+].[NH4+].[NH4+] AJHVISIGTGGHBJ-UHFFFAOYSA-N 0.000 description 1
- GQDOSDRYLASFSP-UHFFFAOYSA-N C(C(=O)[O-])(=O)[O-].[NH4+].C(C)O.C(C)O.C(C)O.[NH4+] Chemical compound C(C(=O)[O-])(=O)[O-].[NH4+].C(C)O.C(C)O.C(C)O.[NH4+] GQDOSDRYLASFSP-UHFFFAOYSA-N 0.000 description 1
- IBBLTGFPYBMFDQ-UHFFFAOYSA-N C(C(=O)[O-])(=O)[O-].[NH4+].C=CC.[NH4+] Chemical compound C(C(=O)[O-])(=O)[O-].[NH4+].C=CC.[NH4+] IBBLTGFPYBMFDQ-UHFFFAOYSA-N 0.000 description 1
- KLZRGLLIKJHYJJ-UHFFFAOYSA-N C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].CC1([NH2+]COC1)C.CC1([NH2+]COC1)C.CC1([NH2+]COC1)C Chemical compound C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].CC1([NH2+]COC1)C.CC1([NH2+]COC1)C.CC1([NH2+]COC1)C KLZRGLLIKJHYJJ-UHFFFAOYSA-N 0.000 description 1
- UFEPXHZGTCZDDX-UHFFFAOYSA-N C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].[NH4+].C=C.[NH4+].[NH4+] Chemical compound C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].[NH4+].C=C.[NH4+].[NH4+] UFEPXHZGTCZDDX-UHFFFAOYSA-N 0.000 description 1
- ZMANCYVCKFHQQG-UHFFFAOYSA-N C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].[NH4+].C=CC.[NH4+].[NH4+] Chemical compound C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].[NH4+].C=CC.[NH4+].[NH4+] ZMANCYVCKFHQQG-UHFFFAOYSA-N 0.000 description 1
- PGRSOGUCRCOLGS-UHFFFAOYSA-M C(CCCCCC)(=O)[O-].C[N+]1(COCC1)C Chemical compound C(CCCCCC)(=O)[O-].C[N+]1(COCC1)C PGRSOGUCRCOLGS-UHFFFAOYSA-M 0.000 description 1
- LEWUDOHRZPWAJL-UHFFFAOYSA-N C(CCCCCCC)(=O)[O-].[NH4+].C(C)O Chemical compound C(CCCCCCC)(=O)[O-].[NH4+].C(C)O LEWUDOHRZPWAJL-UHFFFAOYSA-N 0.000 description 1
- BOPZLMVEORKMGN-UHFFFAOYSA-N C(CCCCCCC)(=O)[O-].[NH4+].C(C)O.C(C)O Chemical compound C(CCCCCCC)(=O)[O-].[NH4+].C(C)O.C(C)O BOPZLMVEORKMGN-UHFFFAOYSA-N 0.000 description 1
- WTOKTWPCUNGSTG-UHFFFAOYSA-N C(CCCCCCC)(=O)[O-].[NH4+].C(C)O.C(C)O.C(C)O Chemical compound C(CCCCCCC)(=O)[O-].[NH4+].C(C)O.C(C)O.C(C)O WTOKTWPCUNGSTG-UHFFFAOYSA-N 0.000 description 1
- LDXPXKKABZZWMD-UHFFFAOYSA-N CCC[NH+](CCC)CCC.CCC[NH+](CCC)CCC.CCC[NH+](CCC)CCC.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O Chemical compound CCC[NH+](CCC)CCC.CCC[NH+](CCC)CCC.CCC[NH+](CCC)CCC.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O LDXPXKKABZZWMD-UHFFFAOYSA-N 0.000 description 1
- IZCHGGKNCDBPFZ-UHFFFAOYSA-N CC[NH2+]CC.CC[NH2+]CC.CC[NH2+]CC.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O Chemical compound CC[NH2+]CC.CC[NH2+]CC.CC[NH2+]CC.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O IZCHGGKNCDBPFZ-UHFFFAOYSA-N 0.000 description 1
- AJPDWYQHCWWYMM-UHFFFAOYSA-N CC[NH3+].CC[NH3+].CC[NH3+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O Chemical compound CC[NH3+].CC[NH3+].CC[NH3+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O AJPDWYQHCWWYMM-UHFFFAOYSA-N 0.000 description 1
- VEHUINAFRHVAKP-UHFFFAOYSA-N C[NH3+].C[NH3+].C[NH3+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O Chemical compound C[NH3+].C[NH3+].C[NH3+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O VEHUINAFRHVAKP-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 125000003535 D-glucopyranosyl group Chemical group [H]OC([H])([H])[C@@]1([H])OC([H])(*)[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H] 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 241000212314 Foeniculum Species 0.000 description 1
- 241000295146 Gallionellaceae Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 244000025221 Humulus lupulus Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 229930195714 L-glutamate Natural products 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 244000108452 Litchi chinensis Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-O Methylammonium ion Chemical compound [NH3+]C BAVYZALUXZFZLV-UHFFFAOYSA-O 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-TURZORIXSA-N N-hexadecanoylsphingosine Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)\C=C\CCCCCCCCCCCCC YDNKGFDKKRUKPY-TURZORIXSA-N 0.000 description 1
- 229930182559 Natural dye Natural products 0.000 description 1
- 235000015742 Nephelium litchi Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000282372 Panthera onca Species 0.000 description 1
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 244000305267 Quercus macrolepis Species 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical group OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 240000006001 Thymus serpyllum Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
- 240000000377 Tussilago farfara Species 0.000 description 1
- 235000004869 Tussilago farfara Nutrition 0.000 description 1
- 239000004904 UV filter Substances 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 229920001938 Vegetable gum Polymers 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- VOUVMKALUSNQDI-UHFFFAOYSA-N acetic acid 4,4-dimethyl-1,3-oxazolidine Chemical compound CC(O)=O.CC1(C)COCN1 VOUVMKALUSNQDI-UHFFFAOYSA-N 0.000 description 1
- DDQAGDLHARKUFX-UHFFFAOYSA-N acetic acid;methanamine Chemical compound [NH3+]C.CC([O-])=O DDQAGDLHARKUFX-UHFFFAOYSA-N 0.000 description 1
- MIJRUQYZDSEMBD-UHFFFAOYSA-N acetic acid;morpholine Chemical compound CC(O)=O.C1COCCN1 MIJRUQYZDSEMBD-UHFFFAOYSA-N 0.000 description 1
- FFPBZKBPQXTOSC-UHFFFAOYSA-N acetic acid;n-phenylaniline Chemical compound CC(O)=O.C=1C=CC=CC=1NC1=CC=CC=C1 FFPBZKBPQXTOSC-UHFFFAOYSA-N 0.000 description 1
- VNNMQWJKFKKJLV-UHFFFAOYSA-N acetic acid;n-propan-2-ylpropan-2-amine Chemical compound CC(O)=O.CC(C)NC(C)C VNNMQWJKFKKJLV-UHFFFAOYSA-N 0.000 description 1
- LKDMDHMCNGRIAS-UHFFFAOYSA-N acetic acid;n-propylpropan-1-amine Chemical compound CC([O-])=O.CCC[NH2+]CCC LKDMDHMCNGRIAS-UHFFFAOYSA-N 0.000 description 1
- SVBXPEXMMWJPIE-UHFFFAOYSA-N acetic acid;propan-1-amine Chemical compound CCC[NH3+].CC([O-])=O SVBXPEXMMWJPIE-UHFFFAOYSA-N 0.000 description 1
- UEYFKZOEGBKMKP-UHFFFAOYSA-N acetic acid;propan-2-amine Chemical compound CC(C)[NH3+].CC([O-])=O UEYFKZOEGBKMKP-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000005041 acyloxyalkyl group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229920013820 alkyl cellulose Polymers 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- LYAMWDLJZCJQEZ-UHFFFAOYSA-N aniline;2-hydroxypropanoic acid Chemical compound CC(O)C(O)=O.NC1=CC=CC=C1 LYAMWDLJZCJQEZ-UHFFFAOYSA-N 0.000 description 1
- DQTRUCSKJZOPCX-UHFFFAOYSA-N aniline;formic acid Chemical compound [O-]C=O.[NH3+]C1=CC=CC=C1 DQTRUCSKJZOPCX-UHFFFAOYSA-N 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 150000001449 anionic compounds Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- GMSWRMUHJLKEIL-UHFFFAOYSA-N azane;ethene Chemical compound N.C=C GMSWRMUHJLKEIL-UHFFFAOYSA-N 0.000 description 1
- WQHNYCWYERJTLK-UHFFFAOYSA-N azane;ethene;oxalic acid Chemical compound N.N.C=C.OC(=O)C(O)=O WQHNYCWYERJTLK-UHFFFAOYSA-N 0.000 description 1
- GLAKNHGQBRSLIO-UHFFFAOYSA-N azane;prop-1-ene Chemical compound N.CC=C GLAKNHGQBRSLIO-UHFFFAOYSA-N 0.000 description 1
- DCGSEAHKKUGAOD-UHFFFAOYSA-N azanium 2-hydroxypropanoate prop-1-ene Chemical compound [NH4+].CC=C.CC(O)C([O-])=O DCGSEAHKKUGAOD-UHFFFAOYSA-N 0.000 description 1
- QEFQBSQRPXCRPA-UHFFFAOYSA-N azanium ethene 2-hydroxypropanoate Chemical compound [NH4+].C=C.CC(O)C([O-])=O QEFQBSQRPXCRPA-UHFFFAOYSA-N 0.000 description 1
- WHKYYWGDYWMJHW-UHFFFAOYSA-N azanium ethene acetate Chemical compound C(C)(=O)[O-].[NH4+].C=C WHKYYWGDYWMJHW-UHFFFAOYSA-N 0.000 description 1
- KENJNYQTJNLMQK-UHFFFAOYSA-N azanium ethene nonanoate Chemical compound [NH4+].C=C.CCCCCCCCC([O-])=O KENJNYQTJNLMQK-UHFFFAOYSA-N 0.000 description 1
- XDLJWPUGXLRHDD-UHFFFAOYSA-N azanium ethene octanoate Chemical compound [NH4+].C=C.CCCCCCCC([O-])=O XDLJWPUGXLRHDD-UHFFFAOYSA-N 0.000 description 1
- MBHUOVZIQUATBY-UHFFFAOYSA-N azanium ethene pentanoate Chemical compound [NH4+].C=C.CCCCC([O-])=O MBHUOVZIQUATBY-UHFFFAOYSA-N 0.000 description 1
- FXFLXDJYNLKQBD-UHFFFAOYSA-N azanium ethene undecanoate Chemical compound [NH4+].C=C.CCCCCCCCCCC([O-])=O FXFLXDJYNLKQBD-UHFFFAOYSA-N 0.000 description 1
- DSWJKQDLJYVMNB-UHFFFAOYSA-N azanium nonanoate prop-1-ene Chemical compound [NH4+].CC=C.CCCCCCCCC([O-])=O DSWJKQDLJYVMNB-UHFFFAOYSA-N 0.000 description 1
- GNJVGSKGNUFFBC-UHFFFAOYSA-N azanium octanoate prop-1-ene Chemical compound [NH4+].CC=C.CCCCCCCC([O-])=O GNJVGSKGNUFFBC-UHFFFAOYSA-N 0.000 description 1
- MSYUTVHTOHYUCW-UHFFFAOYSA-N azanium pentanoate prop-1-ene Chemical compound [NH4+].CC=C.CCCCC([O-])=O MSYUTVHTOHYUCW-UHFFFAOYSA-N 0.000 description 1
- WGDQXFFHXUEDOM-UHFFFAOYSA-N azanium prop-1-ene acetate Chemical compound C=CC.C(C)(=O)[O-].[NH4+] WGDQXFFHXUEDOM-UHFFFAOYSA-N 0.000 description 1
- HFRLEDHSIHPXAZ-UHFFFAOYSA-N azanium prop-1-ene undecanoate Chemical compound [NH4+].CC=C.CCCCCCCCCCC([O-])=O HFRLEDHSIHPXAZ-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- JBIROUFYLSSYDX-UHFFFAOYSA-M benzododecinium chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 JBIROUFYLSSYDX-UHFFFAOYSA-M 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- HRDKTPJEDYOOPH-UHFFFAOYSA-N benzoic acid;n-ethylethanamine Chemical compound CC[NH2+]CC.[O-]C(=O)C1=CC=CC=C1 HRDKTPJEDYOOPH-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- HOWJQLVNDUGZBI-UHFFFAOYSA-N butane;propane Chemical compound CCC.CCCC HOWJQLVNDUGZBI-UHFFFAOYSA-N 0.000 description 1
- OUVNAZAUHZDDSD-UHFFFAOYSA-N butanoic acid;methanamine Chemical compound [NH3+]C.CCCC([O-])=O OUVNAZAUHZDDSD-UHFFFAOYSA-N 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229960004256 calcium citrate Drugs 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- HXJOEVTXZQOPIT-UHFFFAOYSA-N decanoate;methylazanium Chemical compound [NH3+]C.CCCCCCCCCC([O-])=O HXJOEVTXZQOPIT-UHFFFAOYSA-N 0.000 description 1
- MPVJKNUBHTTYFY-UHFFFAOYSA-N decanoate;piperidin-1-ium Chemical compound C1CC[NH2+]CC1.CCCCCCCCCC([O-])=O MPVJKNUBHTTYFY-UHFFFAOYSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- BEDANMKNAHCTEL-UHFFFAOYSA-N decanoic acid 4,4-dimethyl-1,3-oxazolidine Chemical compound CC1(C)COCN1.CCCCCCCCCC(O)=O BEDANMKNAHCTEL-UHFFFAOYSA-N 0.000 description 1
- NBSJLWVJXSBMPD-UHFFFAOYSA-N decanoic acid;morpholine Chemical compound C1COCCN1.CCCCCCCCCC(O)=O NBSJLWVJXSBMPD-UHFFFAOYSA-N 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- YTICXJFCZMOCRH-UHFFFAOYSA-N di(propan-2-yl)azanium 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].C(C)(C)[NH2+]C(C)C.C(C)(C)[NH2+]C(C)C.C(C)(C)[NH2+]C(C)C YTICXJFCZMOCRH-UHFFFAOYSA-N 0.000 description 1
- QRSGJEXVSNGDOD-UHFFFAOYSA-N di(propan-2-yl)azanium nonanoate Chemical compound CC(C)[NH2+]C(C)C.CCCCCCCCC([O-])=O QRSGJEXVSNGDOD-UHFFFAOYSA-N 0.000 description 1
- KHDRGAMRWABYGJ-UHFFFAOYSA-N di(propan-2-yl)azanium oxalate Chemical compound [O-]C(=O)C([O-])=O.CC(C)[NH2+]C(C)C.CC(C)[NH2+]C(C)C KHDRGAMRWABYGJ-UHFFFAOYSA-N 0.000 description 1
- ZVUAEKQESHINDI-UHFFFAOYSA-N di(propan-2-yl)azanium;octanoate Chemical compound CC(C)[NH2+]C(C)C.CCCCCCCC([O-])=O ZVUAEKQESHINDI-UHFFFAOYSA-N 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-O diethylammonium Chemical compound CC[NH2+]CC HPNMFZURTQLUMO-UHFFFAOYSA-O 0.000 description 1
- MOOPYOBWOPWWJD-UHFFFAOYSA-N diethylazanium undecanoate Chemical compound CC[NH2+]CC.CCCCCCCCCCC([O-])=O MOOPYOBWOPWWJD-UHFFFAOYSA-N 0.000 description 1
- SZFOVHICZJAJSE-UHFFFAOYSA-N diethylazanium;2,3-dihydroxybutanedioate Chemical compound CC[NH2+]CC.CC[NH2+]CC.[O-]C(=O)C(O)C(O)C([O-])=O SZFOVHICZJAJSE-UHFFFAOYSA-N 0.000 description 1
- UEHUZQKLOWYOMO-UHFFFAOYSA-N diethylazanium;acetate Chemical compound CC(O)=O.CCNCC UEHUZQKLOWYOMO-UHFFFAOYSA-N 0.000 description 1
- WQRQUQORGUDTNX-UHFFFAOYSA-N diethylazanium;nonanoate Chemical compound CC[NH2+]CC.CCCCCCCCC([O-])=O WQRQUQORGUDTNX-UHFFFAOYSA-N 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- GQDKFIOHDREMOR-UHFFFAOYSA-N dimethylazanium;2-hydroxyacetate Chemical compound C[NH2+]C.OCC([O-])=O GQDKFIOHDREMOR-UHFFFAOYSA-N 0.000 description 1
- QHNXEVRKFKHMRL-UHFFFAOYSA-N dimethylazanium;acetate Chemical compound CNC.CC(O)=O QHNXEVRKFKHMRL-UHFFFAOYSA-N 0.000 description 1
- MRQFCJJRLCSCFG-UHFFFAOYSA-N dimethylazanium;formate Chemical compound C[NH2+]C.[O-]C=O MRQFCJJRLCSCFG-UHFFFAOYSA-N 0.000 description 1
- NCCHJUUQNUANKR-UHFFFAOYSA-N dimethylazanium;nonanoate Chemical compound C[NH2+]C.CCCCCCCCC([O-])=O NCCHJUUQNUANKR-UHFFFAOYSA-N 0.000 description 1
- DGNLFUNAGWQPMU-UHFFFAOYSA-N dimethylazanium;octanoate Chemical compound C[NH2+]C.CCCCCCCC([O-])=O DGNLFUNAGWQPMU-UHFFFAOYSA-N 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- DNXIQOYYAOPJPP-UHFFFAOYSA-N diphenylazanium 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].C1(=CC=CC=C1)[NH2+]C1=CC=CC=C1.C1(=CC=CC=C1)[NH2+]C1=CC=CC=C1.C1(=CC=CC=C1)[NH2+]C1=CC=CC=C1 DNXIQOYYAOPJPP-UHFFFAOYSA-N 0.000 description 1
- SFNBIVBARBGBNU-UHFFFAOYSA-N diphenylazanium 2-hydroxypropanoate Chemical compound CC(O)C([O-])=O.[NH2+](c1ccccc1)c1ccccc1 SFNBIVBARBGBNU-UHFFFAOYSA-N 0.000 description 1
- FGQMGTMROCMETF-UHFFFAOYSA-N diphenylazanium formate Chemical compound C(=O)O.C1(=CC=CC=C1)NC1=CC=CC=C1 FGQMGTMROCMETF-UHFFFAOYSA-N 0.000 description 1
- RUSUGLLYXSEWHD-UHFFFAOYSA-N diphenylazanium nonanoate Chemical compound CCCCCCCCC([O-])=O.[NH2+](c1ccccc1)c1ccccc1 RUSUGLLYXSEWHD-UHFFFAOYSA-N 0.000 description 1
- KXVYLWWAXUVSAX-UHFFFAOYSA-N diphenylazanium octanoate Chemical compound CCCCCCCC(O)=O.N(c1ccccc1)c1ccccc1 KXVYLWWAXUVSAX-UHFFFAOYSA-N 0.000 description 1
- LNEWRSKRTHQHKZ-UHFFFAOYSA-N dipropylazanium 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].C(CC)[NH2+]CCC.C(CC)[NH2+]CCC.C(CC)[NH2+]CCC LNEWRSKRTHQHKZ-UHFFFAOYSA-N 0.000 description 1
- GJCURCBNXXQXKE-UHFFFAOYSA-N dipropylazanium 2-hydroxypropanoate Chemical compound CC(O)C([O-])=O.CCC[NH2+]CCC GJCURCBNXXQXKE-UHFFFAOYSA-N 0.000 description 1
- YAKBXPMWOBCXPS-UHFFFAOYSA-N dipropylazanium dodecanoate Chemical compound CCC[NH2+]CCC.CCCCCCCCCCCC([O-])=O YAKBXPMWOBCXPS-UHFFFAOYSA-N 0.000 description 1
- QFACQATVJYEFPH-UHFFFAOYSA-N dipropylazanium nonanoate Chemical compound CCC[NH2+]CCC.CCCCCCCCC([O-])=O QFACQATVJYEFPH-UHFFFAOYSA-N 0.000 description 1
- YJKIOLVYLFZJQU-UHFFFAOYSA-N dipropylazanium octanoate Chemical compound CCC[NH2+]CCC.CCCCCCCC([O-])=O YJKIOLVYLFZJQU-UHFFFAOYSA-N 0.000 description 1
- CVRYWQFDHUXAFD-UHFFFAOYSA-N dipropylazanium oxalate Chemical compound [O-]C(=O)C([O-])=O.CCC[NH2+]CCC.CCC[NH2+]CCC CVRYWQFDHUXAFD-UHFFFAOYSA-N 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- XNSNNQJSLLDSPY-UHFFFAOYSA-N dodecanoate propylazanium Chemical compound C(CCCCCCCCCCC)(=O)[O-].C(CC)[NH3+] XNSNNQJSLLDSPY-UHFFFAOYSA-N 0.000 description 1
- PGQAXGHQYGXVDC-UHFFFAOYSA-N dodecyl(dimethyl)azanium;chloride Chemical compound Cl.CCCCCCCCCCCCN(C)C PGQAXGHQYGXVDC-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- VAIUNGBQMLPPDL-UHFFFAOYSA-N ethanamine;2-hydroxypropanoic acid Chemical compound CC[NH3+].CC(O)C([O-])=O VAIUNGBQMLPPDL-UHFFFAOYSA-N 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-O ethylaminium Chemical compound CC[NH3+] QUSNBJAOOMFDIB-UHFFFAOYSA-O 0.000 description 1
- QRMKTNANRJCRCY-UHFFFAOYSA-N ethylammonium acetate Chemical compound CC[NH3+].CC([O-])=O QRMKTNANRJCRCY-UHFFFAOYSA-N 0.000 description 1
- DYWODRJVMZCPDO-UHFFFAOYSA-N ethylammonium formate Chemical compound CC[NH3+].[O-]C=O DYWODRJVMZCPDO-UHFFFAOYSA-N 0.000 description 1
- NLVSLJGVLOGRER-UHFFFAOYSA-N ethylazanium undecanoate Chemical compound CC[NH3+].CCCCCCCCCCC([O-])=O NLVSLJGVLOGRER-UHFFFAOYSA-N 0.000 description 1
- UJQMLKHNXLNNJL-UHFFFAOYSA-N ethylazanium;nonanoate Chemical compound CC[NH3+].CCCCCCCCC([O-])=O UJQMLKHNXLNNJL-UHFFFAOYSA-N 0.000 description 1
- DQUAPSISBYVXIO-UHFFFAOYSA-N ethylazanium;octanoate Chemical compound CC[NH3+].CCCCCCCC([O-])=O DQUAPSISBYVXIO-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- BAONHUZQTANSBI-UHFFFAOYSA-N formic acid;methanamine Chemical compound [NH3+]C.[O-]C=O BAONHUZQTANSBI-UHFFFAOYSA-N 0.000 description 1
- BDHPJXPOQGPUNI-UHFFFAOYSA-N formic acid;morpholine Chemical compound [O-]C=O.C1COCC[NH2+]1 BDHPJXPOQGPUNI-UHFFFAOYSA-N 0.000 description 1
- ZGLZWNUJPHIQOP-UHFFFAOYSA-N formic acid;n-propan-2-ylpropan-2-amine Chemical compound [O-]C=O.CC(C)[NH2+]C(C)C ZGLZWNUJPHIQOP-UHFFFAOYSA-N 0.000 description 1
- REINQNFUQDCADG-UHFFFAOYSA-N formic acid;n-propylpropan-1-amine Chemical compound OC=O.CCCNCCC REINQNFUQDCADG-UHFFFAOYSA-N 0.000 description 1
- KNPWRSVXYPZCOS-UHFFFAOYSA-N formic acid;piperidine Chemical compound [O-]C=O.C1CC[NH2+]CC1 KNPWRSVXYPZCOS-UHFFFAOYSA-N 0.000 description 1
- ISSANPNWPVRCPL-UHFFFAOYSA-N formic acid;propan-1-amine Chemical compound [O-]C=O.CCC[NH3+] ISSANPNWPVRCPL-UHFFFAOYSA-N 0.000 description 1
- LYQODQONVIAZNB-UHFFFAOYSA-N formic acid;propan-2-amine Chemical compound [O-]C=O.CC(C)[NH3+] LYQODQONVIAZNB-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940102465 ginger root Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000002307 glutamic acids Chemical class 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 230000003694 hair properties Effects 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 230000003741 hair volume Effects 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- GDELFPCVQGMMKJ-UHFFFAOYSA-N heptanoate;methylazanium Chemical compound [NH3+]C.CCCCCCC([O-])=O GDELFPCVQGMMKJ-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- HUDXSBXYGZKDRN-UHFFFAOYSA-N hexanoate morpholin-4-ium Chemical compound C1COCC[NH2+]1.CCCCCC([O-])=O HUDXSBXYGZKDRN-UHFFFAOYSA-N 0.000 description 1
- 235000010181 horse chestnut Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- DOUHZFSGSXMPIE-UHFFFAOYSA-N hydroxidooxidosulfur(.) Chemical group [O]SO DOUHZFSGSXMPIE-UHFFFAOYSA-N 0.000 description 1
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 150000004693 imidazolium salts Chemical class 0.000 description 1
- 229910001412 inorganic anion Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-O isopropylaminium Chemical compound CC(C)[NH3+] JJWLVOIRVHMVIS-UHFFFAOYSA-O 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000004337 magnesium citrate Substances 0.000 description 1
- 235000002538 magnesium citrate Nutrition 0.000 description 1
- 229960005336 magnesium citrate Drugs 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- OVGXLJDWSLQDRT-UHFFFAOYSA-L magnesium lactate Chemical compound [Mg+2].CC(O)C([O-])=O.CC(O)C([O-])=O OVGXLJDWSLQDRT-UHFFFAOYSA-L 0.000 description 1
- 239000000626 magnesium lactate Substances 0.000 description 1
- 235000015229 magnesium lactate Nutrition 0.000 description 1
- 229960004658 magnesium lactate Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 235000001035 marshmallow Nutrition 0.000 description 1
- 239000010487 meadowfoam seed oil Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- XVVHPMWSAPIRKJ-UHFFFAOYSA-N methanamine;undecanoic acid Chemical compound NC.CCCCCCCCCCC(O)=O XVVHPMWSAPIRKJ-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- OQJGHCPOWNDUMF-UHFFFAOYSA-N methylazanium;nonanoate Chemical compound [NH3+]C.CCCCCCCCC([O-])=O OQJGHCPOWNDUMF-UHFFFAOYSA-N 0.000 description 1
- YCDPMWUIBVZJCS-UHFFFAOYSA-N methylazanium;octanoate Chemical compound [NH3+]C.CCCCCCCC([O-])=O YCDPMWUIBVZJCS-UHFFFAOYSA-N 0.000 description 1
- AUJBWBGETPUHHU-UHFFFAOYSA-N methylazanium;propanoate Chemical compound [NH3+]C.CCC([O-])=O AUJBWBGETPUHHU-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 150000002763 monocarboxylic acids Chemical class 0.000 description 1
- NXKVZKDVVRPGGX-UHFFFAOYSA-N morpholin-4-ium;oxalate Chemical compound C1COCC[NH2+]1.C1COCC[NH2+]1.[O-]C(=O)C([O-])=O NXKVZKDVVRPGGX-UHFFFAOYSA-N 0.000 description 1
- WIJLPVTYBVKNSO-UHFFFAOYSA-N morpholine propanoic acid Chemical compound C(CC)(=O)O.N1CCOCC1 WIJLPVTYBVKNSO-UHFFFAOYSA-N 0.000 description 1
- NKJHSNBLMRLJOE-UHFFFAOYSA-N morpholine;nonanoic acid Chemical compound C1COCCN1.CCCCCCCCC(O)=O NKJHSNBLMRLJOE-UHFFFAOYSA-N 0.000 description 1
- LAQVFXAFEYMPTI-UHFFFAOYSA-N morpholine;octanoic acid Chemical compound C1COCCN1.CCCCCCCC(O)=O LAQVFXAFEYMPTI-UHFFFAOYSA-N 0.000 description 1
- GGDGJALLJXHWDB-UHFFFAOYSA-N morpholine;pentanoic acid Chemical compound C1COCCN1.CCCCC(O)=O GGDGJALLJXHWDB-UHFFFAOYSA-N 0.000 description 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-O morpholinium Chemical compound [H+].C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-O 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- WORLLILUGHBXRR-UHFFFAOYSA-N n,n-diethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound CCN(CC)CC.CCN(CC)CC.CCN(CC)CC.OC(=O)CC(O)(C(O)=O)CC(O)=O WORLLILUGHBXRR-UHFFFAOYSA-N 0.000 description 1
- VOUQMQSMMFZEJE-UHFFFAOYSA-N n,n-diethylethanamine;2-hydroxypropanoic acid Chemical compound CC(O)C([O-])=O.CC[NH+](CC)CC VOUQMQSMMFZEJE-UHFFFAOYSA-N 0.000 description 1
- UGBSRTACPDOKSJ-UHFFFAOYSA-N n,n-diethylethanamine;dodecanoic acid Chemical compound CC[NH+](CC)CC.CCCCCCCCCCCC([O-])=O UGBSRTACPDOKSJ-UHFFFAOYSA-N 0.000 description 1
- CNWGYUFHGPCIBU-UHFFFAOYSA-N n,n-diethylethanamine;oxalic acid Chemical compound [O-]C(=O)C([O-])=O.CC[NH+](CC)CC.CC[NH+](CC)CC CNWGYUFHGPCIBU-UHFFFAOYSA-N 0.000 description 1
- BUFZQIYUXMIVTB-UHFFFAOYSA-N n,n-dimethylmethanamine;2-hydroxyacetic acid Chemical compound C[NH+](C)C.OCC([O-])=O BUFZQIYUXMIVTB-UHFFFAOYSA-N 0.000 description 1
- ZFDCUGYFOSTYOL-UHFFFAOYSA-N n,n-dimethylmethanamine;propanoic acid Chemical compound CN(C)C.CCC(O)=O ZFDCUGYFOSTYOL-UHFFFAOYSA-N 0.000 description 1
- QQZOPKMRPOGIEB-UHFFFAOYSA-N n-butyl methyl ketone Natural products CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 1
- BOQCCAZJWHZMBG-UHFFFAOYSA-N n-ethylethanamine;2-hydroxypropanoic acid Chemical compound CCNCC.CC(O)C(O)=O BOQCCAZJWHZMBG-UHFFFAOYSA-N 0.000 description 1
- VWQMDHRZIPQGJQ-UHFFFAOYSA-N n-ethylethanamine;formic acid Chemical compound [O-]C=O.CC[NH2+]CC VWQMDHRZIPQGJQ-UHFFFAOYSA-N 0.000 description 1
- NAVUWPHDMDZAIK-UHFFFAOYSA-N n-ethylethanamine;octanoic acid Chemical compound CC[NH2+]CC.CCCCCCCC([O-])=O NAVUWPHDMDZAIK-UHFFFAOYSA-N 0.000 description 1
- SKSVCKGZZUFGGC-UHFFFAOYSA-N n-methylmethanamine;propanoic acid Chemical compound C[NH2+]C.CCC([O-])=O SKSVCKGZZUFGGC-UHFFFAOYSA-N 0.000 description 1
- XLQAAABQDQWCGG-UHFFFAOYSA-N n-methylmethanamine;undecanoic acid Chemical compound CNC.CCCCCCCCCCC(O)=O XLQAAABQDQWCGG-UHFFFAOYSA-N 0.000 description 1
- 239000000978 natural dye Substances 0.000 description 1
- UQFRYERUXPDUFM-UHFFFAOYSA-N nonanoate phenylazanium Chemical compound Nc1ccccc1.CCCCCCCCC(O)=O UQFRYERUXPDUFM-UHFFFAOYSA-N 0.000 description 1
- NJRDNFZHEVCJQJ-UHFFFAOYSA-N nonanoate propan-2-ylazanium Chemical compound CC(C)[NH3+].CCCCCCCCC([O-])=O NJRDNFZHEVCJQJ-UHFFFAOYSA-N 0.000 description 1
- QZAIINYSURXIAW-UHFFFAOYSA-N nonanoate tri(propan-2-yl)azanium Chemical compound CC(C)[NH+](C(C)C)C(C)C.CCCCCCCCC([O-])=O QZAIINYSURXIAW-UHFFFAOYSA-N 0.000 description 1
- BRUQMEZHCQIJIJ-UHFFFAOYSA-N nonanoate triphenylazanium Chemical compound CCCCCCCCC([O-])=O.c1ccc(cc1)[NH+](c1ccccc1)c1ccccc1 BRUQMEZHCQIJIJ-UHFFFAOYSA-N 0.000 description 1
- PSOAFZLTNHCLRR-UHFFFAOYSA-N nonanoate;piperidin-1-ium Chemical compound C1CC[NH2+]CC1.CCCCCCCCC([O-])=O PSOAFZLTNHCLRR-UHFFFAOYSA-N 0.000 description 1
- MGXXZOCJKWHKOT-UHFFFAOYSA-N nonanoate;triethylazanium Chemical compound CC[NH+](CC)CC.CCCCCCCCC([O-])=O MGXXZOCJKWHKOT-UHFFFAOYSA-N 0.000 description 1
- VHTVQHYOFAZRHT-UHFFFAOYSA-N nonanoate;trimethylazanium Chemical compound C[NH+](C)C.CCCCCCCCC([O-])=O VHTVQHYOFAZRHT-UHFFFAOYSA-N 0.000 description 1
- CBQFSZQRTPDVGD-UHFFFAOYSA-N nonanoate;tripropylazanium Chemical compound CCC[NH+](CCC)CCC.CCCCCCCCC([O-])=O CBQFSZQRTPDVGD-UHFFFAOYSA-N 0.000 description 1
- ROVIKCUGYCSTEZ-UHFFFAOYSA-N octanoate phenylazanium Chemical compound Nc1ccccc1.CCCCCCCC(O)=O ROVIKCUGYCSTEZ-UHFFFAOYSA-N 0.000 description 1
- CBSKTSVIUYQRQU-UHFFFAOYSA-N octanoate propan-2-ylazanium Chemical compound CC(C)[NH3+].CCCCCCCC([O-])=O CBSKTSVIUYQRQU-UHFFFAOYSA-N 0.000 description 1
- OJEVGBGSMFMTOJ-UHFFFAOYSA-N octanoate tri(propan-2-yl)azanium Chemical compound CCCCCCCC([O-])=O.CC(C)[NH+](C(C)C)C(C)C OJEVGBGSMFMTOJ-UHFFFAOYSA-N 0.000 description 1
- IXBCKWHDEWECOY-UHFFFAOYSA-N octanoate triphenylazanium Chemical compound CCCCCCCC([O-])=O.c1ccc(cc1)[NH+](c1ccccc1)c1ccccc1 IXBCKWHDEWECOY-UHFFFAOYSA-N 0.000 description 1
- XKXMYYUQFSBYHN-UHFFFAOYSA-N octanoate;piperidin-1-ium Chemical compound C1CC[NH2+]CC1.CCCCCCCC([O-])=O XKXMYYUQFSBYHN-UHFFFAOYSA-N 0.000 description 1
- BKTYINKAJAUDOL-UHFFFAOYSA-N octanoate;triethylazanium Chemical compound CC[NH+](CC)CC.CCCCCCCC([O-])=O BKTYINKAJAUDOL-UHFFFAOYSA-N 0.000 description 1
- OAEQDPIKTGPJHA-UHFFFAOYSA-N octanoate;tripropylazanium Chemical compound CCCCCCCC([O-])=O.CCC[NH+](CCC)CCC OAEQDPIKTGPJHA-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002891 organic anions Chemical class 0.000 description 1
- SMODUZGGRADSEU-UHFFFAOYSA-N oxalate propan-2-ylazanium Chemical compound CC(C)[NH3+].CC(C)[NH3+].[O-]C(=O)C([O-])=O SMODUZGGRADSEU-UHFFFAOYSA-N 0.000 description 1
- SAFWKEWCJXHXOQ-UHFFFAOYSA-N oxalate tri(propan-2-yl)azanium Chemical compound [O-]C(=O)C([O-])=O.CC(C)[NH+](C(C)C)C(C)C.CC(C)[NH+](C(C)C)C(C)C SAFWKEWCJXHXOQ-UHFFFAOYSA-N 0.000 description 1
- BUPVQXPLSCYTDT-UHFFFAOYSA-N oxalate triphenylazanium Chemical compound [O-]C(=O)C([O-])=O.c1ccc(cc1)[NH+](c1ccccc1)c1ccccc1.c1ccc(cc1)[NH+](c1ccccc1)c1ccccc1 BUPVQXPLSCYTDT-UHFFFAOYSA-N 0.000 description 1
- KTFFTVGPHKWIOK-UHFFFAOYSA-N oxalate;phenylazanium Chemical compound OC(=O)C(O)=O.NC1=CC=CC=C1.NC1=CC=CC=C1 KTFFTVGPHKWIOK-UHFFFAOYSA-N 0.000 description 1
- KOXZKJOOLJCVBJ-UHFFFAOYSA-N oxalate;propylazanium Chemical compound CCC[NH3+].CCC[NH3+].[O-]C(=O)C([O-])=O KOXZKJOOLJCVBJ-UHFFFAOYSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- CAQWKFWJZWIMRD-UHFFFAOYSA-N oxalic acid;n-phenylaniline Chemical compound OC(=O)C(O)=O.C=1C=CC=CC=1NC1=CC=CC=C1.C=1C=CC=CC=1NC1=CC=CC=C1 CAQWKFWJZWIMRD-UHFFFAOYSA-N 0.000 description 1
- LKSWHQFYFLFHSK-UHFFFAOYSA-N oxalic acid;piperidine Chemical compound C1CC[NH2+]CC1.C1CC[NH2+]CC1.[O-]C(=O)C([O-])=O LKSWHQFYFLFHSK-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- SERHXTVXHNVDKA-UHFFFAOYSA-N pantolactone Chemical compound CC1(C)COC(=O)C1O SERHXTVXHNVDKA-UHFFFAOYSA-N 0.000 description 1
- 229940115458 pantolactone Drugs 0.000 description 1
- SIEVQTNTRMBCHO-UHFFFAOYSA-N pantolactone Natural products CC1(C)OC(=O)CC1O SIEVQTNTRMBCHO-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- HKFGARLFKQTKNM-UHFFFAOYSA-N pentanoate;piperidin-1-ium Chemical compound C1CC[NH2+]CC1.CCCCC([O-])=O HKFGARLFKQTKNM-UHFFFAOYSA-N 0.000 description 1
- FHSWXOCOMAVQKE-UHFFFAOYSA-N phenylazanium;acetate Chemical compound CC([O-])=O.[NH3+]C1=CC=CC=C1 FHSWXOCOMAVQKE-UHFFFAOYSA-N 0.000 description 1
- 150000004986 phenylenediamines Chemical class 0.000 description 1
- ACVYVLVWPXVTIT-UHFFFAOYSA-M phosphinate Chemical group [O-][PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-M 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical group [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- 229910052615 phyllosilicate Inorganic materials 0.000 description 1
- RAIYODFGMLZUDF-UHFFFAOYSA-N piperidin-1-ium;acetate Chemical compound CC([O-])=O.C1CC[NH2+]CC1 RAIYODFGMLZUDF-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- UNAMXVVAADBAGX-UHFFFAOYSA-N propylazanium undecanoate Chemical compound CCC[NH3+].CCCCCCCCCCC([O-])=O UNAMXVVAADBAGX-UHFFFAOYSA-N 0.000 description 1
- AOHJOMMDDJHIJH-UHFFFAOYSA-N propylenediamine Chemical compound CC(N)CN AOHJOMMDDJHIJH-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 229940079053 quaternium-27 Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- VIDTVPHHDGRGAF-UHFFFAOYSA-N selenium sulfide Chemical compound [Se]=S VIDTVPHHDGRGAF-UHFFFAOYSA-N 0.000 description 1
- 229960005265 selenium sulfide Drugs 0.000 description 1
- 125000005373 siloxane group Chemical group [SiH2](O*)* 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 229940086735 succinate Drugs 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229960005349 sulfur Drugs 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical group [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- GILXVWJOYLORAY-UHFFFAOYSA-N tri(propan-2-yl)azanium acetate Chemical compound CC([O-])=O.CC(C)[NH+](C(C)C)C(C)C GILXVWJOYLORAY-UHFFFAOYSA-N 0.000 description 1
- VJIOQRHUTLEILL-UHFFFAOYSA-N tri(propan-2-yl)azanium;formate Chemical compound OC=O.CC(C)N(C(C)C)C(C)C VJIOQRHUTLEILL-UHFFFAOYSA-N 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 229940085654 trideceth-5 Drugs 0.000 description 1
- CMJWZHGNNCHHAH-UHFFFAOYSA-N triethylazanium undecanoate Chemical compound CC[NH+](CC)CC.CCCCCCCCCCC([O-])=O CMJWZHGNNCHHAH-UHFFFAOYSA-N 0.000 description 1
- PTMFUWGXPRYYMC-UHFFFAOYSA-N triethylazanium;formate Chemical compound OC=O.CCN(CC)CC PTMFUWGXPRYYMC-UHFFFAOYSA-N 0.000 description 1
- FAGMGMRSURYROS-UHFFFAOYSA-M trihexadecyl(methyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(CCCCCCCCCCCCCCCC)CCCCCCCCCCCCCCCC FAGMGMRSURYROS-UHFFFAOYSA-M 0.000 description 1
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 description 1
- LCSWHKFLVMHLNG-UHFFFAOYSA-N trimethylazanium undecanoate Chemical compound C[NH+](C)C.CCCCCCCCCCC([O-])=O LCSWHKFLVMHLNG-UHFFFAOYSA-N 0.000 description 1
- KYWVDGFGRYJLPE-UHFFFAOYSA-N trimethylazanium;acetate Chemical compound CN(C)C.CC(O)=O KYWVDGFGRYJLPE-UHFFFAOYSA-N 0.000 description 1
- UPVCRZBVVOXMDA-UHFFFAOYSA-N trimethylazanium;formate Chemical compound OC=O.CN(C)C UPVCRZBVVOXMDA-UHFFFAOYSA-N 0.000 description 1
- ODHXBMXNKOYIBV-UHFFFAOYSA-N triphenylamine Chemical compound C1=CC=CC=C1N(C=1C=CC=CC=1)C1=CC=CC=C1 ODHXBMXNKOYIBV-UHFFFAOYSA-N 0.000 description 1
- ODHXBMXNKOYIBV-UHFFFAOYSA-O triphenylazanium Chemical compound C1=CC=CC=C1[NH+](C=1C=CC=CC=1)C1=CC=CC=C1 ODHXBMXNKOYIBV-UHFFFAOYSA-O 0.000 description 1
- QTERFZWEBUDGDE-UHFFFAOYSA-N triphenylazanium acetate Chemical compound C(C)(=O)O.C1(=CC=CC=C1)N(C1=CC=CC=C1)C1=CC=CC=C1 QTERFZWEBUDGDE-UHFFFAOYSA-N 0.000 description 1
- DBOLCXYYVIOKCM-UHFFFAOYSA-N triphenylazanium formate Chemical compound [O-]C=O.c1ccc(cc1)[NH+](c1ccccc1)c1ccccc1 DBOLCXYYVIOKCM-UHFFFAOYSA-N 0.000 description 1
- AHCOTIVAMFIJQL-UHFFFAOYSA-N tripropylazanium;acetate Chemical compound CC(O)=O.CCCN(CCC)CCC AHCOTIVAMFIJQL-UHFFFAOYSA-N 0.000 description 1
- RVNKLJTZJZYGBF-UHFFFAOYSA-N tripropylazanium;formate Chemical compound OC=O.CCCN(CCC)CCC RVNKLJTZJZYGBF-UHFFFAOYSA-N 0.000 description 1
- UPCXAARSWVHVLY-UHFFFAOYSA-N tris(2-hydroxyethyl)azanium;acetate Chemical compound CC(O)=O.OCCN(CCO)CCO UPCXAARSWVHVLY-UHFFFAOYSA-N 0.000 description 1
- 229910052722 tritium Inorganic materials 0.000 description 1
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 1
- KJIOQYGWTQBHNH-UHFFFAOYSA-N undecanol Chemical compound CCCCCCCCCCCO KJIOQYGWTQBHNH-UHFFFAOYSA-N 0.000 description 1
- 125000004417 unsaturated alkyl group Chemical group 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000001841 zingiber officinale Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
Definitions
- the invention relates to hair treatment compositions, in particular shampoos and so-called conditioners, with a combination of active ingredients for gentle and effective care of the hair.
- hair treatment compositions in particular shampoos and so-called conditioners
- active ingredients for gentle and effective care of the hair.
- care products affect the natural structure and properties of the hair.
- the wet and dry combability of the hair, the hold and the fullness of the hair can be optimized or the hair can be protected from increased splits following such care treatments.
- the hair is treated with special active ingredients, for example quaternary ammonium salts or special polymers, usually in the form of a rinse.
- special active ingredients for example quaternary ammonium salts or special polymers, usually in the form of a rinse.
- this treatment improves the combability, the hold and the fullness of the hair and reduces the splitting rate.
- multifunctional cosmetic products are known in the prior art.
- these include the so-called “2 in 1" shampoos, which not only cleanse the hair, but also condition it.
- These products are highly appreciated by the consumer because of their product performance, at least one process step, for example, conditioning with a classical hair conditioner; unnecessary.
- the term "undesired change” is understood to mean the fading or bleeding and loss of color brilliance of the hue of the hair as a result of the respective dyeing.Environmental influences and / or sun effects may exacerbate these changes.There is still a need for active ingredients or active ingredient combinations for hair treatment products with good nourishing properties, which also strengthen the adhesion of dyes to the hair fibers and thus preserve the authenticity of the artificially produced hair color, and further develop hair treatment products in this regard.
- the present application was therefore based on the object to provide good skin-friendly and nourishing hair treatment compositions which have excellent foam properties and have a good rinsability with water and also reduce or prevent the washing out of color from dyed hair.
- the nourishing hair treatment products should have a constant conditioning performance regardless of the water quality and in particular fine hair and / or damaged hair and thereby strengthen the hair in their structure and so protect against splits and breakage and improve combability and grip. In addition, they should have a germ-reducing effect.
- a first object of the present invention are hair treatment compositions containing by weight
- Hair treatment compositions for the purposes of the present invention are, for example, hair shampoos, hair conditioners, conditioning shampoos, hairsprays, hair conditioners, hair conditioners, hair wraps, hair tonics, perming solutions, hair dye shampoos, hair dyes, hair fixatives, hair dressings, hairstyling preparations, hair lotions, mousses, hair gels , Hair waxes or their combinations.
- Preferred agents are therefore shampoos, conditioners or hair tonics.
- the hair treatment compositions contain as the first essential ingredient 0.001 to 10 wt .-% of at least one amine salt of a carboxylic acid.
- Amine salts of carboxylic acids are formed from a (primary, secondary or tertiary) amine with a carboxylic acid from their -COOH group.
- the acidic acid of the acid protonates the amine to an ammonium.
- Suitable amines are, for example, methylamine, dimethylamine, trimethylamine, ethylamine, diethylamine, triethylamine, n-propylamine, di-n-propylamine, tri-n-propylamine, isopropylamine, diisopropylamine, triisopropylamine, phenylamine (aniline), diphenylamine, triphenylamine, monoethanolamine, Diethanolamine, triethanolamine, ethylenediamine, propylenediamine, the phenylenediamines 1, 2-diaminobenzene, 1, 3-diaminobenzene and 1, 4-diaminobenzene, piperidine, morpholine,
- Typical representatives of aliphatic mono- and dicarboxylic acids are, for example, acetic acid, propionic acid, oxalic acid and 1,3-propanedioic acid and aromatic carboxylic acids such as benzoic acid.
- Further organic acids are, for example, hydroxy carboxylic acids such as glycolic acid, citric acid, tartaric acid, malic acid and lactic acid.
- unsaturated mono- or dicarboxylic acids such as fumaric acid or ⁇ -ketocarboxylic acids such as pyruvic acid (2-oxopropionic acid) are inventively used as the amine salt.
- Methyl ammonium formate dimethyl ammonium formate, trimethyl ammonium formate
- Ethylammoniumpropionat Diethylammoniumpropionat, Triethylammoniumpropionat, n- Propyylammoniumpropionat, di-n-Propylammoniumpropionat, tri-n-Propylammoniumpropionat Isopropylammoniumpropionat, Diisopropylammoniumpropionat, Triisopropylammoniumpropionat Phenylammoniumpropionat, Diphenylammoniumpropionat, Triphenylammoniumpropionat Monoethanolammoniumpropionat, Diethanolammoniumpropionat, Triethanolammoniumpropionat Ethylenammoniumpropionat, Propylenammoniumpropionat, piperidinium
- Dimethylammoniumbutyrat Trimethylammoniumbutyrat, Ethylammoniumbutyrat Diethylammoniumbutyrat, Triethylammoniumbutyrat, n-Propyylammoniumbutyrat, di-n Propylammoniumbutyrat, tri-n-Propylammoniumbutyrat, Isopropylammoniumbutyrat Diisopropylammoniumbutyrat, Triisopropylammoniumbutyrat, Phenylammoniumbutyrat Diphenylammoniumbutyrat, Triphenylammoniumbutyrat, Monoethanolammoniumbutyrat Diethanolammoniumbutyrat, Triethanolammoniumbutyrat, Ethylenammoniumbutyrat Propylenammoniumbutyrat, Piperidiniumbutyrat, Morpholiniumbutyrat, 4.4 - Dimethyloxazolidiniumbutyrat, Methylammoniumpentanoat,
- Propylammoniumdodecanoat Isopropylammoniumdodecanoat, Diisopropylammoniumdodecanoat Triisopropylammoniumdodecanoat, Phenylammoniumdodecanoat, Diphenylammoniumdodecanoat Triphenylammoniumdodecanoat, Monoethanolammoniumdodecanoat Diethanolammoniumdodecanoat, Triethanolammoniumdodecanoat, Ethylenammoniumdodecanoat Propylenammoniumdodecanoat, Piperidiniumdodecanoat, Morpholiniumdodecanoat, 4,4 Dimethyloxazolidiniumdodecanoat, Methylammoniumoxalat, Dimethylammoniumoxalat Trimethylammoniumoxalat, Ethylammoniumoxalat, Diethylammoniumoxalat
- Triphenylammoniumoxalat Monoethanolammoniumoxalat Diethanolammoniumoxalat Triethanolammoniumoxalat, Ethylenammoniumoxalat, Propylenammoniumoxalat Piperidiniumoxalat, Morpholiniumoxalat, 4,4-Dimethyloxazolidiniumoxalat Methylammoniumbenzoat, Dimethylammoniumbenzoat, Trimethylammoniumbenzoat Ethylammoniumbenzoat, Diethylammoniumbenzoat, Triethylammoniumbenzoat, n- Propyylammoniumbenzoat, di-n-Propylammoniumbenzoat, tri-n-Propylammoniumbenzoat Isopropylammoniumbenzoat, Diisopropylammoniumbenzoat, Triisopropylammoniumbenzoat Phenylammoniumbenzoat , Diphenyl
- Trimethylammonium glycolate Ethylammoniumglykolat, Diethylammoniumglykolat
- Methyl ammonium citrate dimethyl ammonium citrate, trimethyl ammonium citrate, ethyl ammonium citrate, diethyl ammonium citrate, triethyl ammonium citrate, n-propyl ammonium citrate, di-n-propyl ammonium citrate, tri-n-propyl ammonium citrate, isopropyl ammonium citrate
- Ethylammonium tartrate diethylammonium tartrate, triethylammonium tartrate, n-
- Trimethylammonium malate Trimethylammonium malate, ethylammonium malate, diethylammonium malate
- Triethylammonium malate Triethylammonium malate, n-propylammonium malate, di-n-propylammonium malate, tri-n-propylammonium malate, isopropylammonium malate, diisopropylammonium malate
- Triphenylammonium malate monoethanolammonium malate, diethanolammonium malate
- Triethanolammonium malate ethylene ammonium malate, propylene ammonium malate, piperidinium malate, morpholinium malate, 4,4-dimethyloxazolidinium malate, methyl ammonium lactate
- Particularly preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.01 to 10% by weight, preferably from 0.05 to 7.5% by weight, more preferably from 0 to 1 to 6% by weight. and in particular from 0.15 to 5% by weight of amine salt (s) of carboxylic acid (s) of the formula (I)
- R 1, R 2 and R 3 are independently selected from -H, -CH 3 , -CH 2 CH 3 , -CH 2 CH 2 OH,
- R is an optionally substituted saturated or unsaturated, linear, branched or cyclic, aliphatic or aromatic hydrocarbon radical having at least 2 C atoms.
- Very particularly preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.01 to 10% by weight, preferably from 0.05 to 7.5% by weight, more preferably from 0 to 1 to 6% by weight. % and in particular 0, 15 to 5 wt .-% of at least one amine salt from the group
- the agents according to the invention contain from 0.001 to 20% by weight of at least one protein hydrolyzate.
- Protein hydrolysates are according to the invention degradation products of proteins which are produced by acidic, basic or enzymatic reaction. Due to the manufacturing process, protein hydrolysates have a distribution of molecular weight.
- the protein hydrolysates according to the invention also include oligopeptides, since these can likewise be prepared by corresponding reactions from proteins. Individual amino acids, which are present as a discrete single compound, according to the invention do not belong to the protein hydrolysates in the sense of this invention.
- protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used.
- Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein hydrolysates, which may also be present in the form of salts.
- Such products are, for example, under the trademarks Dehylan ® (Cognis), Promois® ® (Interorgana) Collapuron ® (Cognis), Nutrilan® ® (Cognis), Gelita-Sol ® (German Gelatinefabriken Stoess & Co), Lexein ® (Inolex) ProSina ® (Croda) and kerasol tm ® (Croda) sold.
- Further preferred vegetable protein hydrolysates according to the invention are, for example, soybean, almond, pea, moringa, potato and wheat protein hydrolysates.
- Such products are, for example, under the trademarks Gluadin ® (Cognis), diamine ® (Diamalt) ® (Inolex), Hydrosoy ® (Croda), hydro Lupine ® (Croda), hydro Sesame ® (Croda), Hydro tritium ® (Croda), Crotein ® (Croda) and Puricare ® LS 9658 from Laboratoires Serobi unanimouss.
- protein hydrolysates according to the invention are of maritime origin. These include, for example, collagen hydrolyzates of fish or algae as well as protein hydrolysates of mussels or pearl hydrolyzates.
- pearl extracts according to the invention are the commercial products Pearl Protein Extract BG ® or Crodarom ® Pearl.
- cationized protein hydrolysates are to be counted among the protein hydrolysates and their derivatives, the underlying protein hydrolyzate being derived from the animal, for example from collagen, milk or keratin, from the plant, for example from wheat, maize, rice, potatoes, soya or almonds, from marine life forms, from fish collagen or algae, or biotechnologically derived protein hydrolysates.
- the cationic protein hydrolyzates and derivatives according to the invention those mentioned under the INCI names in the "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry and Fragrance Association 1 101 17 th Street, NW, Suite 300, Washington, DC 20036-4702) and commercially available products.
- Hair treatment compositions which are preferred according to the invention are characterized in that they contain -0.01 to 15% by weight, preferably 0.05 to 10% by weight, more preferably 0.1 to 7.5% by weight, based on their weight in particular 0.15 to 5 wt .-% protein hydrolyzate (s) from the group elastin, collagen, keratin, silk and milk protein protein hydrolyzate, soybean, almond, pea, Moringa, potato and wheat protein hydrolyzate ,
- Oligopeptides may be preferred in the hair treatment compositions of the invention because of their defined amino acid sequence.
- An oligopeptide which has at least one amino acid sequence Glu-Glu-Glu
- amino group may be free or protonated and the carboxy groups may be free or deprotonated, may be particularly preferred according to the invention.
- the parenthesized hydrogen atom of the amino group as well as the bracketed hydroxy group of the acid function means that the respective groups may be present as such (then it is an oligopeptide with the relevant number of amino acids as in the above formula or but that the amino acid sequence is present in an oligopeptide comprising even more amino acids - depending on where the other amino acid (s) is / are bound, the parenthetical components of the above formula are represented by the additional amino acid residue (s) replaced.
- Oligopeptides in the sense of the present application are acid amide-like linked by peptide bonds condensation products of amino acids comprising at least 3 and a maximum of 25 amino acids.
- the oligopeptide comprises 5 to 15 amino acids, preferably 6 to 13 amino acids, particularly preferably 7 to 12 amino acids and in particular 8, 9 or 10 amino acids.
- the molecular weight of the oligopeptide contained in the agents of the invention may vary.
- Hair treatment compositions preferred according to the invention are characterized in that the oligopeptide has a molecular weight of from 650 to 3000 Da, preferably from 750 to 2500 Da, particularly preferably from 850 to 2000 Da and in particular from 1000 to 1600 Da.
- oligopeptides are used which do not consist solely of the three glutamic acids but have further amino acids bound to this sequence. These other amino acids are preferably selected from certain amino acids, while certain other representatives are less preferred in the present invention.
- a particularly preferred oligopeptide additionally contains tyrosine, which is preferably linked via its acid function to the Glu-Glu-Glu sequence.
- Hair treatment compositions which are preferred according to the invention are therefore characterized in that the oligopeptide contained in them has at least one amino acid sequence Tyr-Glu-Glu-Glu, where the amino group can be free or protonated and the carboxy groups can be free or deprotonated.
- Another particularly preferred oligopeptide additionally contains isoleucine, which is preferably linked to the Glu-Glu-Glu sequence via its amino function.
- Hair treatment agents which are preferred according to the invention are therefore characterized in that the oligopeptide contained in them has at least one amino acid sequence Glu-Glu-Glu-Ile, where the amino group can be free or protonated and the carboxy groups can be free or deprotonated.
- Oligopeptides which have both the abovementioned amino acids (tyrosine and isoleucine) are preferred according to the invention.
- Hair-treatment compositions according to the invention in which the oligopeptide contained in them is at least one of them are particularly preferred Amino acid sequence Tyr-Glu-Glu-Glu-Ile, wherein the amino group is free or protonated and the carboxy groups may be free or deprotonated.
- oligopeptides additionally contain arginine, which is preferably bound to isoleucine.
- Still further preferred oligopeptides additionally contain valine, which is preferably bound to the arginine.
- Hair-treatment agents which are further preferred according to the invention are therefore characterized in that the oligopeptide contained in them has at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val, the amino groups being free or protonated and the carboxy groups being free or deprotonated can.
- Still further preferred oligopeptides additionally contain leucine, which is preferably bound to the valine.
- Further preferred hair treatment compositions according to the invention are characterized in that the oligopeptide contained in them has at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups are free or deprotonated may be present.
- Particularly preferred oligopeptides additionally contain leucine, which is preferably bound to the tyrosine.
- Further preferred hair treatment compositions according to the invention are characterized in that the oligopeptide contained in them has at least one amino acid sequence Leu-Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups are free or may be present deprotonated.
- protein hydrolysates according to the invention are, for example, based on keratin, silk, wheat, moringa and marine protein hydrolysates. Most preferred are protein hydrolysates based on silk, keratin and wheat.
- the protein hydrolysates are present in the compositions in concentrations of 0.001% by weight to 20% by weight, preferably from 0.05% by weight to 15% by weight and most preferably in amounts of from 0.05% by weight to 5% % By weight.
- agents according to the invention may contain amino-functional silicones to further increase the conditioning effects.
- Preferred agents according to the invention contain from 0.001 to 50% by weight of at least one amino-functional silicone.
- Particularly preferred agents according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (Si-IIa)
- n and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes.
- compositions according to the invention which are an amino-functional silicone of the formula (Si-IIb) R- [Si (CH 3 ) 2-O] nl [Si (R) -O] m- [Si (CH 3 ) 2] n 2 -R (Si-Ilb),
- R is -OH, -O-Ch or a -CH3 group and m
- n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2,000, preferably between 50 and 150, wherein the sum (n1 + n2) preferably assumes values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.
- silicones are referred to as amodimethicones according to the INCI declaration.
- agents according to the invention which contain an amino-functional silicone whose amine number is above 0.25 meq / g, preferably above 0.3 meq / g and in particular above 0.4 meq / g, are preferred ,
- the amine number stands for the milliequivalents of amine per gram of the amino-functional silicone. It can be determined by titration and also expressed in mg KOH / g.
- Hair-treatment agents preferred according to the invention are characterized in that, based on their weight, they contain from 0.01 to 20% by weight, preferably from 0.05 to 10% by weight, more preferably from 0.1 to 7.5% by weight and in particular from 0.15 to 5% by weight of amino-functional silicone (s).
- the agents according to the invention contain amino-functional silicone (s) with terminal (r / n) hydroxy group (s).
- pretreatment agents which contain at least one silicone of the formula (Si-V) have proven particularly effective with regard to the desired effects:
- A represents a group -OH, -0-Si (CH 3) 3, -0-Si (CH3) 20H, -0-Si (CH 3) 20ch 3, D is a group of -H, -Si (CH 3 ) 3 , -Si (CH 3 ) 2 OH, -Si (CH 3 ) 2 OCH 3 ,
- n and c are integers between 0 and 1000,
- Hair treatment compositions according to the invention which - based on their weight - 0.01 to 20 wt.%, Preferably 0.01 to 20 wt .-%, preferably 0.1 to 10 wt .-%, more preferably 0.5 to 7.5 Wt .-% and in particular 0.1 to 5 wt .-% of at least one silicone of the formula (Si-V) contain:
- A represents a group -OH, -0-Si (CH 3) 3, -0-Si (CH3) 20H, -0-Si (CH 3) 20ch 3, D is a group of -H, -Si (CH 3 ) 3 , -Si (CH 3 ) 2 OH, -Si (CH 3 ) 2 OCH 3 ,
- n and c are integers between 0 and 1000,
- the individual siloxane units having the indices b, c and n are randomly distributed, i. it does not necessarily have to be block copolymers.
- compositions according to the invention which, based on their weight, 0.001 to 20 wt.%, Preferably 0.01 to 10 wt.%, Particularly preferably 0.05 to 7.5 wt.% And in particular 0.5 to 5 wt.% Of at least one 4-morpholinomethyl-substituted silicone containing structural units of the formulas (Si-Via), (Si-Vlb) and (Si-Vlc)
- R 2 is -CH 3 , -OH, or -OCH 3 ,
- Particularly preferred hair treatment compositions according to the invention contain, based on their weight, from 0.001 to 20% by weight, preferably from 0.01 to 10% by weight, particularly preferably from 0.05 to 7.5% by weight and in particular from 0.5 to 5% by weight.
- R 1 is -CH 3 , -OH, -OCH 3, -O-CH 2 CH 3 , -O-CH 2 CH 2 CH 3 , or -O-CH (CH 3 ) 2 ;
- R2 is -CH 3 , -OH, or -OCH 3 .
- B represents a group -OH, -0-Si (CH 3) 3, -0-Si (CH3) 20H, -0-Si (CH 3) 20ch 3;
- D is a group -H, -Si (CH 3 ) 3 , -Si (CH 3 ) 2 OH, -Si (CH 3 ) 2 OCH 3 ,
- a, b and c independently represent integers between 0 and 1000, with the proviso that a + b + c> 0
- the units a, b, c, m and n are distributed randomly or in blocks in the molecule.
- Structural formula (Si-VI) is intended to illustrate that the siloxane groups n and m do not necessarily have to be bound directly to an end grouping B or D, respectively. Rather, in preferred formulas (Si-VI) a> 0 or b> 0 and in particularly preferred formulas (Si-Vl) a> 0 and c> 0, i. the terminal moiety B or D is preferably attached to a dimethylsiloxy moiety. Also in formula (Si-Vl), the siloxane units a, b, c, m and n are preferably randomly distributed.
- silicones particularly preferably used in the present invention are selected from silicones in which
- the agents of the invention preferably contain the silicone (s) in the form of an emulsion, more preferably in the form of a microemulsion ,
- Nonionic components which are particularly suitable here are ethoxylates of decanol, undecanol, dodecanol, tridecanol, etc. Ethoxylated tridecanols have proven to be particularly suitable, which are incorporated with particular preference into the compositions according to the invention.
- compositions which are particularly preferred according to the invention are characterized in that they contain 0.00001 to 5% by weight, preferably 0.0001 to 3.5% by weight, particularly preferably 0.001 to 2% by weight, based on their weight preferably 0.01 to 1 wt .-% and in particular 0.1 to 0.5 wt .-% branched, ethoxylated tridecanol (INCI name: Trideceth-5) or o iso-tridecyl-u hydroxypolyglycolether (INCI name: Trideceth -10) or mixtures thereof.
- compositions of the invention may contain other silicone (s) which are not amino functional.
- Preferred agents according to the invention are characterized in that they contain at least one silicone selected from:
- polyalkyl siloxanes polyaryl siloxanes, polyalkylaryl siloxanes which are volatile or nonvolatile, straight chain, branched or cyclic, crosslinked or uncrosslinked;
- grafted silicone polymers having a non-silicone organic backbone consisting of an organic backbone formed from organic monomers containing no silicone grafted with at least one polysiloxane macromer in the chain and optionally at least one chain end;
- preferred hair treatment compositions are characterized in that they - based on their weight - 0.01 to 20 wt .-%, preferably 0, 1 to 10 wt .-%, more preferably 0.5 to 7.5 wt .-% and in particular 1 to 5 wt .-% non-amino-functional silicone (s) included.
- Preferred silicones are described below.
- x is a number from 0 to 100, preferably from 0 to 50, more preferably from 0 to 20 and in particular 0 to 10.
- the hair treatment compositions of the invention may contain surfactant (s).
- surfactant in cleaning compositions (shampoos), in particular anionic surfactants have proven useful, in conditioning compositions, cationic surfactants are often used ingredients; Due to their advantageous properties, amphoteric surfactants are used with particular advantage both in shampoos and in conditioners.
- the hair treatment compositions of the invention may contain at least one anionic surfactant.
- Suitable anionic surfactants and emulsifiers for the compositions according to the invention are all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic Group such as As a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms.
- anionic Group such as As a carboxylate, sulfate, sulfonate or phosphate group
- a lipophilic alkyl group having about 8 to 30 carbon atoms.
- glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups may be present in the molecule.
- Preferred hair treatment compositions contain - based on their weight - 0.5 to 20 wt .-%, preferably 0.75 to 15 wt .-%, more preferably 1 to 12 wt .-% and in particular 2 to 10 wt .-% of anionic ( s) surfactant (s).
- Particularly preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.5 to 20% by weight, preferably from 0.75 to 15% by weight, more preferably from 1 to 12% by weight and in particular from 2 to 10% by weight of alkyl (ether) sulfates of the general formula R- (OCH 2 -CH 2) n -OSO 3 X, in which R is a straight-chain or branched, saturated or unsaturated alkyl group having 8 to 24 C atoms, n is the number 0 or 1 to 12, and X represents an alkali, alkaline earth, ammonium or alkanolamine ion included.
- alkyl (ether) sulfates of the general formula R- (OCH 2 -CH 2) n -OSO 3 X, in which R is a straight-chain or branched, saturated or unsaturated alkyl group having 8 to 24 C atoms, n is the number 0 or 1 to 12, and X represents an
- the hair treatment compositions of the invention may contain at least one amphoteric surfactant and / or at least one nonionic surfactant.
- Particularly preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.3 to 20% by weight, preferably from 0.5 to 8% by weight, more preferably from 0.75 to 6% by weight and in particular 1 to 5 wt .-% amphoteric surfactant (s) included.
- amphoteric surfactants or as zwitterionic surfactants called surfactants, which have both a negative and a positively charged functional group.
- Particularly suitable zwitterionic surfactants are the so-called betaines such as the N-alkyl-N, N-dimethylammoniumglycinate, for example Kokosalkyldimethylammoniumglycinat, N-acyl aminopropyl-N, N-dimethylammoniumglycinate, for example Kokosacylaminopropyldimethyl- ammoniumglycinat, and 2-alkyl-3-carboxymethyl 3-hydroxyethylimidazolines having in each case 8 to 18 C atoms in the alkyl or acyl group, and also the cocoacylaminoethylhydroxyethylcarboxymethyl-glycinate.
- a preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.
- ampholytic surfactants are N-alkylglycines, N-alkylaminopropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidoproylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 carbon atoms in the alkyl group.
- Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C12-C18-acylsarcosine.
- Particularly preferred hair treatment compositions contain as amphoteric surfactants betaines of the formula (Bet-I)
- R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms.
- Cocoamidopropylbetaine Representatives derived from coconut fatty acids, are preferred and are referred to as Cocoamidopropylbetaine. According to the invention, particular preference is given to using surfactants of the formula (Bet-I) which are a mixture of the following representatives:
- hair-treatment compositions according to the invention are preferred which - based on their weight - 0.25 to 8 wt .-%, more preferably 0.5 to 7 wt .-%, more preferably 0.75 to 6.5 wt .-% and in particular 1 to 5.5 wt .-% of surfactant (s) of the formula (Bet-I) included.
- the hair-treatment compositions of the invention may be used with particular preference as amphoteric surfactants betaines of the formula (Bet-II)
- R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms.
- surfactants are referred to according to the INCI nomenclature as amphoacetates, wherein the representatives derived from coconut fatty acids are preferred and are referred to as cocoamphoactetates.
- surfactants of this type also always contain betaines of the formula (Bet-I 1a)
- R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms and M is a cation.
- surfactants are referred to according to the INCI nomenclature as Amphodiacetate, wherein the representatives derived from coconut fatty acids are preferred and are referred to as Cocoamphodiactetate.
- hair-treatment compositions according to the invention which - based on their weight - 0.25 to 8 wt .-%, more preferably 0.5 to 7 wt .-%, more preferably 0.75 to 6.5 wt .-% and in particular 1 to 5.5 wt .-% of surfactant (s) of the formula (Bet-II) included.
- cosmetic agents according to the invention are preferred in which the radical R in the formulas (Bet-I) and (Bet-II) is selected from
- the hair treatment agents may contain nonionic surfactant (s).
- Hair treatment agents preferred according to the invention contain, based on their weight, 0.3 to 10% by weight, preferably 0.5 to 8% by weight, more preferably 0.75 to 6% by weight and in particular 1 to 5% by weight. % nonionic surfactant (s).
- the hair treatment agents may contain cationic surfactant (s).
- Cationic surfactants of the quaternary ammonium compound type, the esterquats and the amidoamines can be used according to the invention.
- Preferred quaternary ammonium compounds are ammonium halides, in particular chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides.
- the long alkyl chains of these surfactants preferably have 10 to 18 carbon atoms, such as.
- cetyl trimethyl ammonium chloride stearyl trimethyl ammonium chloride, distearyl dimethyl ammonium chloride, lauryl dimethyl ammonium chloride, lauryl dimethyl benzyl ammonium chloride and tricetylmethyl ammonium chloride.
- Further preferred cationic surfactants are the imidazolium compounds known under the INCI names Quaternium-27 and Quaternium-83.
- Particularly preferred hair treatment compositions according to the invention are characterized in that they contain as cationic care substance - based on their weight - 0.05 to 7.5 wt .-%, preferably 0.1 to 5 wt .-%, particularly preferably 0.2 to 3, 5 wt .-% and in particular 0.25 to 2.5 wt .-% cationic surfactant (s) from the group of quaternary ammonium compounds and / or esterquats and / or amidoamines.
- cationic care substance - based on their weight - 0.05 to 7.5 wt .-%, preferably 0.1 to 5 wt .-%, particularly preferably 0.2 to 3, 5 wt .-% and in particular 0.25 to 2.5 wt .-% cationic surfactant (s) from the group of quaternary ammonium compounds and / or esterquats and / or amidoamines.
- Particularly preferred hair treatment compositions according to the invention are characterized in that they contain, based on the weight of the composition, from 0.05 to 20% by weight, preferably from 0.1 to 10% by weight, more preferably from 0.25 to 8% by weight. and in particular from 0.5 to 7% by weight of cationic surfactant (s), preferably from 0.05 to 20% by weight, preferably from 0.1 to 10% by weight, more preferably from 0.25 to 8% by weight .-% and in particular 0.5 to 7 wt .-% behenyl trimethyl ammonium chloride.
- cationic surfactant preferably from 0.05 to 20% by weight, preferably from 0.1 to 10% by weight, more preferably from 0.25 to 8% by weight .-% and in particular 0.5 to 7 wt .-% behenyl trimethyl ammonium chloride.
- compositions of the invention may contain at least one cationic polymer.
- Cationic polymers increase the care performance of the hair treatment compositions according to the invention (in particular the effectiveness of the hair breakage compositions according to the invention).
- preferred hair treatment agents contain, based on the weight of the composition, 0.01 to 3% by weight, preferably 0.05 to 2% by weight, more preferably 0.1 to 1, 5 wt .-% and in particular 0.15 to 0.8 wt .-% cationic (s) polymer (s).
- Cationic polysaccharide polymers increase the care performance of the hair treatment compositions according to the invention (in particular the effectiveness of the hair breakage compositions according to the invention).
- Suitable cationic polysaccharide polymers may be selected from cationic cellulose compounds and / or from cationic guar derivatives.
- Particularly preferred hair treatment compositions according to the invention contain as cationic polysaccharide polymer (s) - based on the weight of the composition - 0.01 to 3 wt .-%, preferably 0.05 to 2 wt .-%, more preferably 0.1 to 1, 5 wt .-% and in particular 0.15 to 0.8 wt .-% of at least one polymer from the group of cationic cellulose polymers and / or cationic guar derivatives.
- s cationic polysaccharide polymer
- Cationic cellulose compounds in the sense of the invention are those which carry more than one permanent cationic charge in at least one side chain.
- Cellulose is composed of beta-1, 4-glycosidically linked D-glucopyranose units and forms unbranched, water-insoluble chains.
- side chain of a cellulose chemical substituents are defined which bind to the cellulose skeleton and do not belong to the native cellulose since they have been subsequently introduced, for example, by chemical synthesis.
- Such polymers are known to those skilled in the art and commercially available from various companies. Particularly preferred are the cationic cellulose derivatives known under the INCI names Polyquaternium-4, Polyquaternium-10, Polyquaternium-24, Polyquaternium-67 and / or Polyquaternium-72. Very particular preference is given to polyquaternium-10, polyquaternium-24 and / or polyquaternium-67 and particular preference to polyquaternium-10.
- Preferred hair treatment compositions according to the invention contain as cationic polysaccharide polymers), based on the weight of the composition, from 0.01 to 3% by weight, preferably from 0.05 to 2 Wt .-%, more preferably 0.1 to 1, 5 wt .-% and in particular 0, 15 to 0.8 wt .-% of at least one polymer from the group of Polyquaternium-4, Polyquaternium-10, Polyquaternium-24, Polyquaternium-67 and / or Polyquaternium-72.
- cationic polysaccharide polymers based on the weight of the composition, from 0.01 to 3% by weight, preferably from 0.05 to 2 Wt .-%, more preferably 0.1 to 1, 5 wt .-% and in particular 0, 15 to 0.8 wt .-% of at least one polymer from the group of Polyquaternium-4, Polyquaternium-10, Polyquaternium-24, Polyquaternium-67 and / or Polyquaternium-72.
- Particularly preferred hair treatment compositions according to the invention contain as cationic polysaccharide polymer (s) - based on the weight of the composition - 0.01 to 3 wt .-%, preferably 0.05 to 2 wt .-%, more preferably 0.1 to 1, 5 wt .-% and in particular 0.15 to 0.8 wt .-% Polyquaternium-10.
- Suitable cationic guar derivatives in the context of the invention are cationic hydroxyalkyl guar derivatives, preferably cationic hydroxyethyltrimethylammonium guar and / or cationic hydroxypropyltrimethylammonium guar with average molecular weights between 100,000 and 2,000,000 daltons. Particularly preferred are the cationic guar polymers having a molecular weight (weight average) between 200,000 and 1,600,000 daltons known by the INCI name Guar Hydroxypropyltrimonium Chloride.
- the cationic charge density of these guar polymers is preferably at least 0.4 meq / g, preferably at least 0.5 meq / g and especially at least 0.6 meq / g.
- Their nitrogen content is preferably in the range of 1, 1 to 1, 8 wt .-% (based on their total weight).
- Cationic guar derivatives which are known under the INCI designation Guar Hydroxypropyltrimonium Chloride, are known in the art and available, for example under the trade name Cosmedia Guar ®, N-Hance ® and / or Jaguar ® from different vendors.
- Particularly preferred hair treatment compositions according to the invention contain as cationic polysaccharide polymer (s) - based on the weight of the composition - 0.01 to 3 wt .-%, preferably 0.05 to 2 wt .-%, more preferably 0, 1 to 1, 5 wt .-% and in particular 0, 15 to 0.8 wt .-% guar hydroxypropyltrimonium chlorides.
- preferred hair treatment compositions are characterized in that they - based on the weight of the composition - 0.01 to 3 wt .-%, preferably 0.05 to 2 wt .-%, more preferably 0.1 to 1, 5 wt. % and in particular 0.15 to 0.8% by weight of cationic polymer (s), preferably 0.01 to 3% by weight, preferably 0.05 to 2% by weight, more preferably 0, 1 to 1, 5 wt .-% and in particular 0, 15 to 0.8 wt .-% of at least one polymer from the group of cationic cellulose polymers and / or cationic guar derivatives.
- alpha-substituted aldehydes can further enhance the action of the compositions of the invention.
- significant increases in performance are observed.
- Hair treatment compositions which are preferred according to the invention are therefore characterized in that, based on the weight of the composition, they additionally contain from 0.001 to 20% by weight of at least one alpha-substituted aldehyde.
- Preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.01 to 10% by weight, preferably from 0.05 to 7.5% by weight, more preferably from 0.1 to 6% by weight and in particular from 0.15 to 5% by weight of alpha-substituted aldehyde (s) of the formula (I)
- Preferred aldehydes to be used according to the invention are described by the numbers 1 to 176 on pages 38 to 41 of the priority document.
- Very particularly preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.01 to 10% by weight, preferably from 0.05 to 7.5% by weight, more preferably from 0 to 1 to 6% by weight. % and in particular 0, 15 to 5 wt .-% of at least one alpha-substituted aldehyde from the group
- succinimidyl esters can further enhance the effect of the agents according to the invention.
- significant increases in performance are observed.
- Hair treatment compositions which are preferred according to the invention are therefore characterized in that they contain, based on the weight of the composition, additionally from 0.001 to 10% by weight of at least one succinimidyl ester.
- Succinimidyl esters are esters of carboxylic acids with (optionally substituted) / V-hydroxysuccinimide (NHS, IUPAC 1-hydroxy-2,5-pyrrolidinedione) and are also referred to as NHS esters.
- Hair treatment compositions which are preferred according to the invention are characterized in that they additionally contain from 0.01 to 10% by weight, preferably from 0.05 to 7.5% by weight, more preferably from 0.1 to 6% by weight, based on the weight of the composition. % and in particular 0.15 to 5% by weight of (one) succinimidyl ester (s) of the formula (III)
- R1 represents -H or an ionic group.
- R is an optionally substituted saturated or unsaturated, linear, branched or cyclic, aliphatic or aromatic hydrocarbon radical having at least 5 C atoms.
- Suitable ionic groups R1 include both anionic groups such as phosphate, phosphonate, phosphinate, sulfate, sulfonate, sulfinate, sulfenate, oxysulfonate, carboxylate groups and cationic groups such as substituted or unsubstituted ammonium groups. Zwitterionic / betainic groups such as carboxybetaine or sulfobetaine groups are also possible.
- R 1 is -H or -OSO 3 " or -SO 3 " or -SO 2 - or -COO " or -NH 3 + or -N (CH 3 ) H 2 + or -N (CH 3 ) 2 H + or -N (CH 3 ) 3 + or -N + (CH 3 ) 2 (CH 2 ) 2-COO- or -N + (CH 3 ) 2 (CH 2 ) 3 -SO 3 -.
- succinimidyl esters to be used according to the invention are described in the priority document on pages 45 to 47 with the numbers 1 to 72.
- Very particularly preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.01 to 10% by weight, preferably from 0.05 to 7.5% by weight, more preferably from 0 to 1 to 6% by weight. % and in particular 0, 15 to 5 wt .-% of at least one Succinimidylesters from the group
- Complexing agents can increase the effect of the agents according to the invention even further, in particular complexing agents which are derived from polycarboxylic acids have proved useful.
- Hair treatment compositions which are preferred according to the invention are therefore characterized in that they contain, based on their weight, from 0.001 to 20% by weight of complexing agents from the group consisting of tetrasodium A / A / bis (carboxylatomethyl) -L-glutamate (Tetrasodium glutamate diacetate, GLDA).
- complexing agents from the group consisting of tetrasodium A / A / bis (carboxylatomethyl) -L-glutamate (Tetrasodium glutamate diacetate, GLDA).
- Pentasodium diethylenetriaminepentaacetate DTPA
- tetrasodiumiminodisuccinate IDS
- EDTA tetrasodium ethylenediaminetetraacetate
- EDDS tetrasodium ethylenediamine disuccinic acid
- HEDTA trisodium hydroxyethylethylenediaminetriacetic acid
- Extremely preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.001 to 20% by weight, preferably from 0.005 to 15% by weight, preferably from 0.01 to 10% by weight, more preferably from 0.05 to 7.5 wt .-% and in particular 0, 1 to 5 wt .-% complexing agent from the group a.
- Tetrasodium A /, A / -bis (carboxylatomethyl) -L-glutamate Tetrasodium Glutamate Diacetate, GLDA
- the agents according to the invention may contain only one of the three complexing agents mentioned. But it is also possible that the means according to the invention two or all three of the above. Complexing agents, the manganese of all the complexing agents contained in the agents from the o.g. Group within the quantitative range 0.01 to 20 wt .-% is.
- Hair treatment compositions which are preferred according to the invention are characterized in that they contain, based on their weight, from 0.005 to 15% by weight, preferably from 0.01 to 10% by weight, more preferably from 0.05 to 7.5% by weight and in particular from 0 , 1 to 5 wt .-% tetrasodium A /, A / -bis (carboxylatomethyl) - L-glutamate (Tetrasodium Glutamate Diacetate, GLDA) included.
- Hair treatment compositions which are likewise preferred according to the invention are characterized in that they contain, based on their weight, from 0.005 to 15% by weight, preferably from 0.01 to 10% by weight, more preferably from 0.05 to 7.5% by weight and in particular 0, 1 to 5 wt .-% pentasodium Diethylenetriaminepentaacetate (DTPA) included.
- DTPA pentasodium Diethylenetriaminepentaacetate
- Hair treatment compositions which are likewise preferred according to the invention are characterized in that they contain, based on their weight, from 0.005 to 15% by weight, preferably from 0.01 to 10% by weight, more preferably from 0.05 to 7.5% by weight and in particular 0.1 to 5 wt .-% tetrasodium imino disuccinate (IDS) included.
- IDDS tetrasodium imino disuccinate
- According to the invention also contain preferred hair treatment agent - based on their weight
- DTPA pentasodium diethylenetriaminepentaacetate
- IDMS tetrasodium imino disuccinate
- DTPA pentasodium diethylenetriamine pentaacetate
- IDS tetrasodium imino disuccinate
- preferred hair treatment compositions contain - based on their weight -0, 1 to 5 wt .-% tetrasodium A /, A / -bis (carboxylatomethyl) -L-glutamate (Tetrasodium glutamate diacetates, GLDA) and 0, 1 to 5 wt % Pentasodium diethylenetriaminepentaacetate (DTPA) and 0.1 to 5% by weight tetrasodiumiminodisuccinate (IDS).
- the hair treatment compositions may contain at least one divalent or trivalent metal salt. These lead to an improved washout prevention. To achieve an optimum effect, it is advantageous if the metal salts are present in dissolved form in the compositions according to the invention.
- the hair cleansing and care compositions according to the invention therefore contain water-soluble divalent or trivalent metal salts.
- water-soluble is understood to mean that at 20 ° C. at least 1 g of the respective salt can be completely dissolved in 1 l of water.
- Suitable divalent or trivalent metal salts may be selected from divalent or trivalent organic and / or inorganic salts.
- Particularly suitable cations within these salts may preferably be selected from alkaline earth metal cations and from copper, zinc, iron (II), iron (III) and / or aluminum cations. Very particularly preferred are alkaline earth metal cations and particularly preferably calcium and magnesium cations.
- Particularly suitable organic anions within these salts may preferably be selected from formate, acetate, lactate, succinate, citrate, tartrate, malate, maleate, oxalate and / or glycolate ions. Very particular preference is given to acetate, lactate and / or citrate salts with the abovementioned cations.
- Particularly preferred organic salts are calcium, calcium, calcium, magnesium, magnesium and / or magnesium acetate.
- Particularly suitable inorganic anions within these salts can be selected from halide, sulfate, phosphate and / or carbonate ions. Very particular preference is given to sulfate and / or halide ions, such as chloride and bromide ions.
- Particularly preferred inorganic salts are calcium chloride, calcium sulfate, magnesium chloride and / or magnesium sulfate.
- the proportion by weight of the at least one divalent or trivalent metal salt in the total weight of the hair treatment compositions according to the invention is preferably from 0.01 to 10% by weight, preferably from 0.1 to 7.5% by weight, more preferably from 0.2 to 5% by weight. % and in particular 0.3 to 3 wt .-%.
- preferred hair treatment compositions contain - based on their weight - 0.01 to 10 wt .-%, preferably 0.1 to 7.5 wt .-%, more preferably 0.2 to 5 wt .-% and in particular 0.3 to 3 wt .-% of at least one divalent or trivalent metal salt from the group of organic or inorganic copper, zinc, iron (II), calcium, magnesium, iron (III) and / or aluminum salts.
- the water-soluble salts are particularly preferred. Most particularly preferred within this embodiment are calcium lactate, calcium citrate, calcium acetate, magnesium lactate, magnesium citrate, magnesium acetate, calcium halides, calcium hydroxide, magnesium halides and / or magnesium hydroxide.
- the hair treatment compositions preferably contain the active ingredients described above in a cosmetically acceptable carrier.
- a cosmetically acceptable carrier for the purposes of the invention, this is preferably understood as meaning an aqueous or aqueous-alcoholic carrier.
- the cosmetic carrier preferably contains at least 50% by weight, more preferably at least 60% by weight, particularly preferably at least 70% by weight and especially preferably at least 75% by weight of water.
- the cosmetic carrier may contain 0.01 to 40 wt .-%, preferably 0.05 to 30 wt .-% and in particular 0, 1 to 20 wt .-% of at least one alcohol.
- Suitable alcohols are, for example, ethanol, ethyl diglycol, 1-propanol, 2-propanol, isopropanol, 1,2-propylene glycol, glycerol, diglycerol, triglycerol, 1-butanol, 2-butanol, 1, 2-butanediol, 1, 3-butanediol, 1-pentanol, 2-pentanol, 1, 2-pentanediol, 1, 5-pentanediol, 1, hexanol, 2-hexanol, 1, 2-hexanediol, 1, 6-hexanediol, polyethylene glycols, sorbitol, sorbitan, benzyl alcohol or mixtures thereof alcohols.
- the hair treatment compositions according to the invention it is advantageous if they have a slightly acidic pH.
- compositions according to the invention in a pH range from 4.2 to 5.8 have a particularly good skin tolerance and mildness.
- the hair treatment compositions of the invention preferably have a pH in the range of 4.2 to 5.8, more preferably from 4.3 to 5.6, more preferably from 4.4 to 5.5, most preferably from 4.5 to 5.4, and most preferably from 4.7 to 5.3.
- the hair treatment compositions according to the invention may contain vegetable oils, vegetable butters and / or vegetable waxes. These vegetable oil components give the hair improved combability and manageability and increase hair shine.
- Suitable vegetable oil components include natural (vegetable) oils and / or butters, which commonly contain triglycerides and mixtures of triglycerides.
- Preferred natural oils are coconut oil, (sweet) almond oil, walnut oil, peach kernel oil, apricot kernel oil, argan oil, avocado oil, tea tree oil, soybean oil, sesame oil, sunflower oil, tsubaki oil, evening primrose oil, rice bran oil, palm kernel oil, mango seed oil, marula oil, meadowfoam oil, thistle oil, Macadamia nut oil, grape seed oil, amaranth seed oil, bamboo oil, olive oil, wheat germ oil, pumpkin seed oil, mallow oil, hazelnut oil, safflower oil, canola oil, sasanqua oil, jojoba oil, rambutan oil, cocoa butter and / or shea butter.
- Carnauba waxes, beeswaxes and / or candelilla waxes may be used as suitable natural or vegetable waxes.
- Particularly preferred vegetable oil components are (sweet) almond oil, peach kernel oil, apricot kernel oil, amaranth seed oil, argan oil, olive oil, jojoba oil, cocoa butter and / or shea butter.
- Apricot kernel oil, argan oil, olive oil and / or jojoba oil are particularly preferred.
- the hair treatment compositions according to the invention preferably contain coconut oil, (sweet) almond oil, walnut oil, peach kernel oil, apricot kernel oil, argan oil, avocado oil, tea tree oil, soybean oil, sesame oil, sunflower oil, tsubaki oil, evening primrose oil, rice bran oil, palm kernel oil, mango seed oil, marula oil , Meadowfoam seed oil, thistle oil, macadamia nut oil, grape seed oil, amaranth seed oil, bamboo oil, olive oil, wheat germ oil, pumpkin seed oil, mallow oil, hazelnut oil, safflower oil, canola oil, sasanqua oil, jojoba oil, rambutan oil, cocoa butter and / or shea butter.
- coconut oil (sweet) almond oil, walnut oil, peach kernel oil, apricot kernel oil, argan oil, avocado oil, tea tree oil, soybean oil, sesame oil, sunflower oil, tsubaki oil, evening primrose oil, rice bran oil, palm kernel oil, mango
- the hair treatment compositions according to the invention contain (sweet) almond oil, peach kernel oil, apricot kernel oil, amaranth seed oil, argan oil, olive oil, jojoba oil, cocoa butter and / or shea butter.
- the proportion by weight of the at least one vegetable oil, the vegetable butter and / or the vegetable wax in the total weight of the hair treatment compositions according to the invention is preferably 0.02 to 2.50 wt .-%, more preferably from 0.03 to 2.00 wt .-% , Particularly preferably 0.04 to 1, 50 wt .-% and in particular 0.05 to 1, 00 wt .-%.
- the hair treatment compositions according to the invention may contain at least one further hair-conditioning active agent, which may be selected from the group of US Pat
- Glycerol Particular preference is given to vitamins, provitamins and vitamin precursors from groups A, B, E and H. Particular preference is given to nicotinamide, biotin, pantolactone and / or panthenol.
- the proportion by weight of the vitamin (s), vitamin derivative (s), and / or the vitamin precursor (s) in the total weight of the hair treatment agent is preferably from 0.001 to 2% by weight, particularly preferably from 0.005 to 1% by weight and in particular 0, 01 to 0.5 wt .-%.
- Suitable plant extracts are extracts that can be made from any part of a plant. Usually these extracts are produced by extraction of the whole plant. However, in individual cases it may also be preferred to prepare the extracts exclusively from flowers and / or leaves of the plant. Particularly suitable are the extracts of green tea, oak bark, stinging nettle, witch hazel, hops, chamomile, burdock root, horsetail, linden, lychee, almond, aloe vera, spruce needle, horse chestnut, sandalwood, juniper, coconut, mango, apricot, lime , Wheat, Kiwi, Melon, Orange, Grapefruit, Sage, Rosemary, Birch, Mallow, Meadowfoam, Quendel, Yarrow, Thyme, Melissa, Hominy, Coltsfoot, Marshmallow, Ginseng, Ginger root, Echinacea purpurea, Olea europea, Boerhavia diffusa roots, Foeniculum vulgaris and Apim graveolens.
- compositions of the invention are the extracts of green tea, stinging nettle, witch hazel, chamomile, aloe vera, ginseng, echinacea purpurea, olea europea and / or Boerhavia diffusa roots.
- the plant extracts may in the hair treatment compositions according to the invention (based on the total weight of the compositions) preferably in an amount of 0.01 to 10 wt .-%, more preferably from 0.05 to 7.5 wt .-% and in particular from 0, 1 be used to 5 wt .-%.
- Glycerin may be added to the hair cleansing and care products separately in an amount of up to 10% by weight (based on the total weight of the composition). However, it may also be part of the aforementioned aqueous-alcoholic carrier.
- hair treatment compositions according to the invention are also suitable for use as antidandruff preparation.
- the total weight of anti-dandruff agents in the total weight of the hair treatment agent may preferably 0.01 to 10 wt .-%, more preferably 0.025 to 7.5 wt .-%, particularly preferably 0.05 to 5 wt .-% and in particular 0.075 to 3 wt. -%.
- Suitable antidandruff active ingredients may be selected from piroctone olamine, climbazole, zinc pyrithione, ketoconazole, salicylic acid, sulfur, selenium sulfide, tar preparations, undecenoic acid derivatives, burdock root extracts, poplar extracts, nettle extracts, walnut shell extracts, birch extracts, willow bark extracts, rosemary extracts and / or arnica extracts.
- auxiliaries and additives which may preferably be present in the hair treatment compositions according to the invention are, for example:
- Thickening agents such as gelatin or vegetable gums, for example agar-agar, guar gum, alginates, xanthan gum, gum arabic, karaya gum, locust bean gum, linseed gums, dextrans, cellulose derivatives, e.g. As methyl cellulose, hydroxyalkyl cellulose and carboxymethyl cellulose, starch fractions and derivatives such as amylose, amylopectin and dextrins, clays and phyllosilicates such. As bentonite or fully synthetic hydrocolloids such.
- polyvinyl alcohol the Ca, Mg or Zn - soaps,
- Structurants such as maleic acid and lactic acid
- fiber-structure-improving active ingredients in particular mono-, di- and oligosaccharides such as, for example, glucose, galactose, fructose, fructose and lactose,
- Active ingredients such as bisabolol and / or allantoin
- Ceramides are understood as meaning N-acylsphingosine (fatty acid amides of sphingosine) or synthetic analogues of such lipids (so-called pseudo-ceramides), propellants such as propane-butane mixtures, N 2 O, dimethyl ether, CO 2 and air,
- Additional viscosity regulators such as salts (NaCl).
- the agents of the invention can be formulated as so-called rinse-off products, i. are rinsed out of the hair after a certain exposure time. This exposure time is preferably less than one hour, i. the consumer preferably does not leave the products until the next hair wash in the hair.
- Another object of the present invention is therefore a method for hair treatment in which an agent according to the invention is applied to dry or damp hair, left there for a period of 10 to 300 seconds and then rinsed out.
- the agents of the invention may also be formulated as so-called leave-on products, i. are not rinsed out of the hair, but left there until the next hair wash.
- Another object of the present invention is therefore a method for hair treatment, in which an agent according to the invention is applied to dry or damp hair and left there until the next hair wash.
- the agents according to the invention lead to a significantly increased strengthening of the inner and outer hair structure.
- Another object of the present invention is therefore the use of agents according to the invention for strengthening the hair structure, in particular the inner hair structure.
- Structural strengthening in the sense of the invention is to be understood as meaning a reduction in the damage of keratinic fibers which has arisen due to the most diverse influences.
- the restoration of natural strength plays an essential role.
- RefiguredABLE fibers are characterized for example by an improved gloss, by a improved grip and easier combing.
- they have an optimized strength and elasticity.
- Successful structural reinforcement or restructuring can be physically detected as a melting point increase compared to the damaged fiber.
- compositions of the invention also lead to a significantly increased stability of artificial dyeings against the washing out of paint.
- chemically dyed hairs can be washed significantly more frequently with the compositions according to the invention, without the undesired bleeding or color fading occurring.
- Another object of the present invention is therefore the use of agents according to the invention for reducing the washout of color from chemically colored hair.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Hair treatment products comprising, in relation to its weight, 0.001 to 10 % by weight of at least one amine salt of a carboxylic acid and 0.001 to 20 % by weight of at least one protein hydrolysate, which lead to improved structural reinforcement of keratin fibres and improved hair care, and which reduce or prevent colour washout in dyed hair.
Description
"verbessert konditionierende Haarbehandlungsmittel mit Auswaschschutz" "improves conditioning hair wash with leach protection"
Die Erfindung betrifft Haarbehandlungsmittel, insbesondere Shampoos und sogenannte Konditionierer, mit einer Wirkstoffkombination zur schonenden und effektiven Pflege der Haare. Nicht zuletzt durch starke Beanspruchung der Haare, beispielsweise durch Färben oder Dauerwellen als auch durch Reinigung der Haare mit Shampoos und durch Umweltbelastungen, nimmt die Bedeutung von Pflegeprodukten mit möglichst langanhaltender Wirkung zu. Derartige Pflegemittel beeinflussen die natürliche Struktur und die Eigenschaften der Haare. So können anschließend an solche Pflegebehandlungen beispielsweise die Naß- und Trockenkämmbarkeit des Haares, der Halt und die Fülle des Haares optimiert sein oder die Haare vor erhöhtem Spliß geschützt sein. The invention relates to hair treatment compositions, in particular shampoos and so-called conditioners, with a combination of active ingredients for gentle and effective care of the hair. Last but not least, by heavy use of the hair, for example by dyeing or perming as well as by cleaning the hair with shampoos and environmental pollution, the importance of care products with the longest possible effect increases. Such care products affect the natural structure and properties of the hair. Thus, for example, the wet and dry combability of the hair, the hold and the fullness of the hair can be optimized or the hair can be protected from increased splits following such care treatments.
Es ist daher seit langem üblich, Haare einer speziellen Nachbehandlung zu unterziehen. Dabei werden, üblicherweise in Form einer Spülung, die Haare mit speziellen Wirkstoffen, beispielsweise quaternären Ammoniumsalzen oder speziellen Polymeren, behandelt. Durch diese Behandlung werden je nach Formulierung die Kämmbarkeit, der Halt und die Fülle der Haare verbessert und die Splißrate verringert. It has therefore long been customary to subject hair to a special after-treatment. In this case, the hair is treated with special active ingredients, for example quaternary ammonium salts or special polymers, usually in the form of a rinse. Depending on the formulation, this treatment improves the combability, the hold and the fullness of the hair and reduces the splitting rate.
Ebenso sind im Stand der Technik multifunktionale kosmetische Produkte bekannt. Insbesondere zählen hierzu die so genannten„2 in 1 " Shampoos, welche nicht nur das Haar reinigen, sondern es auch konditionieren. Derartige Produkte werden vom Verbraucher sehr geschätzt, weil sie durch ihre Produktleistung mindestens einen Verfahrensschritt, beispielsweise das Konditionieren mit einer klassischen Haarspülung, erübrigen. Likewise, multifunctional cosmetic products are known in the prior art. In particular, these include the so-called "2 in 1" shampoos, which not only cleanse the hair, but also condition it.These products are highly appreciated by the consumer because of their product performance, at least one process step, for example, conditioning with a classical hair conditioner; unnecessary.
Ebenso spielen Produkte zur Veränderung der natürlichen Haarfarbe in der Haarkosmetik eine herausragende Rolle. Man unterscheidet permanente, semipermanente oder temporäre Färbesysteme, die auf chemischen und/oder natürlichen Farbstoffen basieren. Die durch permanente, semipermanente oder temporäre Färbesysteme künstlich erzeugten Haarfarben weisen jedoch den Nachteil auf, daß sie sich - beispielsweise während oder nach der Haarreinigung - in unerwünschter Weise verändern können. Likewise, products for altering the natural hair color in hair cosmetics play a prominent role. A distinction is made between permanent, semi-permanent or temporary dyeing systems based on chemical and / or natural dyes. However, the hair dyes artificially produced by permanent, semi-permanent or temporary dyeing systems have the disadvantage that they can change in an undesirable manner, for example during or after the hair cleansing.
Unter„unerwünschter Veränderung" wird das Verblassen oder Ausbluten sowie der Verlust der Farbbrillanz des durch die jeweilige Färbung erzielten Farbtons der Haare verstanden. Umwelteinflüsse und/oder Sonneneinwirkungen können diese Veränderungen noch verstärken. Es besteht nach wie vor das Bedürfnis, Wirkstoffe oder Wirkstoffkombinationen für Haarbehandlungsmittel mit guten pflegenden Eigenschaften, die zudem die Haftung von Farbstoffen auf den Haarfasern stärken und so die Echtheit der künstlich erzeugten Haarfarbe erhalten, bereitzustellen und Haarbehandlungsmittel diesbezüglich weiterzuentwickeln. The term "undesired change" is understood to mean the fading or bleeding and loss of color brilliance of the hue of the hair as a result of the respective dyeing.Environmental influences and / or sun effects may exacerbate these changes.There is still a need for active ingredients or active ingredient combinations for hair treatment products with good nourishing properties, which also strengthen the adhesion of dyes to the hair fibers and thus preserve the authenticity of the artificially produced hair color, and further develop hair treatment products in this regard.
Es wurde jedoch beobachtet, daß die Wasserhärte die Pflegeeigenschaften von Haarbehandlungsmitteln mitunter negativ beeinflussen kann, so daß die Pflegeleistung ein und desselben Produktes je nach Wasserqualität entweder zu gering oder zu hoch ist. However, it has been observed that water hardness can sometimes adversely affect the care properties of hair treatment products, so that the care performance of one and the same product is either too low or too high depending on the water quality.
Unter zur hoher Pflegeleistung oder„Überpflegung" (Auftreten eines sogenannten Builtup-Effekts) der Haare ist vor allem ein schmieriges Haargefühl, wenig Haarvolumen und/oder ein strähniges,
ungepflegtes Aussehen der Haare zu verstehen, während geschädigte (brüchige, splissanfällige, stumpfe) Haare ein Indiz für eine zu geringe Pflegeleistung sind. Among the high care performance or "over-food" (occurrence of a so-called built-up effect) of the hair is especially a greasy hair feeling, little hair volume and / or a stringy, To understand the neglected appearance of the hair, while damaged (brittle, split-susceptible, dull) hair is an indication of a low care performance.
Der vorliegenden Anmeldung lag daher die Aufgabe zugrunde, gut hautverträgliche und pflegende Haarbehandlungsmittel bereitzustellen, die hervorragende Schaumeigenschaften aufweisen und eine gute Abspülbarkeit mit Wasser aufweisen und darüber hinaus das Auswaschen von Farbe aus gefärbten Haaren verringern oder verhindern. The present application was therefore based on the object to provide good skin-friendly and nourishing hair treatment compositions which have excellent foam properties and have a good rinsability with water and also reduce or prevent the washing out of color from dyed hair.
Die pflegenden Haarbehandlungsmittel sollten unabhängig von der Wasserqualität eine gleichbleibende Konditionierungsleistung aufweisen und insbesondere feine Haare und/oder geschädigte Haare nicht beschweren und dabei die Haare in ihrer Struktur stärken und so vor Spliß und Bruch schützen und die Kämmbarkeit und den Griff verbessern. Darüber hinaus sollten sie keimreduzierend wirken. The nourishing hair treatment products should have a constant conditioning performance regardless of the water quality and in particular fine hair and / or damaged hair and thereby strengthen the hair in their structure and so protect against splits and breakage and improve combability and grip. In addition, they should have a germ-reducing effect.
Es wurde nun gefunden, daß eine Kombination bestimmter Inhaltsstoffe eine besonders positive Wirkung auf damit behandeltem, gefärbten Haar und den Haarfollikel besitzt. It has now been found that a combination of certain ingredients has a particularly positive effect on treated, colored hair and the hair follicle.
Ein erster Gegenstand der vorliegenden Erfindung sind Haarbehandlungsmittel, enthaltend bezogen auf ihr Gewicht A first object of the present invention are hair treatment compositions containing by weight
a) 0,001 bis 10 Gew.-% mindestens eines Aminsalzes einer Carbonsäure; a) 0.001 to 10 wt .-% of at least one amine salt of a carboxylic acid;
b) 0,001 bis 20 Gew.-% mindestens eines Proteinhydrolysats. b) 0.001 to 20 wt .-% of at least one protein hydrolyzate.
Haarbehandlungsmittel im Sinne der vorliegenden Erfindung sind beispielsweise Haarshampoos, Haarkonditionierer, konditionierende Shampoos, Haarsprays, Haarspülungen, Haarkuren, Haarpackungen, Haar-Tonics, Dauerwell-Fixierlösungen, Haarfärbeshampoos, Haarfärbemittel, Haarfestiger, Haarlegemittel, Haarstyling-Zubereitungen, Fönwell-Lotionen, Schaumfestiger, Haargele, Haarwachse oder deren Kombinationen. Im Hinblick auf die Tatsache, daß insbesondere Männer oft die Anwendung mehrerer unterschiedlicher Mittel und/oder mehrere Anwendungsschritte scheuen, sind solche Mittel bevorzugt, die der Mann ohnehin anwendet. Bevorzugte Mittel sind daher Shampoos, Konditioniermittel oder Haar-Tonics. Hair treatment compositions for the purposes of the present invention are, for example, hair shampoos, hair conditioners, conditioning shampoos, hairsprays, hair conditioners, hair conditioners, hair wraps, hair tonics, perming solutions, hair dye shampoos, hair dyes, hair fixatives, hair dressings, hairstyling preparations, hair lotions, mousses, hair gels , Hair waxes or their combinations. In view of the fact that, in particular, men often shy away from the use of several different means and / or several application steps, preference is given to means which the man applies anyway. Preferred agents are therefore shampoos, conditioners or hair tonics.
Die Haarbehandlungsmittel enthalten als ersten wesentlichen Inhaltsstoff 0,001 bis 10 Gew.-% mindestens eines Aminsalzes einer Carbonsäure. The hair treatment compositions contain as the first essential ingredient 0.001 to 10 wt .-% of at least one amine salt of a carboxylic acid.
Aminsalze von Carbonsäuren werden aus einem (primären, sekundären oder tertiären) Amin mit einer Carbonsäure aus deren -COOH-Gruppe gebildet. Dabei protoniert das acide H der Säure das Amin zu einem Ammonium. Als Amine eignen sich beispielsweise Methylamin, Dimethylamin, Trimethylamin, Ethylamin, Diethylamin, Triethylamin, n-Propyylamin, Di-n-Propylamin, Tri-n- Propylamin, Isopropylamin, Diisopropylamin, Triisopropylamin, Phenylamin (Anilin), Diphenylamin, Triphenylamin, Monoethanolamin, Diethanolamin, Triethanolamin, Ethylendiamin, Propylendiamin, die Phenylendiamine 1 ,2-Diaminobenzol, 1 ,3-Diaminobenzol und 1 ,4-Diaminobenzol, Piperidin, Morpholin, 4,4-Dimethyloxazolidin usw.. Amine salts of carboxylic acids are formed from a (primary, secondary or tertiary) amine with a carboxylic acid from their -COOH group. The acidic acid of the acid protonates the amine to an ammonium. Suitable amines are, for example, methylamine, dimethylamine, trimethylamine, ethylamine, diethylamine, triethylamine, n-propylamine, di-n-propylamine, tri-n-propylamine, isopropylamine, diisopropylamine, triisopropylamine, phenylamine (aniline), diphenylamine, triphenylamine, monoethanolamine, Diethanolamine, triethanolamine, ethylenediamine, propylenediamine, the phenylenediamines 1, 2-diaminobenzene, 1, 3-diaminobenzene and 1, 4-diaminobenzene, piperidine, morpholine, 4,4-dimethyloxazolidine, etc.
Typische Vertreter für aliphatische Mono- und Dicarbonsäuren sind beispielsweise Essigsäure, Propionsäure, Oxalsäure und 1 ,3-Propandisäure sowie aromatische Carbonsäuren wie beispielsweise Benzoesäure. Weitere organische Säuren sind beispielsweise H yd roxy carbonsäuren wie Glykolsäure, Zitronensäure, Weinsäure, Äpfelsäure und Milchsäure. Auch ungesättigte Mono-
oder Dicarbonsäuren wie beispielsweise Fumarsäure oder α-Ketocarbonsäuren wie beispielsweise Brenztraubensäure (2-Oxopropionsäure) sind erfindungsgemäß als Aminsalz einsetzbar. Typical representatives of aliphatic mono- and dicarboxylic acids are, for example, acetic acid, propionic acid, oxalic acid and 1,3-propanedioic acid and aromatic carboxylic acids such as benzoic acid. Further organic acids are, for example, hydroxy carboxylic acids such as glycolic acid, citric acid, tartaric acid, malic acid and lactic acid. Also unsaturated mono- or dicarboxylic acids such as fumaric acid or α-ketocarboxylic acids such as pyruvic acid (2-oxopropionic acid) are inventively used as the amine salt.
Erfindungsgemäß bevorzugt einzusetzende Aminsalze von Carbonsäuren sind beispielsweiseExamples of preferred amine salts of carboxylic acids to be used according to the invention are
Methylammoniumform iat, Dimethylammoniumformiat, Trimethylammoniumformiat,Methyl ammonium formate, dimethyl ammonium formate, trimethyl ammonium formate,
Ethylammoniumformiat, Diethylammoniumformiat, Triethylammoniumformiat, n-Ethylammonium formate, diethylammonium formate, triethylammonium formate, n-
Propyylammoniumformiat, Di-n-Propylammoniumformiat, Tri-n-PropylammoniumformiatPropylammonium formate, di-n-propylammonium formate, tri-n-propylammonium formate
Isopropylammoniumformiat, Diisopropylammoniumformiat, TriisopropylammoniumformiatIsopropylammonium formate, diisopropylammonium formate, triisopropylammonium formate
Phenylammoniumformiat, Diphenylammoniumformiat, Triphenylammoniumformiat Monoethanolammoniumformiat, Diethanolammoniumformiat, Triethanolammoniumformiat Ethylenammoniumformiat, Propylenammoniumformiat, Piperidiniumformiat, Morpholiniumformiat 4,4-Dimethyloxazolidiniumformiat, Methylammoniumacetat, Dimethylammoniumacetat Trimethylammoniumacetat, Ethylammoniumacetat, DiethylammoniumacetatPhenylammonium formate, diphenylammonium formate, triphenylammonium formate, monoethanolammonium formate, diethanolammonium formate, triethanolammonium formate, ethyleneammonium formate, propylenammonium formate, piperidinium formate, morpholinium formate, 4,4-dimethyloxazolidinium formate, methylammonium acetate, dimethylammonium acetate, trimethylammonium acetate, ethylammonium acetate, diethylammonium acetate
Triethylammoniumacetat, n-Propyylammoniumacetat, Di-n-Propylammoniumacetat, Tri-n- Propylammoniumacetat, Isopropylammoniumacetat, DiisopropylammoniumacetatTriethylammonium acetate, n-propylammonium acetate, di-n-propylammonium acetate, tri-n-propylammonium acetate, isopropylammonium acetate, diisopropylammonium acetate
Triisopropylammoniumacetat, Phenylammoniumacetat, DiphenylammoniumacetatTriisopropylammonium acetate, phenylammonium acetate, diphenylammonium acetate
Triphenylammoniumacetat, Monoethanolammoniumacetat, DiethanolammoniumacetatTriphenylammonium acetate, monoethanolammonium acetate, diethanolammonium acetate
Triethanolammoniumacetat, Ethylenammoniumacetat, PropylenammoniumacetatTriethanolammonium acetate, ethylene ammonium acetate, propylene ammonium acetate
Piperidiniumacetat, Morpholiniumacetat, 4,4-DimethyloxazolidiniumacetatPiperidinium acetate, morpholinium acetate, 4,4-dimethyloxazolidinium acetate
Methylammoniumpropionat, Dimethylammoniumpropionat, TrimethylammoniumpropionatMethylammonium propionate, dimethylammonium propionate, trimethylammonium propionate
Ethylammoniumpropionat, Diethylammoniumpropionat, Triethylammoniumpropionat, n- Propyylammoniumpropionat, Di-n-Propylammoniumpropionat, Tri-n-Propylammoniumpropionat Isopropylammoniumpropionat, Diisopropylammoniumpropionat, Triisopropylammoniumpropionat Phenylammoniumpropionat, Diphenylammoniumpropionat, Triphenylammoniumpropionat Monoethanolammoniumpropionat, Diethanolammoniumpropionat, Triethanolammoniumpropionat Ethylenammoniumpropionat, Propylenammoniumpropionat, PiperidiniumpropionatEthylammoniumpropionat, Diethylammoniumpropionat, Triethylammoniumpropionat, n- Propyylammoniumpropionat, di-n-Propylammoniumpropionat, tri-n-Propylammoniumpropionat Isopropylammoniumpropionat, Diisopropylammoniumpropionat, Triisopropylammoniumpropionat Phenylammoniumpropionat, Diphenylammoniumpropionat, Triphenylammoniumpropionat Monoethanolammoniumpropionat, Diethanolammoniumpropionat, Triethanolammoniumpropionat Ethylenammoniumpropionat, Propylenammoniumpropionat, piperidinium
Morpholiniumpropionat, 4,4-Dimethyloxazolidiniumpropionat, MethylammoniumbutyratMorpholinium propionate, 4,4-dimethyloxazolidinium propionate, methylammonium butyrate
Dimethylammoniumbutyrat, Trimethylammoniumbutyrat, Ethylammoniumbutyrat Diethylammoniumbutyrat, Triethylammoniumbutyrat, n-Propyylammoniumbutyrat, Di-n- Propylammoniumbutyrat, Tri-n-Propylammoniumbutyrat, Isopropylammoniumbutyrat Diisopropylammoniumbutyrat, Triisopropylammoniumbutyrat, Phenylammoniumbutyrat Diphenylammoniumbutyrat, Triphenylammoniumbutyrat, Monoethanolammoniumbutyrat Diethanolammoniumbutyrat, Triethanolammoniumbutyrat, Ethylenammoniumbutyrat Propylenammoniumbutyrat, Piperidiniumbutyrat, Morpholiniumbutyrat, 4,4- Dimethyloxazolidiniumbutyrat, Methylammoniumpentanoat, Dimethylammoniumpentanoat Trimethylammoniumpentanoat, Ethylammoniumpentanoat, Diethylammoniumpentanoat Triethylammoniumpentanoat, n-Propyylammoniumpentanoat, Di-n-Propylammoniumpentanoat, Tri- n-Propylammoniumpentanoat, Isopropylammoniumpentanoat, Diisopropylammoniumpentanoat Triisopropylammoniumpentanoat, Phenylammoniumpentanoat, Diphenylammoniumpentanoat Tnphenylammoniumpentanoat, Monoethanolammoniumpentanoat, Diethanolammoniumpentanoat
Triethanolammoniumpentanoat, Ethylenammoniumpentanoat, Propylenammoniumpentanoat Piperidiniumpentanoat, Morpholiniumpentanoat, 4,4-DimethyloxazolidiniumpentanoatDimethylammoniumbutyrat, Trimethylammoniumbutyrat, Ethylammoniumbutyrat Diethylammoniumbutyrat, Triethylammoniumbutyrat, n-Propyylammoniumbutyrat, di-n Propylammoniumbutyrat, tri-n-Propylammoniumbutyrat, Isopropylammoniumbutyrat Diisopropylammoniumbutyrat, Triisopropylammoniumbutyrat, Phenylammoniumbutyrat Diphenylammoniumbutyrat, Triphenylammoniumbutyrat, Monoethanolammoniumbutyrat Diethanolammoniumbutyrat, Triethanolammoniumbutyrat, Ethylenammoniumbutyrat Propylenammoniumbutyrat, Piperidiniumbutyrat, Morpholiniumbutyrat, 4.4 - Dimethyloxazolidiniumbutyrat, Methylammoniumpentanoat, Dimethylammoniumpentanoat Trimethylammoniumpentanoat, Ethylammoniumpentanoat, Diethylammoniumpentanoat Triethylammoniumpentanoat, n-Propyylammoniumpentanoat, di-n-Propylammoniumpentanoat, tri- n-Propylammoniumpentanoat, Isopropylammoniumpentanoat, Diisopropylammoniumpentanoat Triisopropylammoniumpentanoat, Phenylammoniumpentanoat, Diphenylammoniumpentanoat Tnphenylammoniumpentanoat, monoethanolammonium Penta noate, diethanolammonium pentanoate Triethanolammonium pentanoate, ethylene ammonium pentanoate, propylene ammonium pentanoate, piperidinium pentanoate, morpholinium pentanoate, 4,4-dimethyloxazolidinium pentanoate
Methylammoniumhexanoat, Dimethylammoniumhexanoat, Trimethylammoniumhexanoat Ethylammoniumhexanoat, Diethylammoniumhexanoat, Triethylammoniumhexanoat, n- Propyylammoniumhexanoat, Di-n-Propylammoniumhexanoat, Tri-n-Propylammoniumhexanoat Isopropylammoniumhexanoat, Diisopropylammoniumhexanoat, Triisopropylammoniumhexanoat Phenylammoniumhexanoat, Diphenylammoniumhexanoat, Triphenylammoniumhexanoat Monoethanolammoniumhexanoat, Diethanolammoniumhexanoat, Triethanolammoniumhexanoat Ethylenammoniumhexanoat, Propylenammoniumhexanoat, PiperidiniumhexanoatMethylammoniumhexanoat, Dimethylammoniumhexanoat, Trimethylammoniumhexanoat Ethylammoniumhexanoat, Diethylammoniumhexanoat, Triethylammoniumhexanoat, n- Propyylammoniumhexanoat, di-n-Propylammoniumhexanoat, tri-n-Propylammoniumhexanoat Isopropylammoniumhexanoat, Diisopropylammoniumhexanoat, Triisopropylammoniumhexanoat Phenylammoniumhexanoat, Diphenylammoniumhexanoat, Triphenylammoniumhexanoat Monoethanolammoniumhexanoat, Diethanolammoniumhexanoat, Triethanolammoniumhexanoat Ethylenammoniumhexanoat, Propylenammoniumhexanoat, Piperidiniumhexanoat
Morpholiniumhexanoat, 4,4-Dimethyloxazolidiniumhexanoat, Methylammoniumheptanoat; Dimethylammoniumheptanoat, Trimethylammoniumheptanoat, Ethylammoniumheptanoat Diethylammoniumheptanoat, Triethylammoniumheptanoat, n-Propyylammoniumheptanoat, Di-n- Propylammoniumheptanoat, Tri-n-Propylammoniumheptanoat, Isopropylammoniumheptanoat Diisopropylammoniumheptanoat, Triisopropylammoniumheptanoat, Phenylammoniumheptanoat Diphenylammoniumheptanoat, Triphenylammoniumheptanoat, Monoethanolammoniumheptanoat Diethanolammoniumheptanoat, Triethanolammoniumheptanoat, Ethylenammoniumheptanoat Propylenammoniumheptanoat, Piperidiniumheptanoat, Morpholiniumheptanoat, 4,4- Dimethyloxazolidiniumheptanoat, Methylammoniumoctanoat, Dimethylammoniumoctanoat Trimethylammoniumoctanoat, Ethylammoniumoctanoat, DiethylammoniumoctanoatMorpholinium hexanoate, 4,4-dimethyloxazolidinium hexanoate, methylammonium heptanoate ; Dimethylammoniumheptanoat, Trimethylammoniumheptanoat, Ethylammoniumheptanoat Diethylammoniumheptanoat, Triethylammoniumheptanoat, n-Propyylammoniumheptanoat, di-n Propylammoniumheptanoat, tri-n-Propylammoniumheptanoat, Isopropylammoniumheptanoat Diisopropylammoniumheptanoat, Triisopropylammoniumheptanoat, Phenylammoniumheptanoat Diphenylammoniumheptanoat, Triphenylammoniumheptanoat, Monoethanolammoniumheptanoat Diethanolammoniumheptanoat, Triethanolammoniumheptanoat, Ethylenammoniumheptanoat Propylenammoniumheptanoat, Piperidiniumheptanoat, Morpholiniumheptanoat, 4.4 Dimethyloxazolidinium heptanoate, methylammonium octanoate, dimethylammonium octanoate, trimethylammonium octanoate, ethylammonium octanoate, diethylammonium octanoate
Triethylammoniumoctanoat, n-Propyylammoniumnonanoat, Di-n-Propylammoniumoctanoat, Tri-n- Propylammoniumoctanoat, Isopropylammoniumoctanoat, Diisopropylammoniumoctanoat Triisopropylammoniumoctanoat, Phenylammoniumoctanoat, Diphenylammoniumoctanoat; Triphenylammoniumoctanoat, Monoethanolammoniumoctanoat, Diethanolammoniumoctanoat Triethanolammoniumoctanoat, Ethylenammoniumoctanoat, Propylenammoniumoctanoat; Piperidiniumoctanoat, Morpholiniumoctanoat, 4,4-DimethyloxazolidiniumoctanoatTriethylammonium octanoate, n-propylammonium nonanoate, di-n-propylammonium octanoate, tri-n-propylammonium octanoate, isopropylammonium octanoate, diisopropylammonium octanoate, triisopropylammonium octanoate, phenylammonium octanoate, diphenylammonium octanoate ; Triphenyl ammonium octanoate, monoethanol ammonium octanoate, diethanol ammonium octanoate, triethanol ammonium octanoate, ethylene ammonium octanoate, propylene ammonium octanoate ; Piperidinium octanoate, morpholinium octanoate, 4,4-dimethyloxazolidinium octanoate
Methylammoniumnonanoat, Dimethylammoniumnonanoat, Trimethylammoniumnonanoat Ethylammoniumnonanoat, Diethylammoniumnonanoat, Triethylammoniumnonanoat, n- Propyylammoniumnonanoat, Di-n-Propylammoniumnonanoat, Tri-n-Propylammoniumnonanoat; Isopropylammoniumnonanoat, Diisopropylammoniumnonanoat, Triisopropylammoniumnonanoat Phenylammoniumnonanoat, Diphenylammoniumnonanoat, Triphenylammoniumnonanoat; Monoethanolammoniumnonanoat, Diethanolammoniumnonanoat, Triethanolammoniumnonanoat Ethylenammoniumnonanoat, Propylenammoniumnonanoat, Piperidiniumnonanoat; Methyl ammonium nonanoate, dimethyl ammonium nonanoate, trimethyl ammonium nonanoate, ethyl ammonium nonanoate, diethyl ammonium nonanoate, triethyl ammonium nonanoate, n-propyl ammonium nonanoate, di-n-propyl ammonium nonanoate, tri-n-propyl ammonium nonanoate ; Isopropylammonium nonanoate, diisopropylammonium nonanoate, triisopropylammonium nonanoate, phenylammonium nonanoate, diphenylammonium nonanoate, triphenylammonium nonanoate ; Monoethanolammonium nonanoate, diethanolammonium nonanoate, triethanolammonium nonanoate, ethylene ammonium nonanoate, propylene ammonium nonanoate, piperidinium nonanoate ;
Morpholiniumnonanoat, 4,4-Dimethyloxazolidiniumnonanoat, Methylammoniumdecanoat; Dimethylammoniumdecanoat, Trimethylammoniumdecanoat, Ethylammoniumdecanoat Diethylammoniumdecanoat, Triethylammoniumdecanoat, n-Propyylammoniumdecanoat, Di-n- Propylammoniumdecanoat, Tri-n-Propylammoniumdecanoat, Isopropylammoniumdecanoat Diisopropylammoniumdecanoat, Triisopropylammoniumdecanoat, Phenylammoniumdecanoat Diphenylammoniumdecanoat, Triphenylammoniumdecanoat, Monoethanolammoniumdecanoat Diethanolammoniumdecanoat, Triethanolammoniumdecanoat, Ethylenammoniumdecanoat
Propylenammoniumdecanoat, Piperidiniumdecanoat, Morpholiniumdecanoat, 4,4- Dimethyloxazolidiniumdecanoat, Methylammoniumundecanoat, Dimethylammoniumundecanoat, Trimethylammoniumundecanoat, Ethylammoniumundecanoat, Diethylammoniumundecanoat, Triethylammoniumundecanoat, n-Propyylammoniumundecanoat, Di-n-Morpholinium nonanoate, 4,4-dimethyloxazolidinium nonanoate, methyl ammonium decanoate ; Dimethylammoniumdecanoat, Trimethylammoniumdecanoat, Ethylammoniumdecanoat Diethylammoniumdecanoat, Triethylammoniumdecanoat, n-Propyylammoniumdecanoat, di-n Propylammoniumdecanoat, tri-n-Propylammoniumdecanoat, Isopropylammoniumdecanoat Diisopropylammoniumdecanoat, Triisopropylammoniumdecanoat, Phenylammoniumdecanoat Diphenylammoniumdecanoat, Triphenylammoniumdecanoat, Monoethanolammoniumdecanoat Diethanolammoniumdecanoat, Triethanolammoniumdecanoat, Ethylenammoniumdecanoat Propylenammonium decanoate, piperidinium decanoate, morpholinium decanoate, 4,4-dimethyloxazolidinium decanoate, methylammonium undecanoate, dimethylammonium undecanoate, trimethylammonium undecanoate, ethylammonium undecanoate, diethylammonium undecanoate, triethylammonium undecanoate, n-propylammonium undecanoate, di-n-
Propylammoniumundecanoat, Tri-n-Propylammoniumundecanoat, Isopropylammoniumundecanoat, Diisopropylammoniumundecanoat, Triisopropylammoniumundecanoat, Phenylammoniumundecanoat, Diphenylammoniumundecanoat, Triphenylammoniumundecanoat, Monoethanolammoniumundecanoat, Diethanolammoniumundecanoat, Triethanolammoniumundecanoat, Ethylenammoniumundecanoat, Propylenammoniumundecanoat, Piperidiniumundecanoat, Morpholiniumundecanoat, 4,4-Dimethyloxazolidiniumundecanoat, Methylammoniumdodecanoat, Dimethylammoniumdodecanoat, Trimethylammoniumdodecanoat, Ethylammoniumdodecanoat, Diethylammoniumdodecanoat, Triethylammoniumdodecanoat, n- Propyylammoniumdodecanoat, Di-n-Propylammoniumdodecanoat, Tri-n-Propylammoniumundecanoat, tri-n-Propylammoniumundecanoat, Isopropylammoniumundecanoat, Diisopropylammoniumundecanoat, Triisopropylammoniumundecanoat, Phenylammoniumundecanoat, Diphenylammoniumundecanoat, Triphenylammoniumundecanoat, monoethanolammonium undecanoate, Diethanolammoniumundecanoat, Triethanolammoniumundecanoat, ethylene ammonium undecanoate, propylene ammonium undecanoate, Piperidiniumundecanoat, Morpholiniumundecanoat, 4,4-Dimethyloxazolidiniumundecanoat, Methylammoniumdodecanoat, Dimethylammoniumdodecanoat, Trimethylammoniumdodecanoat, Ethylammoniumdodecanoat, Diethylammoniumdodecanoat, Triethylammonium dodecanoate, n-propylammonium dodecanoate, di-n-propylammonium dodecanoate, tri-n-
Propylammoniumdodecanoat, Isopropylammoniumdodecanoat, Diisopropylammoniumdodecanoat Triisopropylammoniumdodecanoat, Phenylammoniumdodecanoat, Diphenylammoniumdodecanoat Triphenylammoniumdodecanoat, Monoethanolammoniumdodecanoat Diethanolammoniumdodecanoat, Triethanolammoniumdodecanoat, Ethylenammoniumdodecanoat Propylenammoniumdodecanoat, Piperidiniumdodecanoat, Morpholiniumdodecanoat, 4,4- Dimethyloxazolidiniumdodecanoat, Methylammoniumoxalat, Dimethylammoniumoxalat Trimethylammoniumoxalat, Ethylammoniumoxalat, DiethylammoniumoxalatPropylammoniumdodecanoat, Isopropylammoniumdodecanoat, Diisopropylammoniumdodecanoat Triisopropylammoniumdodecanoat, Phenylammoniumdodecanoat, Diphenylammoniumdodecanoat Triphenylammoniumdodecanoat, Monoethanolammoniumdodecanoat Diethanolammoniumdodecanoat, Triethanolammoniumdodecanoat, Ethylenammoniumdodecanoat Propylenammoniumdodecanoat, Piperidiniumdodecanoat, Morpholiniumdodecanoat, 4,4 Dimethyloxazolidiniumdodecanoat, Methylammoniumoxalat, Dimethylammoniumoxalat Trimethylammoniumoxalat, Ethylammoniumoxalat, Diethylammoniumoxalat
Triethylammoniumoxalat, n-Propyylammoniumoxalat, Di-n-Propylammoniumoxalat, Tri-n- Propylammoniumoxalat, Isopropylammoniumoxalat, DiisopropylammoniumoxalatTriethylammonium oxalate, n-propylammonium oxalate, di-n-propylammonium oxalate, tri-n-propylammonium oxalate, isopropylammonium oxalate, diisopropylammonium oxalate
Triisopropylammoniumoxalat, Phenylammoniumoxalat, DiphenylammoniumoxalatTriisopropylammonium oxalate, phenylammonium oxalate, diphenylammonium oxalate
Triphenylammoniumoxalat, Monoethanolammoniumoxalat Diethanolammoniumoxalat Triethanolammoniumoxalat, Ethylenammoniumoxalat, Propylenammoniumoxalat Piperidiniumoxalat, Morpholiniumoxalat, 4,4-Dimethyloxazolidiniumoxalat Methylammoniumbenzoat, Dimethylammoniumbenzoat, Trimethylammoniumbenzoat Ethylammoniumbenzoat, Diethylammoniumbenzoat, Triethylammoniumbenzoat, n- Propyylammoniumbenzoat, Di-n-Propylammoniumbenzoat, Tri-n-Propylammoniumbenzoat Isopropylammoniumbenzoat, Diisopropylammoniumbenzoat, Triisopropylammoniumbenzoat Phenylammoniumbenzoat, Diphenylammoniumbenzoat, Triphenylammoniumbenzoat Monoethanolammoniumbenzoat, Diethanolammoniumbenzoat, Triethanolammoniumbenzoat Ethylenammoniumbenzoat, Propylenammoniumbenzoat Piperidiniumbenzoat Morpholiniumbenzoat, 4,4-Dimethyloxazolidiniumbenzoat, Methylammoniumoxalat Dimethylammoniumoxalat, Trimethylammoniumoxalat, Ethylammoniumoxalat Diethylammoniumoxalat, Triethylammoniumoxalat, n-Propyylammoniumoxalat, Di-n- Propylammoniumoxalat, Tri-n-Propylammoniumoxalat, Isopropylammoniumoxalat Diisopropylammoniumoxalat Triisopropylammoniumoxalat, Phenylammoniumoxalat Diphenylammoniumoxalat, Triphenylammoniumoxalat, Monoethanolammoniumoxalat
Diethanolammoniumoxalat, Triethanolammoniumoxalat, Ethylenammoniumoxalat,Triphenylammoniumoxalat, Monoethanolammoniumoxalat Diethanolammoniumoxalat Triethanolammoniumoxalat, Ethylenammoniumoxalat, Propylenammoniumoxalat Piperidiniumoxalat, Morpholiniumoxalat, 4,4-Dimethyloxazolidiniumoxalat Methylammoniumbenzoat, Dimethylammoniumbenzoat, Trimethylammoniumbenzoat Ethylammoniumbenzoat, Diethylammoniumbenzoat, Triethylammoniumbenzoat, n- Propyylammoniumbenzoat, di-n-Propylammoniumbenzoat, tri-n-Propylammoniumbenzoat Isopropylammoniumbenzoat, Diisopropylammoniumbenzoat, Triisopropylammoniumbenzoat Phenylammoniumbenzoat , Diphenylammoniumbenzoat, Triphenylammoniumbenzoat Monoethanolammoniumbenzoat, Diethanolammoniumbenzoat, Triethanolammoniumbenzoat Ethylenammoniumbenzoat, Propylenammoniumbenzoat Morpholiniumbenzoat piperidinium, 4,4-Dimethyloxazolidiniumbenzoat, Methylammoniumoxalat Dimethylammoniumoxalat, Trimethylammoniumoxalat, Ethylammoniumoxalat Diethylammoniumoxalat, Triethylammoniumoxalat, n-Propyylammoniumoxalat, di-n Propylammoniumoxalat, tri-n- Propylammonium oxalate, isopropylammonium oxalate diisopropylammonium oxalate triisopropylammonium oxalate, phenylammonium oxalate diphenylammonium oxalate, triphenylammonium oxalate, monoethanolammonium oxalate Diethanol ammonium oxalate, triethanol ammonium oxalate, ethylene ammonium oxalate,
Propylenammoniumoxalat, Piperidiniumoxalat, Morpholiniumoxalat, 4,4-Propylene ammonium oxalate, piperidinium oxalate, morpholinium oxalate, 4,4-
Dimethyloxazolidiniumoxalat, Methylammoniumglykolat, DimethylammoniumglykolatDimethyloxazolidinium oxalate, methylammonium glycolate, dimethylammonium glycolate
Trimethylammoniumglykolat, Ethylammoniumglykolat, DiethylammoniumglykolatTrimethylammonium glycolate, Ethylammoniumglykolat, Diethylammoniumglykolat
Triethylammoniumglykolat, n-Propyylammoniumglykolat, Di-n-Propylammoniumglykolat, Tri-n- Propylammoniumglykolat, Isopropylammoniumglykolat, Diisopropylammoniumglykolat Triisopropylammoniumglykolat, Phenylammoniumglykolat, Diphenylammoniumglykolat Triphenylammoniumglykolat, Monoethanolammoniumglykolat, Diethanolammoniumglykolat Triethanolammoniumglykolat, Ethylenammoniumglykolat, PropylenammoniumglykolatTriethylammoniumglykolat, n-Propyylammoniumglykolat, di-n-Propylammoniumglykolat, tri-n Propylammoniumglykolat, Isopropylammoniumglykolat, Diisopropylammoniumglykolat Triisopropylammoniumglykolat, Phenylammoniumglykolat, Diphenylammoniumglykolat Triphenylammoniumglykolat, Monoethanolammoniumglykolat, Diethanolammoniumglykolat Triethanolammoniumglykolat, Ethylenammoniumglykolat, Propylenammoniumglykolat
Piperidiniumglykolat, Morpholiniumglykolat, 4,4-DimethyloxazolidiniumglykolatPiperidinium glycolate, morpholinium glycolate, 4,4-dimethyloxazolidinium glycolate
Methylammoniumcitrat, Dimethylammoniumcitrat, Trimethylammoniumcitrat, Ethylammoniumcitrat Diethylammoniumcitrat, Triethylammoniumcitrat, n-Propyylammoniumcitrat, Di-n- Propylammoniumcitrat, Tri-n-Propylammoniumcitrat, IsopropylammoniumcitratMethyl ammonium citrate, dimethyl ammonium citrate, trimethyl ammonium citrate, ethyl ammonium citrate, diethyl ammonium citrate, triethyl ammonium citrate, n-propyl ammonium citrate, di-n-propyl ammonium citrate, tri-n-propyl ammonium citrate, isopropyl ammonium citrate
Diisopropylammoniumcitrat, Triisopropylammoniumcitrat, PhenylammoniumcitratDiisopropylammonium citrate, triisopropylammonium citrate, phenylammonium citrate
Diphenylammoniumcitrat, Triphenylammoniumcitrat, MonoethanolammoniumcitratDiphenylammonium citrate, triphenylammonium citrate, monoethanolammonium citrate
Diethanolammoniumcitrat, Triethanolammoniumcitrat, EthylenammoniumcitratDiethanolammonium citrate, triethanolammonium citrate, ethylene ammonium citrate
Propylenammoniumcitrat, Piperidiniumcitrat, Morpholiniumcitrat, 4,4-Dimethyloxazolidiniumcitrat Methylammoniumtartrat, Dimethylammoniumtartrat, TrimethylammoniumtartratPropylene ammonium citrate, piperidinium citrate, morpholinium citrate, 4,4-dimethyloxazolidinium citrate, methyl ammonium tartrate, dimethyl ammonium tartrate, trimethyl ammonium tartrate
Ethylammoniumtartrat, Diethylammoniumtartrat, Triethylammoniumtartrat, n-Ethylammonium tartrate, diethylammonium tartrate, triethylammonium tartrate, n-
Propyylammoniumtartrat, Di-n-Propylammoniumtartrat, Tri-n-PropylammoniumtartratPropyl ammonium tartrate, di-n-propyl ammonium tartrate, tri-n-propyl ammonium tartrate
Isopropylammoniumtartrat, Diisopropylammoniumtartrat, Triisopropylammoniumtartrat Phenylammoniumtartrat, Diphenylammoniumtartrat, TriphenylammoniumtartratIsopropylammonium tartrate, diisopropylammonium tartrate, triisopropylammonium tartrate, phenylammonium tartrate, diphenylammonium tartrate, triphenylammonium tartrate
Monoethanolammoniumtartrat, Diethanolammoniumtartrat, Triethanolammoniumtartrat Ethylenammoniumtartrat, Propylenammoniumtartrat, Piperidiniumtartrat, Morpholiniumtartrat, 4,4- Dimethyloxazolidiniumtartrat, Methylammoniummalat, DimethylammoniummalatMonoethanolammonium tartrate, diethanolammonium tartrate, triethanolammonium tartrate, ethyleneammonium tartrate, propylenammonium tartrate, piperidinium tartrate, morpholinium tartrate, 4,4-dimethyloxazolidinium tartrate, methylammonium malate, dimethylammonium malate
Trimethylammoniummalat, Ethylammoniummalat, DiethylammoniummalatTrimethylammonium malate, ethylammonium malate, diethylammonium malate
Triethylammoniummalat, n-Propyylammoniummalat, Di-n-Propylammoniummalat, Tri-n- Propylammoniummalat, Isopropylammoniummalat, DiisopropylammoniummalatTriethylammonium malate, n-propylammonium malate, di-n-propylammonium malate, tri-n-propylammonium malate, isopropylammonium malate, diisopropylammonium malate
Triisopropylammoniummalat, Phenylammoniummalat, DiphenylammoniummalatTriisopropylammonium malate, phenylammonium malate, diphenylammonium malate
Triphenylammoniummalat, Monoethanolammoniummalat, DiethanolammoniummalatTriphenylammonium malate, monoethanolammonium malate, diethanolammonium malate
Triethanolammoniummalat, Ethylenammoniummalat, Propylenammoniummalat, Piperidiniummalat Morpholiniummalat, 4,4-Dimethyloxazolidiniummalat, MethylammoniumlactatTriethanolammonium malate, ethylene ammonium malate, propylene ammonium malate, piperidinium malate, morpholinium malate, 4,4-dimethyloxazolidinium malate, methyl ammonium lactate
Dimethylammoniumlactat, Trimethylammoniumlactat, EthylammoniumlactatDimethyl ammonium lactate, trimethyl ammonium lactate, ethyl ammonium lactate
Diethylammoniumlactat, Triethylammoniumlactat, n-Propyylammoniumlactat, Di-n- Propylammoniumlactat, Tri-n-Propylammoniumlactat, IsopropylammoniumlactatDiethylammonium lactate, triethylammonium lactate, n-propylammonium lactate, di-n-propylammonium lactate, tri-n-propylammonium lactate, isopropylammonium lactate
Diisopropylammoniumlactat, Triisopropylammoniumlactat, PhenylammoniumlactatDiisopropylammonium lactate, triisopropylammonium lactate, phenylammonium lactate
Diphenylammoniumlactat, Triphenylammoniumlactat, MonoethanolammoniumlactatDiphenylammonium lactate, triphenylammonium lactate, monoethanolammonium lactate
Diethanolammoniumlactat, Triethanolammoniumlactat, EthylenammoniumlactatDiethanolammonium lactate, triethanolammonium lactate, ethylene ammonium lactate
Propylenammoniumlactat, Piperidiniumlactat, Morpholiniumlactat, 4,4-Dimethyloxazolidiniumlactat
Methylammoniumfumarat, Dimethylammoniumfumarat, Trimethylammoniumfumarat, Ethylammoniumfumarat, Diethylammoniumfumarat, Triethylammoniumfumarat, n- Propyylammoniumfumarat, Di-n-Propylammoniumfumarat, Tri-n-Propylammoniumfumarat, Isopropylammoniumfumarat, Diisopropylammoniumfumarat, Triisopropylammoniumfumarat, Phenylammoniumfumarat, Diphenylammoniumfumarat, Triphenylammoniumfumarat, Monoethanolammoniumfumarat Diethanolammoniumfumarat, Triethanolammoniumfumarat, Ethylenammoniumfumarat, Propylenammoniumfumarat, Piperidiniumfumarat, Morpholiniumfumarat, 4,4-Dimethyloxazolidiniumfumarat, Methylammoniumpyruvat, Dimethylammoniumpyruvat Trimethylammoniumpyruvat, Ethylammoniumpyruvat, Diethylammoniumpyruvat, Triethylammoniumpyruvat, n-Propyylammoniumpyruvat, Di-n- Propylammoniumpyruvat, Tri-n-Propylammoniumpyruvat, Isopropylammoniumpyruvat, Diisopropylammoniumpyruvat, Triisopropylammoniumpyruvat, Phenylammoniumpyruvat, Diphenylammoniumpyruvat, Triphenylammoniumpyruvat, Monoethanolammoniumpyruvat, Diethanolammoniumpyruvat, Triethanolammoniumpyruvat, Ethylenammoniumpyruvat, Propylenammoniumpyruvat, Piperidiniumpyruvat, Morpholiniumpyruvat, 4,4-Propylene ammonium lactate, piperidinium lactate, morpholinium lactate, 4,4-dimethyloxazolidinium lactate Methylammoniumfumarat, Dimethylammoniumfumarat, Trimethylammoniumfumarat, Ethylammoniumfumarat, Diethylammoniumfumarat, triethylammonium, n- Propyylammoniumfumarat, di-n-Propylammoniumfumarat, tri-n-Propylammoniumfumarat, Isopropylammoniumfumarat, Diisopropylammoniumfumarat, Triisopropylammoniumfumarat, Phenylammoniumfumarat, Diphenylammoniumfumarat, Triphenylammoniumfumarat, Monoethanolammoniumfumarat Diethanolammoniumfumarat, Triethanolammoniumfumarat, Ethylenammoniumfumarat, Propylenammoniumfumarat, Piperidiniumfumarat , Morpholiniumfumarat, 4,4-Dimethyloxazolidiniumfumarat, Methylammoniumpyruvat, Dimethylammoniumpyruvat Trimethylammoniumpyruvat, Ethylammoniumpyruvat, Diethylammoniumpyruvat, Triethylammoniumpyruvat, n-Propyylammoniumpyruvat, di-n Propylammoniumpyruvat, tri-n-Propylammoniumpyruvat, Isopropylammoniumpyruvat, Diisopropylammoniumpyruvat, Triisopropylammoniumpyruvat, Phenylammoniumpyruvat, Diphenylammoniumpyruvat, Triphenylammoniumpyruvat, Monoethanolammoniumpyruv at, diethanolammoniumpyruvate, triethanolammoniumpyruvate, ethyleneammoniumpyruvate, propylenammoniumpyruvate, piperidiniumpyruvate, morpholiniumpyruvate, 4.4-
Dimethyloxazolidiniumpyruvat. Dimethyloxazolidiniumpyruvat.
Besonders bevorzugte erfindungsgemäße Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie - bezogen auf ihr Gewicht - 0,01 bis 10 Gew.-%, vorzugsweise 0,05 bis 7,5 Gew.-%, weiter bevorzugt 0, 1 bis 6 Gew.-% und insbesondere 0, 15 bis 5 Gew.-% Aminsalz(e) von Carbonsäure(n) der Formel (I) Particularly preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.01 to 10% by weight, preferably from 0.05 to 7.5% by weight, more preferably from 0 to 1 to 6% by weight. and in particular from 0.15 to 5% by weight of amine salt (s) of carboxylic acid (s) of the formula (I)
(I) (I)
enthalten, in der included in the
R1 , R2 und R3 unabhängig voneinander ausgewählt sind aus -H, -CH3, -CH2CH3,-CH2CH2OH, R 1, R 2 and R 3 are independently selected from -H, -CH 3 , -CH 2 CH 3 , -CH 2 CH 2 OH,
R für einen optional substituierten gesättigten oder ungesättigten, linearen, verzweigten oder cyclischen, aliphatischen oder aromatischen Kohlenwasserstoffrest mit mindestens 2 C-Atomen steht. R is an optionally substituted saturated or unsaturated, linear, branched or cyclic, aliphatic or aromatic hydrocarbon radical having at least 2 C atoms.
Ganz besonders bevorzugte erfindungsgemäße Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie - bezogen auf ihr Gewicht - 0,01 bis 10 Gew.-%, vorzugsweise 0,05 bis 7,5 Gew.-%, weiter bevorzugt 0, 1 bis 6 Gew.-% und insbesondere 0, 15 bis 5 Gew.-% mindestens eines Aminsalzs aus der Gruppe
Very particularly preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.01 to 10% by weight, preferably from 0.05 to 7.5% by weight, more preferably from 0 to 1 to 6% by weight. % and in particular 0, 15 to 5 wt .-% of at least one amine salt from the group
(la) (La)
in der R für -Ph oder -(CH2)nCH3 mit n = 4, 5, 6, 7, 8, 9, 10, insbesondere für 5 oder 7, steht,
in which R is -Ph or - (CH 2 ) n CH 3 where n = 4, 5, 6, 7, 8, 9, 10, in particular 5 or 7,
(Ib) (Ib)
in der R für -Ph oder -(CH2)nCH3 mit n = 4, 5, 6, 7, 8, 9, 10, insbesondere für 5 oder 7, steht,
in der R für -Ph oder -(CH2)nCH3 mit n = 4, 5, 6, 7, 8, 9, 10, insbesondere für 5 oder 7, steht
in which R is -Ph or - (CH 2 ) n CH 3 where n = 4, 5, 6, 7, 8, 9, 10, in particular 5 or 7, in which R is -Ph or - (CH 2) n CH 3 where n = 4, 5, 6, 7, 8, 9, 10, in particular 5 or 7
(Id) (Id)
in der R und R' unabhängig voneinander für -Ph oder -(CH2)nCH3 mit n = 4, 5, 6, 7, 8, 9, 10, insbesondere für 5 oder 7, stehen, in which R and R ', independently of one another, are -Ph or - (CH 2) n CH 3 where n = 4, 5, 6, 7, 8, 9, 10, in particular 5 or 7,
enthalten. contain.
Als weiteren wesentlichen Bestandteil enthalten die erfindungsgemäßen Mittel 0,001 bis 20 Gew.-% mindestens eines Proteinhydrolysats. As a further essential component, the agents according to the invention contain from 0.001 to 20% by weight of at least one protein hydrolyzate.
Proteinhydrolysate sind erfindungsgemäß Abbauprodukte von Proteinen, welche durch saure, basische oder enzymatische Reaktion hergestellt werden. Aufgrund des Herstellungsprozesses weisen Proteinhydrolysate eine Verteilung des Molekulargewichtes auf. Zu den erfindungsgemäßen Proteinhydrolysaten sind auch Oligopeptide zu zählen, da diese ebenfalls durch entsprechende Reaktionen aus Proteinen hergestellt werden können. Einzelne Aminosäuren, welche als diskrete Einzelverbindung vorliegen, zählen erfindungsgemäß nicht zu den Proteinhydrolysaten im Sinne dieser Erfindung. Protein hydrolysates are according to the invention degradation products of proteins which are produced by acidic, basic or enzymatic reaction. Due to the manufacturing process, protein hydrolysates have a distribution of molecular weight. The protein hydrolysates according to the invention also include oligopeptides, since these can likewise be prepared by corresponding reactions from proteins. Individual amino acids, which are present as a discrete single compound, according to the invention do not belong to the protein hydrolysates in the sense of this invention.
Erfindungsgemäß können Proteinhydrolysate sowohl pflanzlichen als auch tierischen oder marinen oder synthetischen Ursprungs eingesetzt werden.
Tierische Proteinhydrolysate sind beispielsweise Elastin-, Kollagen-, Keratin-, Seiden- und Milchei- weiß-Proteinhydrolysate, die auch in Form von Salzen vorliegen können. Solche Produkte werden beispielsweise unter den Warenzeichen Dehylan® (Cognis), Promois® (Interorgana), Collapuron® (Cognis), Nutrilan® (Cognis), Gelita-Sol® (Deutsche Gelatine Fabriken Stoess & Co), Lexein® (Inolex), ProSina® (Croda) und Kerasol® (Croda) vertrieben. According to the invention, protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used. Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein hydrolysates, which may also be present in the form of salts. Such products are, for example, under the trademarks Dehylan ® (Cognis), Promois® ® (Interorgana) Collapuron ® (Cognis), Nutrilan® ® (Cognis), Gelita-Sol ® (German Gelatinefabriken Stoess & Co), Lexein ® (Inolex) ProSina ® (Croda) and kerasol tm ® (Croda) sold.
Weiterhin sind erfindungsgemäß bevorzugte pflanzliche Proteinhydrolysaten wie beispielsweise Soja-, Mandel-, Erbsen-, Moringa-, Kartoffel- und Weizenproteinhydrolysate. Solche Produkte sind beispielsweise unter den Warenzeichen Gluadin® (Cognis), DiaMin® (Diamalt), Lexein® (Inolex), Hydrosoy® (Croda), Hydrolupin® (Croda), Hydrosesame® (Croda), Hydrotritium® (Croda), Crotein® (Croda) und Puricare® LS 9658 von der Fa. Laboratoires Serobiologiques erhältlich. Further preferred vegetable protein hydrolysates according to the invention are, for example, soybean, almond, pea, moringa, potato and wheat protein hydrolysates. Such products are, for example, under the trademarks Gluadin ® (Cognis), diamine ® (Diamalt) ® (Inolex), Hydrosoy ® (Croda), hydro Lupine ® (Croda), hydro Sesame ® (Croda), Hydro tritium ® (Croda), Crotein ® (Croda) and Puricare ® LS 9658 from Laboratoires Serobiologiques.
Weitere erfindungsgemäß bevorzugte Proteinhydrolysate sind maritimen Ursprunges. Hierzu zählen beispielsweise Kollagenhydrolysate von Fischen oder Algen sowie Proteinhydrolysate von Muscheln bzw. Perlenhydrolysate. Beispiele für erfindungsgemäße Perlenextrakte sind die Handelsprodukte Pearl Protein Extract BG® oder Crodarom® Pearl. Further preferred protein hydrolysates according to the invention are of maritime origin. These include, for example, collagen hydrolyzates of fish or algae as well as protein hydrolysates of mussels or pearl hydrolyzates. Examples of pearl extracts according to the invention are the commercial products Pearl Protein Extract BG ® or Crodarom ® Pearl.
Weiterhin sind kationisierte Proteinhydrolysate zu den Proteinhydrolysaten und deren Derivaten zu zählen, wobei das zugrundeliegende Proteinhydrolysat vom Tier, beispielsweise aus Collagen, Milch oder Keratin, von der Pflanze, beispielsweise aus Weizen, Mais, Reis, Kartoffeln, Soja oder Mandeln, von marinen Lebensformen, beispielsweise aus Fischcollagen oder Algen, oder biotechnologisch gewonnenen Proteinhydrolysaten, stammen kann. Als typische Beispiele für die erfindungsgemäßen kationischen Proteinhydrolysate und -derivate seien die unter den INCI - Bezeichnungen im "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry, and Fragrance Association 1 101 17th Street, N.W., Suite 300, Washington, DC 20036-4702) genannten und im Handel erhältlichen Produkte genannt. Furthermore, cationized protein hydrolysates are to be counted among the protein hydrolysates and their derivatives, the underlying protein hydrolyzate being derived from the animal, for example from collagen, milk or keratin, from the plant, for example from wheat, maize, rice, potatoes, soya or almonds, from marine life forms, from fish collagen or algae, or biotechnologically derived protein hydrolysates. As typical examples of the cationic protein hydrolyzates and derivatives according to the invention, those mentioned under the INCI names in the "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry and Fragrance Association 1 101 17 th Street, NW, Suite 300, Washington, DC 20036-4702) and commercially available products.
Erfindungsgemäß bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie - bezogen auf ihr Gewicht -0,01 bis 15 Gew.-%, vorzugsweise 0,05 bis 10 Gew.-%, weiter bevorzugt 0,1 bis 7,5 Gew.-% und insbesondere 0,15 bis 5 Gew.-% Proteinhydrolysat(e) aus der Gruppe Elastin-, Kollagen-, Keratin-, Seiden- und Milcheiweiß-Proteinhydrolysat, Soja-, Mandel-, Erbsen-, Moringa-, Kartoffel- und Weizenproteinhydrolysat enthalten. Hair treatment compositions which are preferred according to the invention are characterized in that they contain -0.01 to 15% by weight, preferably 0.05 to 10% by weight, more preferably 0.1 to 7.5% by weight, based on their weight in particular 0.15 to 5 wt .-% protein hydrolyzate (s) from the group elastin, collagen, keratin, silk and milk protein protein hydrolyzate, soybean, almond, pea, Moringa, potato and wheat protein hydrolyzate ,
Ebenfalls erfindungsgemäße Proteinhydrolysate sind Oligopeptide. Oligopeptide können in den erfindungsgemäßen Haarbehandlungsmitteln aufgrund ihrer definierten Aminosäuresequenz bevorzugt sein. Likewise protein hydrolysates according to the invention are oligopeptides. Oligopeptides may be preferred in the hair treatment compositions of the invention because of their defined amino acid sequence.
Ein Oligopeptid, welches mindestens eine Aminosäuresequenz Glu-Glu-Glu An oligopeptide which has at least one amino acid sequence Glu-Glu-Glu
aufweist, wobei die Amino-Gruppe frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können, kann erfindungsgemäß besonders bevorzugt sein. wherein the amino group may be free or protonated and the carboxy groups may be free or deprotonated, may be particularly preferred according to the invention.
In dieser wie in allen nachstehenden Formeln bedeutet das eingeklammerte Wasserstoffatom der Aminogruppe ebenso wie die eingeklammerte Hydroxygruppe der Säurefunktion, daß die betreffenden Gruppen als solche vorhanden sein können (dann handelt es sich um ein Oligopeptid mit der betreffenden Anzahl an Aminosäuren wie in der vorstehenden Formel oder aber, daß die Aminosäuresequenz in einem Oligopeptid vorliegt, das noch weitere Anminosäuren umfaßt - je nachdem, wo die weitere(n) Aminosäure(n) gebunden ist/sind, sind die eingeklammerten Bestandteile der o.g. Formel durch den/die weiteren Aminosäurerest(e) ersetzt. In this formula as well as in the formulas below, the parenthesized hydrogen atom of the amino group as well as the bracketed hydroxy group of the acid function means that the respective groups may be present as such (then it is an oligopeptide with the relevant number of amino acids as in the above formula or but that the amino acid sequence is present in an oligopeptide comprising even more amino acids - depending on where the other amino acid (s) is / are bound, the parenthetical components of the above formula are represented by the additional amino acid residue (s) replaced.
Oligopeptide im Sinne der vorliegenden Anmeldung sind durch Peptid-Bindungen Säureamid-artig verknüpfte Kondensationsprodukte von Aminosäuren, die mindestens 3 und maximal 25 Aminosäuren umfassen. In erfindungsgemäß bevorzugten Haarbehandlungsmitteln umfaßt das Oligopeptid 5 bis 15 Aminosäuren, vorzugsweise 6 bis 13 Aminosäuren, besonders bevorzugt 7 bis 12 Aminosäuren und insbesondere 8, 9 oder 10 Aminosäuren. Je nachdem, ob weitere Aminosäuren an die Sequenz Glu-Glu-Glu gebunden sind und je nach Art dieser Aminosäuren kann die Molmasse des in den erfindungsgemäßen Mitteln enthaltenen Oligopeptids variieren. Erfindungsgemäß bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß das Oligopeptid eine Molmasse von 650 bis 3000 Da, vorzugsweise von 750 bis 2500 Da, besonders bevorzugt von 850 bis 2000 Da und insbesondere von 1000 bis 1600 Da aufweist. Wie aus der bevorzugten Anzahl von Aminisäuren in den Oligopeptiden und dem bevorzugten Molmassenbereich zu ersehen ist, werden vorzugsweise Oligopeptide eingesetzt, die nicht allein aus den drei Glutaminsäuren bestehen, sondern weitere, an diese Sequenz gebundene Aminosäuren aufweisen. Diese weiteren Aminosäuren sind vorzugsweise aus bestimmten Aminosäuren ausgewählt, während bestimmte andere Vertreter erfindungsgemäß weniger bevorzugt sind. Ein besonders bevorzugtes Oligopeptid enthält zusätzlich Tyrosin, das vorzugsweise über seine Säurefunktion an die Glu-Glu-Glu-Sequenz gebunden ist. Erfindungsgemäß bevorzugte Haarbehandlungsmittel sind daher dadurch gekennzeichnet, daß das in ihnen enthaltene Oligopeptid mindestens eine Aminosäuresequenz Tyr- Glu-Glu-Glu aufweist, wobei die Amino-Gruppe frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können. Oligopeptides in the sense of the present application are acid amide-like linked by peptide bonds condensation products of amino acids comprising at least 3 and a maximum of 25 amino acids. In hair treatment compositions which are preferred according to the invention, the oligopeptide comprises 5 to 15 amino acids, preferably 6 to 13 amino acids, particularly preferably 7 to 12 amino acids and in particular 8, 9 or 10 amino acids. Depending on whether further amino acids are bound to the sequence Glu-Glu-Glu and depending on the nature of these amino acids, the molecular weight of the oligopeptide contained in the agents of the invention may vary. Hair treatment compositions preferred according to the invention are characterized in that the oligopeptide has a molecular weight of from 650 to 3000 Da, preferably from 750 to 2500 Da, particularly preferably from 850 to 2000 Da and in particular from 1000 to 1600 Da. As can be seen from the preferred number of amino acids in the oligopeptides and the preferred molecular weight range, preferably oligopeptides are used which do not consist solely of the three glutamic acids but have further amino acids bound to this sequence. These other amino acids are preferably selected from certain amino acids, while certain other representatives are less preferred in the present invention. A particularly preferred oligopeptide additionally contains tyrosine, which is preferably linked via its acid function to the Glu-Glu-Glu sequence. Hair treatment compositions which are preferred according to the invention are therefore characterized in that the oligopeptide contained in them has at least one amino acid sequence Tyr-Glu-Glu-Glu, where the amino group can be free or protonated and the carboxy groups can be free or deprotonated.
Ein weiteres besonders bevorzugtes Oligopeptid enthält zusätzlich Isoleucin, das vorzugsweise über seine Aminofunktion an die Glu-Glu-Glu-Sequenz gebunden ist. Erfindungsgemäß bevorzugte Haarbehandlungsmittel sind daher dadurch gekennzeichnet, daß das in ihnen enthaltene das Oligopeptid mindestens eine Aminosäuresequenz Glu-Glu-Glu-Ile aufweist, wobei die Amino- Gruppe frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können. Oligopeptide, die beide vorgenannten Aminosäuren (Tyrosin und Isoleucin) aufweisen, sind erfindungsgemäß bevorzugt. Besonders bevorzugt sind dabei erfindungsgemäße Haarbehandlungsmittel, bei denen das in ihnen enthaltene Oligopeptid mindestens eine
Aminosäuresequenz Tyr-Glu-Glu-Glu-Ile aufweist, wobei die Amino-Gruppe frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können. Another particularly preferred oligopeptide additionally contains isoleucine, which is preferably linked to the Glu-Glu-Glu sequence via its amino function. Hair treatment agents which are preferred according to the invention are therefore characterized in that the oligopeptide contained in them has at least one amino acid sequence Glu-Glu-Glu-Ile, where the amino group can be free or protonated and the carboxy groups can be free or deprotonated. Oligopeptides which have both the abovementioned amino acids (tyrosine and isoleucine) are preferred according to the invention. Hair-treatment compositions according to the invention in which the oligopeptide contained in them is at least one of them are particularly preferred Amino acid sequence Tyr-Glu-Glu-Glu-Ile, wherein the amino group is free or protonated and the carboxy groups may be free or deprotonated.
Weiter bevorzugte Oligopeptide enthalten zusätzlich Arginin, das vorzugsweise an Isoleucin gebunden vorliegt. Further preferred oligopeptides additionally contain arginine, which is preferably bound to isoleucine.
Noch weiter bevorzugte Oligopeptide enthalten zusätzlich Valin, das vorzugsweise an das Arginin gebunden vorliegt. Erfindungsgemäß weiter bevorzugte Haarbehandlungsmittel sind daher dadurch gekennzeichnet, daß das in ihnen enthaltene Oligopeptid mindestens eine Aminosäuresequenz Tyr- Glu-Glu-Glu-Ile-Arg-Val aufweist, wobei die Amino-Gruppen frei oder protoniert und die Carboxy- Gruppen frei oder deprotoniert vorliegen können. Still further preferred oligopeptides additionally contain valine, which is preferably bound to the arginine. Hair-treatment agents which are further preferred according to the invention are therefore characterized in that the oligopeptide contained in them has at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val, the amino groups being free or protonated and the carboxy groups being free or deprotonated can.
Noch weiter bevorzugte Oligopeptide enthalten zusätzlich Leucin, das vorzugsweise an das Valin gebunden vorliegt. Erfindungsgemäß weiter bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß das in ihnen enthaltene Oligopeptid mindestens eine Aminosäuresequenz Tyr- Glu-Glu-Glu-Ile-Arg-Val-Leu aufweist, wobei die Amino-Gruppen frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können. Still further preferred oligopeptides additionally contain leucine, which is preferably bound to the valine. Further preferred hair treatment compositions according to the invention are characterized in that the oligopeptide contained in them has at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups are free or deprotonated may be present.
Insbesondere bevorzugte Oligopeptide enthalten zusätzlich Leucin, das vorzugsweise an das Tyrosin gebunden vorliegt. Erfindungsgemäß weiter bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß das in ihnen enthaltene Oligopeptid mindestens eine Aminosäuresequenz Leu-Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu aufweist, wobei die Amino-Gruppen frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können. Particularly preferred oligopeptides additionally contain leucine, which is preferably bound to the tyrosine. Further preferred hair treatment compositions according to the invention are characterized in that the oligopeptide contained in them has at least one amino acid sequence Leu-Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups are free or may be present deprotonated.
Erfindungsgemäß besonders bevorzugte Proteinhydrolysate sind beispielsweise auf der Basis von Keratin, Seide, Weizen, Moringa und marine Proteinhydrolysate. Höchst bevorzugt sind Proteinhydrolysate auf der Basis von Seide, Keratin und Weizen. Particularly preferred protein hydrolysates according to the invention are, for example, based on keratin, silk, wheat, moringa and marine protein hydrolysates. Most preferred are protein hydrolysates based on silk, keratin and wheat.
Die Proteinhydrolysate sind in den Zusammensetzungen in Konzentrationen von 0,001 Gew.% bis zu 20 Gew.%, vorzugsweise von 0,05 Gew.% bis zu 15 Gew.% und ganz besonders bevorzugt in Mengen von 0,05 Gew.% bis zu 5 Gew.% enthalten. The protein hydrolysates are present in the compositions in concentrations of 0.001% by weight to 20% by weight, preferably from 0.05% by weight to 15% by weight and most preferably in amounts of from 0.05% by weight to 5% % By weight.
Die erfindungsgemäßen Mittel können zur weiteren Steigerung der konditionierenden Effekte aminofunktionelle Silikone enthalten. Bevorzugte erfindungsgemäße Mittel enthalten 0,001 bis 50 Gew.-% mindestens eines aminofunktionellen Silikons. The agents according to the invention may contain amino-functional silicones to further increase the conditioning effects. Preferred agents according to the invention contain from 0.001 to 50% by weight of at least one amino-functional silicone.
Besonders bevorzugte erfindungsgemäße Mittel sind dadurch gekennzeichnet, daß sie mindestens ein aminofunktionelles Silikon der Formel (Si-Ila) Particularly preferred agents according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (Si-IIa)
(CH3)3Si-[0-Si(CH3)2]n[OSi(CH3)]m-OSi(CH3)3 (Si-Ila), (CH 3 ) 3 Si - [0-Si (CH 3 ) 2] n [OSi (CH 3 )] m -OSi (CH 3 ) 3 (Si-Ila),
I I
CH2CH(CH3)CH2NH(CH2)2NH2 CH 2 CH (CH 3 ) CH 2 NH (CH 2 ) 2 NH 2
enthalten, worin m und n Zahlen sind, deren Summe (m + n) zwischen 1 und 2000, vorzugsweise zwischen 50 und 150 beträgt, wobei n vorzugsweise Werte von 0 bis 1999 und insbesondere von 49 bis 149 und m vorzugsweise Werte von 1 bis 2000, insbesondere von 1 bis 10 annimmt. in which m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes.
Diese Silicone werden nach der INCI-Deklaration als Trimethylsilylamodimethicone bezeichnet. Besonders bevorzugt sind auch erfindungsgemäße Mittel, die ein aminofunktionelles Silikon der Formel (Si-Ilb)
R-[Si(CH3)2-0]nl [Si(R)-0]m-[Si(CH3)2]n2-R (Si-Ilb),
These silicones are referred to as trimethylsilylamodimethicones according to the INCI declaration. Particular preference is also given to compositions according to the invention which are an amino-functional silicone of the formula (Si-IIb) R- [Si (CH 3 ) 2-O] nl [Si (R) -O] m- [Si (CH 3 ) 2] n 2 -R (Si-Ilb),
enthalten, worin R für -OH, -O-Ch oder eine -CH3-Gruppe steht und m, n1 und n2 Zahlen sind, deren Summe (m + n1 + n2) zwischen 1 und 2000, vorzugsweise zwischen 50 und 150 beträgt, wobei die Summe (n1 + n2) vorzugsweise Werte von 0 bis 1999 und insbesondere von 49 bis 149 und m vorzugsweise Werte von 1 bis 2000, insbesondere von 1 bis 10 annimmt. in which R is -OH, -O-Ch or a -CH3 group and m, n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2,000, preferably between 50 and 150, wherein the sum (n1 + n2) preferably assumes values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.
Diese Silicone werden nach der INCI-Deklaration als Amodimethicone bezeichnet. These silicones are referred to as amodimethicones according to the INCI declaration.
Unabhängig davon, welche aminofunktionellen Silicone eingesetzt werden, sind erfindungsgemäße Mittel bevorzugt, die ein aminofunktionelles Silikon enthalten dessen Aminzahl oberhalb von 0,25 meq/g, vorzugsweise oberhalb von 0,3 meq/g und insbesondere oberhalb von 0,4 meq/g liegt. Die Aminzahl steht dabei für die Milli-Aquivalente Amin pro Gramm des aminofunktionellen Silicons. Sie kann durch Titration ermittelt und auch in der Einheit mg KOH/g angegeben werden. Regardless of which amino-functional silicones are used, agents according to the invention which contain an amino-functional silicone whose amine number is above 0.25 meq / g, preferably above 0.3 meq / g and in particular above 0.4 meq / g, are preferred , The amine number stands for the milliequivalents of amine per gram of the amino-functional silicone. It can be determined by titration and also expressed in mg KOH / g.
Erfindungsgemäß bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie, bezogen auf ihr Gewicht, 0,01 bis 20 Gew.-%, vorzugsweise 0,05 bis 10 Gew.-%, weiter bevorzugt 0,1 bis 7,5 Gew.-% und insbesondere 0,15 bis 5 Gew.-% aminofunktionelle(s) Silikon(e) enthalten. Mit besonderem Vorzug enthalten die erfindungsgemäßen Mittel aminofunktionelle(s) Silikon(e) mit terminale(r/n) Hydroxygruppe(n). Einige spezielle aminofunktionelle(s) Silikon(e) mit terminale(r/n) Hydroxygruppe(n) haben sich in den erfindungsgemäßen Mitteln als besonders geeignet herausgestellt. Diese werden nachstehend beschrieben. Hair-treatment agents preferred according to the invention are characterized in that, based on their weight, they contain from 0.01 to 20% by weight, preferably from 0.05 to 10% by weight, more preferably from 0.1 to 7.5% by weight and in particular from 0.15 to 5% by weight of amino-functional silicone (s). With particular preference, the agents according to the invention contain amino-functional silicone (s) with terminal (r / n) hydroxy group (s). Some specific amino-functional silicone (s) having terminal hydroxy group (s) have been found to be particularly useful in the compositions of this invention. These are described below.
Als besonders wirkungsvoll im Hinblick auf die gewünschten Effekte haben sich im erfindungsgemäßen Verfahren Vorbehandlungsmittel erwiesen, die mindestens ein Silikon der Formel (Si-V) enthalten: In the process according to the invention, pretreatment agents which contain at least one silicone of the formula (Si-V) have proven particularly effective with regard to the desired effects:
in der in the
A für eine Gruppe -OH, -0-Si(CH3)3,-0-Si(CH3)20H ,-0-Si(CH3)20CH3 steht, D für eine Gruppe -H, -Si(CH3)3,-Si(CH3)2OH, -Si(CH3)2OCH3 steht, A represents a group -OH, -0-Si (CH 3) 3, -0-Si (CH3) 20H, -0-Si (CH 3) 20ch 3, D is a group of -H, -Si (CH 3 ) 3 , -Si (CH 3 ) 2 OH, -Si (CH 3 ) 2 OCH 3 ,
b, n und c für ganze Zahlen zwischen 0 und 1000 stehen, b, n and c are integers between 0 and 1000,
mit den Maßgaben with the stipulations
- n > 0 und b + c > 0 - n> 0 and b + c> 0
- mindestens eine der Bedingungen A = -OH bzw. D = -H ist erfüllt.
Erfindungsgemäße Haarbehandlungsmittel, die - bezogen auf ihr Gewicht - 0,01 bis 20 Gew.%, vorzugsweise 0,01 bis 20 Gew.-%, vorzugsweise 0,1 bis 10 Gew.-%, weiter bevorzugt 0,5 bis 7,5 Gew.-% und insbesondere 0,1 bis 5 Gew.-% mindestens eines Silikons der Formel (Si-V) enthalten: - At least one of the conditions A = -OH or D = -H is satisfied. Hair treatment compositions according to the invention, which - based on their weight - 0.01 to 20 wt.%, Preferably 0.01 to 20 wt .-%, preferably 0.1 to 10 wt .-%, more preferably 0.5 to 7.5 Wt .-% and in particular 0.1 to 5 wt .-% of at least one silicone of the formula (Si-V) contain:
in der in the
A für eine Gruppe -OH, -0-Si(CH3)3,-0-Si(CH3)20H ,-0-Si(CH3)20CH3 steht, D für eine Gruppe -H, -Si(CH3)3,-Si(CH3)2OH, -Si(CH3)2OCH3 steht, A represents a group -OH, -0-Si (CH 3) 3, -0-Si (CH3) 20H, -0-Si (CH 3) 20ch 3, D is a group of -H, -Si (CH 3 ) 3 , -Si (CH 3 ) 2 OH, -Si (CH 3 ) 2 OCH 3 ,
b, n und c für ganze Zahlen zwischen 0 und 1000 stehen, b, n and c are integers between 0 and 1000,
mit den Maßgaben with the stipulations
- n > 0 und b + c > 0 - n> 0 and b + c> 0
- mindestens eine der Bedingungen A = -OH bzw. D = -H ist erfüllt, at least one of the conditions A = -OH or D = -H is fulfilled,
sind demnach erfindungsgemäß bevorzugt. are therefore preferred according to the invention.
In der vorstehend genannten Formel (Si-V) sind die einzelnen Siloxaneinheiten mit den Indices b, c und n statistisch verteilt, d.h. es muß sich nicht zwingend um Blockcopolymere handeln. In the above formula (Si-V), the individual siloxane units having the indices b, c and n are randomly distributed, i. it does not necessarily have to be block copolymers.
Weitere besonders geeignete Silikone sind 4-morpholinomethyl-substituiert. Erfindungsgemäße Haarbehandlungsmittel die, bezogen auf ihr Gewicht, 0,001 bis 20 Gew.%, vorzugsweise 0,01 bis 10 Gew.%, besonders bevorzugt 0,05 bis 7,5 Gew.% und insbesondere 0,5 bis 5 Gew.% mindestens eines 4-morpholinomethyl-substituierten Silikons enthalten, welches Struktureinheiten der Formeln (Si-Via), (Si-Vlb) und (Si-Vlc) aufweist Other particularly suitable silicones are 4-morpholinomethyl substituted. Hair treatment compositions according to the invention which, based on their weight, 0.001 to 20 wt.%, Preferably 0.01 to 10 wt.%, Particularly preferably 0.05 to 7.5 wt.% And in particular 0.5 to 5 wt.% Of at least one 4-morpholinomethyl-substituted silicone containing structural units of the formulas (Si-Via), (Si-Vlb) and (Si-Vlc)
-CH3, -OH, -OCH3, -0-CH2CH3, -0-CH2CH2CH3, oder -0-CH(CH3)2 steht;
R2 für -CH3, -OH, oder -OCH3 steht, -CH 3 , -OH, -OCH 3 , -O-CH 2 CH 3 , -O-CH 2 CH 2 CH 3 , or -O-CH (CH 3 ) 2 ; R 2 is -CH 3 , -OH, or -OCH 3 ,
sind besonders bevorzugt. are particularly preferred.
Besonders bevorzugte erfindungsgemäße Haarbehandlungsmittel enthalten, bezogen auf ihr Gewicht, 0,001 bis 20 Gew.%, vorzugsweise 0,01 bis 10 Gew.%, besonders bevorzugt 0,05 bis 7,5 Gew.% und insbesondere 0,5 bis 5 Gew.% mindestens eines 4-morpholinomethyl-substituierten Silikons der Formel (Si-Vl) Particularly preferred hair treatment compositions according to the invention contain, based on their weight, from 0.001 to 20% by weight, preferably from 0.01 to 10% by weight, particularly preferably from 0.05 to 7.5% by weight and in particular from 0.5 to 5% by weight. at least one 4-morpholinomethyl-substituted silicone of the formula (Si-Vl)
(Si-Vl) (Si-Vl)
in der in the
R1 für -CH3, -OH, -OCH3, -O-CH2CH3, -O-CH2CH2CH3, oder -0-CH(CH3)2 steht;R 1 is -CH 3 , -OH, -OCH 3, -O-CH 2 CH 3 , -O-CH 2 CH 2 CH 3 , or -O-CH (CH 3 ) 2 ;
R2 für -CH3, -OH, oder -OCH3 steht. R2 is -CH 3 , -OH, or -OCH 3 .
B für eine Gruppe -OH, -0-Si(CH3)3,-0-Si(CH3)20H ,-0-Si(CH3)20CH3 steht,B represents a group -OH, -0-Si (CH 3) 3, -0-Si (CH3) 20H, -0-Si (CH 3) 20ch 3;
D für eine Gruppe -H, -Si(CH3)3,-Si(CH3)2OH, -Si(CH3)2OCH3 steht, D is a group -H, -Si (CH 3 ) 3 , -Si (CH 3 ) 2 OH, -Si (CH 3 ) 2 OCH 3 ,
a, b und c unabhängig voneinander für ganze Zahlen zwischen 0 und 1000 stehen, mit der Maßgabe a + b + c > 0 a, b and c independently represent integers between 0 and 1000, with the proviso that a + b + c> 0
m und n unabhängig voneinander für ganze, Zahlen zwischen 1 und 1000 stehen mit den Maßgabe, daß m and n independently of each other for integers, numbers between 1 and 1000 are provided with the proviso that
mindestens eine der Bedingungen B = -OH bzw. D = -H erfüllt ist, die Einheiten a, b, c, m und n statistisch oder blockweise im Molekül verteilt vorliegen. at least one of the conditions B = -OH or D = -H is satisfied, the units a, b, c, m and n are distributed randomly or in blocks in the molecule.
Strukturformel (Si-Vl) soll verdeutlichen, daß die Siloxangruppen n und m nicht zwingend direkt an eine Endgruppierung B bzw. D gebunden sein müssen. Vielmehr gilt in bevorzugten Formeln (Si-Vl) a > 0 oder b > 0 und in besonders bevorzugten Formeln (Si-Vl) a > 0 und c > 0, d.h. die terminale Gruppierung B bzw. D ist vorzugsweise an eine Dimethylsiloxy-Gruppierung gebunden. Auch in Formel (Si-Vl) sind die Siloxaneinheiten a, b, c, m und n vorzugsweise statistisch verteilt. Structural formula (Si-VI) is intended to illustrate that the siloxane groups n and m do not necessarily have to be bound directly to an end grouping B or D, respectively. Rather, in preferred formulas (Si-VI) a> 0 or b> 0 and in particularly preferred formulas (Si-Vl) a> 0 and c> 0, i. the terminal moiety B or D is preferably attached to a dimethylsiloxy moiety. Also in formula (Si-Vl), the siloxane units a, b, c, m and n are preferably randomly distributed.
Die durch Formel (Si-Vl) dargestellten erfindungsgemäß eingesetzten Silikone können trimethylsilyl- terminiert sein (D oder B = -Si(CH3)3), sie können aber auch zweiseitig dimethylsilylhydroxy- oder einseitig dimethylsilylhydroxy- und dimethylsilylmethoxy-terminiert sein. Im Rahmen der
vorliegenden Erfindung besonders bevorzugt eingesetzte Silikone sind ausgewählt aus Silikonen, in denen The silicones used according to the invention represented by formula (Si-VI) may be trimethylsilyl-terminated (D or B = -Si (CH 3 ) 3 ), but they may also be dimethylsilylhydroxy- or dimethylsilylhydroxy- and dimethylsilylmethoxy-terminated on two sides. As part of the Silicones particularly preferably used in the present invention are selected from silicones in which
B = -0-Si(CH3)2OH und D = -Si(CH3)3 B = -O-Si (CH 3 ) 2 OH and D = -Si (CH 3 ) 3
B = -0-Si(CH3)2OH und D = -Si(CH3)2OH B = -O-Si (CH 3 ) 2 OH and D = -Si (CH 3 ) 2 OH
B = -0-Si(CH3)2OH und D = -Si(CH3)2OCH3 B = -O-Si (CH 3 ) 2 OH and D = -Si (CH 3 ) 2 OCH 3
B = -0-Si(CH3)3 und D = -Si(CH3)2OH B = -O-Si (CH 3 ) 3 and D = -Si (CH 3 ) 2 OH
B = -0-Si(CH3)2OCH3 und D = -Si(CH3)2OH B = -O-Si (CH 3 ) 2 OCH 3 and D = -Si (CH 3 ) 2 OH
bedeutet. Diese Silikone führen zu exorbitanten Verbesserungen der Haareigenschaften der mit den erfindungsgemäßen Mitteln behandelten Haare, und zu einem gravierend verbesserten Schutz bei oxidativer Behandlung. means. These silicones lead to exorbitant improvements in the hair properties of the hair treated with the agents according to the invention, and to a significantly improved protection in the case of oxidative treatment.
Unabhängig von der Art des bzw. der eingesetzten aminofunktionellen Silikon(s/e) mit terminale(r/n) Hydroxygruppe(n) enthalten die erfindungsgemäßen Mittel das/die Silikon(e) vorzugsweise in Form einer Emulsion, besonders bevorzugt in Form einer Mikroemulsion. Regardless of the type of aminofunctional silicone (s) used with terminal hydroxyl group (s), the agents of the invention preferably contain the silicone (s) in the form of an emulsion, more preferably in the form of a microemulsion ,
Es hat sich gezeigt, daß die Wirkung der in den erfindungsgemäßen Mitteln eingesetzten Silikone noch gesteigert werden kann, wenn bestimmte nichtionische Komponenten ebenfalls in den Mitteln eingesetzt werden. Zudem haben diese nichtionischen Komponenten positive Effekte auf die Lagerstabilität der Mittel. Nichtionische Komponenten, die hier besonders geeignet sind, sind Ethoxylate von Decanol, Undecanol, Dodecanol, Tridecanol usw.. Als besonders geeignet haben sich ethoxylierte Tridecanole erwiesen, die mit besonderem Vorzug in die erfindungsgemäßen Mittel inkorporiert werden. Erfindungsgemäß besonders bevorzugte Mittel sind dadurch gekennzeichnet, daß sie- bezogen auf ihr Gewicht - 0,00001 bis 5 Gew.-%, vorzugsweise 0,0001 bis 3,5 Gew.-%, besonders bevorzugt 0,001 bis 2 Gew.-%, weiter bevorzugt 0,01 bis 1 Gew.-% und insbesondere 0,1 bis 0,5 Gew.-% verzweigtes, ethoxyliertes Tridecanol (INCI-Bezeichnung: Trideceth-5) oder o iso-Tridecyl-u hydroxypolyglycolether (INCI-Bezeichnung: Trideceth-10) oder deren Mischungen enthält. It has been found that the effect of the silicones used in the compositions according to the invention can be increased even more if certain nonionic components are also used in the compositions. In addition, these nonionic components have positive effects on the storage stability of the funds. Nonionic components which are particularly suitable here are ethoxylates of decanol, undecanol, dodecanol, tridecanol, etc. Ethoxylated tridecanols have proven to be particularly suitable, which are incorporated with particular preference into the compositions according to the invention. Compositions which are particularly preferred according to the invention are characterized in that they contain 0.00001 to 5% by weight, preferably 0.0001 to 3.5% by weight, particularly preferably 0.001 to 2% by weight, based on their weight preferably 0.01 to 1 wt .-% and in particular 0.1 to 0.5 wt .-% branched, ethoxylated tridecanol (INCI name: Trideceth-5) or o iso-tridecyl-u hydroxypolyglycolether (INCI name: Trideceth -10) or mixtures thereof.
Zusätzlich zu dem bzw. den aminofunktionellen Silikon(en) oder an ihrer Stelle können die erfindungsgemäßen Mittel weitere(s) Silikon(e) enthalten, welche nicht aminofunktionell ist/sind. Erfindungsgemäße bevorzugte Mittel sind dadurch gekennzeichnet, daß sie mindestens ein Silicon enthalten, das ausgewählt ist unter: In addition to or in place of the aminofunctional silicone (s), the compositions of the invention may contain other silicone (s) which are not amino functional. Preferred agents according to the invention are characterized in that they contain at least one silicone selected from:
(i) Polyalkylsiloxanen, Polyarylsiloxanen, Polyalkylarylsiloxanen, die flüchtig oder nicht flüchtig, geradkettig, verzweigt oder cyclisch, vernetzt oder nicht vernetzt sind; (i) polyalkyl siloxanes, polyaryl siloxanes, polyalkylaryl siloxanes which are volatile or nonvolatile, straight chain, branched or cyclic, crosslinked or uncrosslinked;
(ii) Polysiloxanen, die in ihrer allgemeinen Struktur eine oder mehrere organofunktionelle Gruppen enthalten, die ausgewählt sind unter: (ii) Polysiloxanes containing in their general structure one or more organofunctional groups selected from:
a) (per)fluorierten Gruppen; a) (per) fluorinated groups;
b) Thiolgruppen; b) thiol groups;
c) Carboxylatgruppen; c) carboxylate groups;
d) hydroxylierten Gruppen; d) hydroxylated groups;
e) alkoxylierten Gruppen; e) alkoxylated groups;
f) Acyloxyalkylgruppen;
g) amphoteren Gruppen; f) acyloxyalkyl groups; g) amphoteric groups;
h) Bisulfitgruppen; h) bisulfite groups;
i) Hydroxyacylaminogruppen; i) hydroxyacylamino groups;
j) Carboxygruppen; j) carboxy groups;
k) Sulfonsäuregruppen; und k) sulfonic acid groups; and
I) Sulfat- oder Thiosulfatgruppen; I) sulphate or thiosulphate groups;
(iii) linearen Polysiloxan(A)- Polyoxyalkylen(B)- Blockcopoylmeren vom Typ (A-B)n mit n > 3; (iii) linear polysiloxane (A) - polyoxyalkylene (B) - block copolymers of the type (AB) n with n>3;
(iv) gepfropften Siliconpolymeren mit nicht siliconhaltigem, organischen Grundgerüst, die aus einer organischen Hauptkette bestehen, welche aus organischen Monomeren gebildet wird, die kein Silicon enthalten, auf die in der Kette sowie gegebenenfalls an mindestens einem Kettenende mindestens ein Polysiloxanmakromer gepfropft wurde; (iv) grafted silicone polymers having a non-silicone organic backbone consisting of an organic backbone formed from organic monomers containing no silicone grafted with at least one polysiloxane macromer in the chain and optionally at least one chain end;
(v) gepfropften Siliconpolymeren mit Polysiloxan-Grundgerüst, auf das nicht siliconhaltige, organische Monomere gepfropft wurden, die eine Polysiloxan-Hauptkette aufweisen, auf die in der Kette sowie gegebenenfalls an mindestens einem ihrer Enden mindestens ein organisches Makromer gepfropft wurde, das kein Silicon enthält; (v) grafted polysiloxane backbone silicone polymers having grafted thereto non-silicone organic monomers having a polysiloxane backbone to which at least one organic macromer not containing silicone has been grafted in the chain, and optionally at least at one of its ends ;
oder deren Gemischen. or their mixtures.
Erfindungsgemäß bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie - bezogen auf ihr Gewicht - 0,01 bis 20 Gew.-%, vorzugsweise 0, 1 bis 10 Gew.-%, weiter bevorzugt 0,5 bis 7,5 Gew.-% und insbesondere 1 bis 5 Gew.-% nicht-aminofunktionelle Silikon(e) enthalten. Bevorzugte Silikone werden nachstehend beschrieben. According to the invention preferred hair treatment compositions are characterized in that they - based on their weight - 0.01 to 20 wt .-%, preferably 0, 1 to 10 wt .-%, more preferably 0.5 to 7.5 wt .-% and in particular 1 to 5 wt .-% non-amino-functional silicone (s) included. Preferred silicones are described below.
Besonders bevorzugte erfindungsgemäße Mittel sind dadurch gekennzeichnet, daß sie mindestens ein Silikon der Formel Si-I Particularly preferred agents according to the invention are characterized in that they contain at least one silicone of the formula Si-I
(CH3)3Si-[0-Si(CH3)2]x-0-Si(CH3)3 (Si-I), (CH 3 ) 3 Si - [0-Si (CH 3 ) 2] x -O-Si (CH 3 ) 3 (Si-I),
enthalten, in der x für eine Zahl von 0 bis 100, vorzugsweise von 0 bis 50, weiter bevorzugt von 0 bis 20 und insbesondere 0 bis 10, steht. in which x is a number from 0 to 100, preferably from 0 to 50, more preferably from 0 to 20 and in particular 0 to 10.
Selbstverständlich können auch Mischungen der o.g. Silikone in den erfindungsgemäßen Mitteln enthalten sein. Bevorzugte erfindungsgemäß einsetzbare Silikone weisen bei 20°C Viskositäten von 0,2 bis 2 mm2s auf, wobei Silikone mit Viskositäten von 0,5 bis 1 mm2s besonders bevorzugt sind. Die erfindungsgemäßen Haarbehandlungsmittel können Tensid(e) enthalten. In reinigenden Zusammensetzungen (Shampoos) haben sich insbesondere anionische Tenside bewährt, in konditionierenden Zusammensetzungen sind kationische Tenside oft genutzte Inhaltsstoffe; amphotere Tenside werden aufgrund ihrer vorteilhaften Eigenschaften mit besonderem Vorteil sowohl in Shampoos als auch in Conditionern eingesetzt. Of course, mixtures of the above-mentioned silicones may also be contained in the agents according to the invention. Preferred silicones which can be used according to the invention have viscosities of from 0.2 to 2 mm 2 s at 20 ° C., silicones having viscosities of from 0.5 to 1 mm 2 s being particularly preferred. The hair treatment compositions of the invention may contain surfactant (s). In cleaning compositions (shampoos), in particular anionic surfactants have proven useful, in conditioning compositions, cationic surfactants are often used ingredients; Due to their advantageous properties, amphoteric surfactants are used with particular advantage both in shampoos and in conditioners.
Die erfindungsgemäßen Haarbehandlungsmittel können mindestens ein anionisches Tensid enthalten. The hair treatment compositions of the invention may contain at least one anionic surfactant.
Als anionische Tenside und Emulgatoren eignen sich für die erfindungsgemäßen Zusammensetzungen alle für die Verwendung am menschlichen Körper geeigneten anionischen oberflächenaktiven Stoffe. Diese sind gekennzeichnet durch eine wasserlöslich machende, anionische
Gruppe wie z. B. eine Carboxylat-, Sulfat-, Sulfonat- oder Phosphat-Gruppe und eine lipophile Alkylgruppe mit etwa 8 bis 30 C-Atomen. Zusätzlich können im Molekül Glycol- oder Polyglycolether- Gruppen, Ester-, Ether- und Amidgruppen sowie Hydroxylgruppen enthalten sein. Suitable anionic surfactants and emulsifiers for the compositions according to the invention are all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic Group such as As a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms. In addition, glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups may be present in the molecule.
Bevorzugte Haarbehandlungsmittel enthalten - bezogen auf ihr Gewicht - 0,5 bis 20 Gew.-%, vorzugsweise 0,75 bis 15 Gew.-%, weiter bevorzugt 1 bis 12 Gew.-% und insbesondere 2 bis 10 Gew.-% anionische(s) Tensid(e). Preferred hair treatment compositions contain - based on their weight - 0.5 to 20 wt .-%, preferably 0.75 to 15 wt .-%, more preferably 1 to 12 wt .-% and in particular 2 to 10 wt .-% of anionic ( s) surfactant (s).
Insbesondere bevorzugte erfindungsgemäße Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie - bezogen auf ihr Gewicht - 0,5 bis 20 Gew.-%, vorzugsweise 0,75 bis 15 Gew.-%, weiter bevorzugt 1 bis 12 Gew.-% und insbesondere 2 bis 10 Gew.-% Alkyl(ether)sulfate der allgemeinen Formel R-(OCH2-CH2)n-OS03X, in der R eine geradkettige oder verzweigte, gesättigte oder ungesättigte Alkylgruppe mit 8 bis 24 C-Atomen, n die Zahl 0 oder 1 bis 12, und X ein Alkali-, Erdalkali-, Ammonium- oder Alkanolaminion bedeutet, enthalten. Particularly preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.5 to 20% by weight, preferably from 0.75 to 15% by weight, more preferably from 1 to 12% by weight and in particular from 2 to 10% by weight of alkyl (ether) sulfates of the general formula R- (OCH 2 -CH 2) n -OSO 3 X, in which R is a straight-chain or branched, saturated or unsaturated alkyl group having 8 to 24 C atoms, n is the number 0 or 1 to 12, and X represents an alkali, alkaline earth, ammonium or alkanolamine ion included.
Die erfindungsgemäßen Haarbehandlungsmittel können mindestens ein amphoteres Tensid und/oder mindestens ein nichtionisches Tensid enthalten. The hair treatment compositions of the invention may contain at least one amphoteric surfactant and / or at least one nonionic surfactant.
Besonders bevorzugte erfindungsgemäße Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie - bezogen auf ihr Gewicht - 0,3 bis 20 Gew.-%, vorzugsweise 0,5 bis 8 Gew.-%, weiter bevorzugt 0,75 bis 6 Gew.-% und insbesondere 1 bis 5 Gew.-% amphotere(s) Tensid(e) enthalten. Als amphotere Tenside oder auch als zwitterionische Tenside bezeichnet man Tenside, die sowohl eine negativ als auch eine positiv geladene funktionelle Gruppe besitzen. Particularly preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.3 to 20% by weight, preferably from 0.5 to 8% by weight, more preferably from 0.75 to 6% by weight and in particular 1 to 5 wt .-% amphoteric surfactant (s) included. As amphoteric surfactants or as zwitterionic surfactants called surfactants, which have both a negative and a positively charged functional group.
Besonders geeignete zwitterionische Tenside sind die sogenannten Betaine wie die N-Alkyl-N,N- dimethylammoniumglycinate, beispielsweise das Kokosalkyldimethylammoniumglycinat, N-Acyl- aminopropyl-N,N-dimethylammoniumglycinate, beispielsweise das Kokosacylaminopropyldimethyl- ammoniumglycinat, und 2-Alkyl-3-carboxymethyl-3-hydroxyethylimidazoline mit jeweils 8 bis 18 C- Atomen in der Alkyl- oder Acylgruppe sowie das Kokosacylaminoethylhydroxyethylcarboxymethyl- glycinat. Ein bevorzugtes zwitterionisches Tensid ist das unter der INCI-Bezeichnung Cocamidopropyl Betaine bekannte Fettsäureamidderivat. Particularly suitable zwitterionic surfactants are the so-called betaines such as the N-alkyl-N, N-dimethylammoniumglycinate, for example Kokosalkyldimethylammoniumglycinat, N-acyl aminopropyl-N, N-dimethylammoniumglycinate, for example Kokosacylaminopropyldimethyl- ammoniumglycinat, and 2-alkyl-3-carboxymethyl 3-hydroxyethylimidazolines having in each case 8 to 18 C atoms in the alkyl or acyl group, and also the cocoacylaminoethylhydroxyethylcarboxymethyl-glycinate. A preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.
Weitere Beispiele für geeignete ampholytische Tenside sind N-Alkylglycine, N-Alkylaminopropion- säuren, N-Alkylaminobuttersäuren, N-Alkyliminodipropionsäuren, N-Hydroxyethyl-N-alkylamidopro- pylglycine, N-Alkyltaurine, N-Alkylsarcosine, 2-Alkylaminopropionsäuren und Alkyl- aminoessigsäuren mit jeweils etwa 8 bis 24 C-Atomen in der Alkylgruppe. Besonders bevorzugte ampholytische Tenside sind das N-Kokosalkylaminopropionat, das Kokosacylaminoethylamino- propionat und das C12 - C18 - Acylsarcosin. Further examples of suitable ampholytic surfactants are N-alkylglycines, N-alkylaminopropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidoproylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 carbon atoms in the alkyl group. Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C12-C18-acylsarcosine.
Besonders bevorzugte Haarbehandlungsmittel enthalten als amphotere Tenside Betaine der Formel (Bet-I) Particularly preferred hair treatment compositions contain as amphoteric surfactants betaines of the formula (Bet-I)
(Bet-I),
in der R für einen geradkettigen oder verzweigten, gesättigten oder ein- bzw. mehrfach ungesättigten Alkyl- oder Alkenylrest mit 8 bis 24 Kohlenstoffatomen steht. (Bet-I), in which R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms.
Diese Tenside werden nach der INCI-Nomenklatur als Amidopropylbetaine bezeichnet, wobei die These surfactants are referred to the INCI nomenclature as Amidopropylbetaine, the
Vertreter, die sich von Kokosfettsäuren ableiten, bevorzugt sind und als Cocoamidopropylbetaine bezeichnet werden. Besonders bevorzugt werden erfindungsgemäß Tenside der Formel (Bet-I) eingesetzt, die ein Gemisch der folgenden Vertreter sind: Representatives derived from coconut fatty acids, are preferred and are referred to as Cocoamidopropylbetaine. According to the invention, particular preference is given to using surfactants of the formula (Bet-I) which are a mixture of the following representatives:
H3C-(CH2)7-C(0)-NH-(CH2)3N+(CH3)2CH2COO-H 3 C- (CH 2) 7-C (O) -NH- (CH 2) 3 N + (CH 3) 2 CH 2 COO-
H3C-(CH2)9-C(0)-NH-(CH2)3N+(CH3)2CH2COO-H 3 C- (CH 2) 9-C (O) -NH- (CH 2) 3 N + (CH 3) 2 CH 2 COO-
H3C-(CH2)i i-C(0)-NH-(CH2)3N+(CH3)2CH2COO-H 3 C- (CH 2) i iC (O) -NH- (CH 2) 3 N + (CH 3) 2 CH 2 COO-
H3C-(CH2)i3-C(0)-NH-(CH2)3N+(CH3)2CH2COO-H 3 C- (CH 2) 3- C (O) -NH- (CH 2) 3 N + (CH 3) 2 CH 2 COO-
H3C-(CH2)i5-C(0)-NH-(CH2)3N+(CH3)2CH2COO-H 3 C- (CH 2) i5-C (O) -NH- (CH 2) 3 N + (CH 3) 2 CH 2 COO-
H3C-(CH2)7-CH=CH-(CH2)7-C(0)-NH-(CH2)3N+(CH3)2CH2COO-H 3 C- (CH 2) 7 -CH = CH- (CH 2) 7-C (O) -NH- (CH 2) 3 N + (CH 3) 2 CH 2 COO-
Besonders bevorzugt werden Tenside der Formel (Bet-I) innerhalb engerer Mengenbereiche eingesetzt. Hier sind erfindungsgemäße Haarbehandlungsmittel bevorzugt, die - bezogen auf ihr Gewicht - 0,25 bis 8 Gew.-%, weiter bevorzugt 0,5 bis 7 Gew.-%, weiter bevorzugt 0,75 bis 6,5 Gew.-% und insbesondere 1 bis 5,5 Gew.-% Tensid(e) der Formel (Bet-I) enthalten. Particular preference is given to using surfactants of the formula (Bet-I) within narrower ranges of amounts. Here hair-treatment compositions according to the invention are preferred which - based on their weight - 0.25 to 8 wt .-%, more preferably 0.5 to 7 wt .-%, more preferably 0.75 to 6.5 wt .-% and in particular 1 to 5.5 wt .-% of surfactant (s) of the formula (Bet-I) included.
Zusätzlich zu dem bzw. den Amphotensiden der Formel (Bet-I) oder an deren Stelle können die erfindungsgemäßen Haarbehandlungsmittel mit besonderem Vorzug als amphotere Tenside Betaine der Formel (Bet-Il) In addition to the amphoteric surfactant (s) of the formula (Bet-I) or in its place, the hair-treatment compositions of the invention may be used with particular preference as amphoteric surfactants betaines of the formula (Bet-II)
enthalten, in der R für einen geradkettigen oder verzweigten, gesättigten oder ein- bzw. mehrfach ungesättigten Alkyl- oder Alkenylrest mit 8 bis 24 Kohlenstoffatomen steht. in which R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms.
Diese Tenside werden nach der INCI-Nomenklatur als Amphoacetate bezeichnet, wobei die Vertreter, die sich von Kokosfettsäuren ableiten bevorzugt sind und als Cocoamphoactetate bezeichnet werden. These surfactants are referred to according to the INCI nomenclature as amphoacetates, wherein the representatives derived from coconut fatty acids are preferred and are referred to as cocoamphoactetates.
Aus herstellungstechnischen Gründen enthalten Tenside dieses Typs immer auch Betaine der Formel (Bet-I la) For manufacturing reasons, surfactants of this type also always contain betaines of the formula (Bet-I 1a)
(Bet-Ila),
in der R für einen geradkettigen oder verzweigten, gesättigten oder ein- bzw. mehrfach ungesättigten Alkyl- oder Alkenlyrest mit 8 bis 24 Kohlenstoffatomen und M für ein Kation steht. (Bet-Ila) in which R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms and M is a cation.
Diese Tenside werden nach der INCI-Nomenklatur als Amphodiacetate bezeichnet, wobei die Vertreter, die sich von Kokosfettsäuren ableiten, bevorzugt sind und als Cocoamphodiactetate bezeichnet werden. These surfactants are referred to according to the INCI nomenclature as Amphodiacetate, wherein the representatives derived from coconut fatty acids are preferred and are referred to as Cocoamphodiactetate.
Besonders bevorzugt werden erfindungsgemäß Tenside der Formel (Bet-Il) eingesetzt, die ein According to the invention, particular preference is given to using surfactants of the formula (Bet-II) which have a
Gemisch der folgenden Vertreter sind: Mixture of the following representatives are:
H3C-(CH2)7-C(0)-NH-(CH2)2NH+(CH2CH20H)CH2CH2COO-H 3 C- (CH 2) 7-C (O) -NH- (CH 2 ) 2 NH + (CH 2 CH 2 OH) CH 2 CH 2 COO-
H3C-(CH2)9-C(0)-NH-(CH2)2NH+(CH2CH2OH)CH2CH2COO-H3C- (CH2) 9-C (0) -NH- (CH2) 2 NH + (CH 2 CH 2 OH) CH2CH2COO-
H3C-(CH2)i i-C(0)-NH-(CH2)2NH+(CH2CH20H)CH2CH2COO-H 3 C- (CH 2) i iC (O) -NH- (CH 2) 2 NH + (CH 2 CH 2 OH) CH 2 CH 2 COO-
H3C-(CH2)i3-C(0)-NH-(CH2)2NH+(CH2CH2OH)CH2CH2COO-H3C- (CH2) i3-C (0) -NH- (CH2) 2 NH + (CH 2 CH 2 OH) CH2CH2COO-
H3C-(CH2)i5-C(0)-NH-(CH2)2NH+(CH2CH20H)CH2CH2COO-H 3 C- (CH 2) i5-C (O) -NH- (CH 2 ) 2 NH + (CH 2 CH 2 OH) CH 2 CH 2 COO-
H3C-(CH2)7-CH=CH-(CH2)7-C(0)-NH-(CH2)2NH+(CH2CH20H)CH2CH2COO-H 3 C- (CH 2 ) 7 -CH = CH- (CH 2 ) 7-C (O) -NH- (CH 2 ) 2 NH + (CH 2 CH 2 OH) CH 2 CH 2 COO-
Besonders bevorzugt werden Tenside der Formel (Bet-Il) innerhalb engerer Mengenbereiche eingesetzt. Hier sind erfindungsgemäße Haarbehandlungsmittel bevorzugt, die - bezogen auf ihr Gewicht - 0,25 bis 8 Gew.-%, weiter bevorzugt 0,5 bis 7 Gew.-%, weiter bevorzugt 0,75 bis 6,5 Gew.-% und insbesondere 1 bis 5,5 Gew.-% Tensid(e) der Formel (Bet-Il) enthalten. Particular preference is given to using surfactants of the formula (Bet-II) within narrower ranges of amounts. Here hair-treatment compositions according to the invention are preferred which - based on their weight - 0.25 to 8 wt .-%, more preferably 0.5 to 7 wt .-%, more preferably 0.75 to 6.5 wt .-% and in particular 1 to 5.5 wt .-% of surfactant (s) of the formula (Bet-II) included.
Zusammenfassend sind erfindungsgemäße kosmetische Mittel bevorzugt, bei denen der Rest R in den Formeln (Bet-I) und (Bet-Il) ausgewählt ist aus In summary, cosmetic agents according to the invention are preferred in which the radical R in the formulas (Bet-I) and (Bet-II) is selected from
H3C-(CH2)7- H3C-(CH2)9- H3C-(CH2)ii- H3C-(CH2)i3- H3C-(CH2)i5-H 3 C- (CH 2 ) 7 - H 3 C- (CH 2 ) 9 - H 3 C- (CH 2 ) ii- H 3 C- (CH 2 ) i 3 -H 3 C- (CH 2 ) i5 -
H3C-(CH2)7-CH=CH-(CH2)7- oder Mischungen aus diesen. H 3 C- (CH 2) 7 -CH = CH- (CH 2) 7- or mixtures of these.
Die Haarbehandlungsmittel können nichtionische(s) Tensid(e) enthalten. The hair treatment agents may contain nonionic surfactant (s).
Erfindungsgemäß bevorzugte Haarbehandlungsmittel enthalten - bezogen auf ihr Gewicht - 0,3 bis 10 Gew.-%, vorzugsweise 0,5 bis 8 Gew.-%, weiter bevorzugt 0,75 bis 6 Gew.-% und insbesondere 1 bis 5 Gew.-% nichtionische(s) Tensid(e). Hair treatment agents preferred according to the invention contain, based on their weight, 0.3 to 10% by weight, preferably 0.5 to 8% by weight, more preferably 0.75 to 6% by weight and in particular 1 to 5% by weight. % nonionic surfactant (s).
Die Haarbehandlungsmittel können kationische(s) Tensid(e) enthalten. Erfindungsgemäß einsetzbar sind kationische Tenside vom Typ der quartären Ammoniumverbindungen, der Esterquats und der Amidoamine. Bevorzugte quaternäre Ammoniumverbindungen sind Ammoniumhalogenide, insbesondere Chloride und Bromide, wie Alkyltrimethylammoniumchloride, Dialkyldimethyl- ammoniumchloride und Trialkylmethylammoniumchloride. Die langen Alkylketten dieser Tenside weisen bevorzugt 10 bis 18 Kohlenstoffatome auf, wie z. B. in Cetyltrimethylammoniumchlorid, Stea- ryltrimethylammoniumchlorid, Distearyldimethylammoniumchlorid, Lauryldimethylammoniumchlorid, Lauryldimethylbenzylammoniumchlorid und Tricetylmethylammoniumchlorid. Weitere bevorzugte kationische Tenside sind die unter den INCI-Bezeichnungen Quaternium-27 und Quaternium-83 bekannten Imidazolium-Verbindungen. The hair treatment agents may contain cationic surfactant (s). Cationic surfactants of the quaternary ammonium compound type, the esterquats and the amidoamines can be used according to the invention. Preferred quaternary ammonium compounds are ammonium halides, in particular chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides. The long alkyl chains of these surfactants preferably have 10 to 18 carbon atoms, such as. In cetyl trimethyl ammonium chloride, stearyl trimethyl ammonium chloride, distearyl dimethyl ammonium chloride, lauryl dimethyl ammonium chloride, lauryl dimethyl benzyl ammonium chloride and tricetylmethyl ammonium chloride. Further preferred cationic surfactants are the imidazolium compounds known under the INCI names Quaternium-27 and Quaternium-83.
Besonders bevorzugte erfindungsgemäße Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie als kationischen Pflegestoff - bezogen auf ihr Gewicht - 0,05 bis 7,5 Gew.-%, vorzugsweise 0,1 bis 5 Gew.-%, besonders bevorzugt 0,2 bis 3,5 Gew.-% und insbesondere 0,25 bis 2,5 Gew.-%
kationische(s) Tensid(e) aus der Gruppe der quartären Ammoniumverbindungen und/oder der Esterquats und/oder der Amidoamine enthalten. Particularly preferred hair treatment compositions according to the invention are characterized in that they contain as cationic care substance - based on their weight - 0.05 to 7.5 wt .-%, preferably 0.1 to 5 wt .-%, particularly preferably 0.2 to 3, 5 wt .-% and in particular 0.25 to 2.5 wt .-% cationic surfactant (s) from the group of quaternary ammonium compounds and / or esterquats and / or amidoamines.
Besonders bevorzugte erfindungsgemäße Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie - bezogen auf das Gewicht des Mittels -0,05 bis 20 Gew.-%, vorzugsweise 0, 1 bis 10 Gew.-%, weiter bevorzugt 0,25 bis 8 Gew.-% und insbesondere 0,5 bis 7 Gew.-% kationische(s) Tensid(e), vorzugsweise 0,05 bis 20 Gew.-%, vorzugsweise 0, 1 bis 10 Gew.-%, weiter bevorzugt 0,25 bis 8 Gew.-% und insbesondere 0,5 bis 7 Gew.-% Behenyltrimethyl-ammoniumchlorid enthalten. Particularly preferred hair treatment compositions according to the invention are characterized in that they contain, based on the weight of the composition, from 0.05 to 20% by weight, preferably from 0.1 to 10% by weight, more preferably from 0.25 to 8% by weight. and in particular from 0.5 to 7% by weight of cationic surfactant (s), preferably from 0.05 to 20% by weight, preferably from 0.1 to 10% by weight, more preferably from 0.25 to 8% by weight .-% and in particular 0.5 to 7 wt .-% behenyl trimethyl ammonium chloride.
Die erfindungsgemäßen Mittel können mindestens ein kationisches Polymer enthalten. The compositions of the invention may contain at least one cationic polymer.
Kationische Polymere steigern die Pflegeleistung der erfindungsgemäßen Haarbehandlungsmittel (insbesondere die Wirksamkeit der erfindungsgemäßen Mittel gegen Haarbruch). Cationic polymers increase the care performance of the hair treatment compositions according to the invention (in particular the effectiveness of the hair breakage compositions according to the invention).
Unabhängig davon, welche(s) kationische(n) Polymer(e) eingesetzt werden, enthalten bevorzugte Haarbehandlungsmittel - bezogen auf das Gewicht des Mittels - 0,01 bis 3 Gew.-%, vorzugsweise 0,05 bis 2 Gew.-%, weiter bevorzugt 0,1 bis 1 ,5 Gew.-% und insbesondere 0,15 bis 0,8 Gew.-% kationische(s) Polymer(e). Regardless of which cationic polymer (s) are used, preferred hair treatment agents contain, based on the weight of the composition, 0.01 to 3% by weight, preferably 0.05 to 2% by weight, more preferably 0.1 to 1, 5 wt .-% and in particular 0.15 to 0.8 wt .-% cationic (s) polymer (s).
Kationische Polysaccharid-Polymere steigern die Pflegeleistung der erfindungsgemäßen Haarbehandlungsmittel (insbesondere die Wirksamkeit der erfindungsgemäßen Mittel gegen Haarbruch). Geeignete kationische Polysaccharid-Polymere können ausgewählt sein aus kationischen Celluloseverbindungen und/oder aus kationischen Guar-Derivaten. Cationic polysaccharide polymers increase the care performance of the hair treatment compositions according to the invention (in particular the effectiveness of the hair breakage compositions according to the invention). Suitable cationic polysaccharide polymers may be selected from cationic cellulose compounds and / or from cationic guar derivatives.
Besonders bevorzugte erfindungsgemäße Haarbehandlungsmittel enthalten als kationische(s) Polysaccharid-Polymer(e) - bezogen auf das Gewicht des Mittels - 0,01 bis 3 Gew.-%, vorzugsweise 0,05 bis 2 Gew.-%, weiter bevorzugt 0,1 bis 1 ,5 Gew.-% und insbesondere 0,15 bis 0,8 Gew.-% mindestens eines Polymers aus der Gruppe der kationischen Cellulosepolymeren und/oder der kationischen Guarderivate. Particularly preferred hair treatment compositions according to the invention contain as cationic polysaccharide polymer (s) - based on the weight of the composition - 0.01 to 3 wt .-%, preferably 0.05 to 2 wt .-%, more preferably 0.1 to 1, 5 wt .-% and in particular 0.15 to 0.8 wt .-% of at least one polymer from the group of cationic cellulose polymers and / or cationic guar derivatives.
Kationische Celluloseverbindungen im Sinne der Erfindung sind solche, die in mindestens einer Seitenkette mehr als eine permanente kationische Ladung tragen. Cellulose ist aus beta-1 ,4- glycosidisch-verknüpften D-Glucopyranose-Einheiten aufgebaut und bildet unverzweigte, wasserunlösliche Ketten. Als „Seitenkette" einer Cellulose werden chemische Substituenten definiert, die an das Cellulosegerüst binden und nicht zur nativen Cellulose zählen, da sie z. B. durch chemische Synthese nachträglich eingeführt wurden. Cationic cellulose compounds in the sense of the invention are those which carry more than one permanent cationic charge in at least one side chain. Cellulose is composed of beta-1, 4-glycosidically linked D-glucopyranose units and forms unbranched, water-insoluble chains. As a "side chain" of a cellulose, chemical substituents are defined which bind to the cellulose skeleton and do not belong to the native cellulose since they have been subsequently introduced, for example, by chemical synthesis.
Bevorzugt sind quaternisierte Cellulosepolymere, die aus Hydroxy(C2-C4)alkylcellulosen hervorgehen, besonders bevorzugt aus Hydroxyethylcellulosen. Preference is given to quaternized cellulose polymers derived from hydroxy (C 2 -C 4) -alkylcelluloses, more preferably from hydroxyethylcelluloses.
Solche Polymere sind dem Fachmann bekannt und im Handel von verschiedenen Firmen erhältlich. Besonders bevorzugt sind die unter den INCI-Bezeichnungen Polyquaternium-4, Polyquaternium- 10, Polyquaternium-24, Polyquaternium-67 und/oder Polyquaternium-72 bekannten kationischen Cellulosederivate. Ganz besonders bevorzugt sind Polyquaternium-10, Polyquaternium-24 und/oder Polyquaternium-67 und insbesondere bevorzugt ist Polyquaternium-10. Such polymers are known to those skilled in the art and commercially available from various companies. Particularly preferred are the cationic cellulose derivatives known under the INCI names Polyquaternium-4, Polyquaternium-10, Polyquaternium-24, Polyquaternium-67 and / or Polyquaternium-72. Very particular preference is given to polyquaternium-10, polyquaternium-24 and / or polyquaternium-67 and particular preference to polyquaternium-10.
Bevorzugte erfindungsgemäße Haarbehandlungsmittel enthalten als kationische(s) Polysaccharid- Polymere) - bezogen auf das Gewicht des Mittels - 0,01 bis 3 Gew.-%, vorzugsweise 0,05 bis 2
Gew.-%, weiter bevorzugt 0,1 bis 1 ,5 Gew.-% und insbesondere 0, 15 bis 0,8 Gew.-% mindestens eines Polymers aus der Gruppe der Polyquaternium-4, Polyquaternium-10, Polyquaternium-24, Polyquaternium-67 und/oder Polyquaternium-72. Preferred hair treatment compositions according to the invention contain as cationic polysaccharide polymers), based on the weight of the composition, from 0.01 to 3% by weight, preferably from 0.05 to 2 Wt .-%, more preferably 0.1 to 1, 5 wt .-% and in particular 0, 15 to 0.8 wt .-% of at least one polymer from the group of Polyquaternium-4, Polyquaternium-10, Polyquaternium-24, Polyquaternium-67 and / or Polyquaternium-72.
Besonders bevorzugte erfindungsgemäße Haarbehandlungsmittel enthalten als kationische(s) Polysaccharid-Polymer(e) - bezogen auf das Gewicht des Mittels - 0,01 bis 3 Gew.-%, vorzugsweise 0,05 bis 2 Gew.-%, weiter bevorzugt 0,1 bis 1 ,5 Gew.-% und insbesondere 0,15 bis 0,8 Gew.-% Polyquaternium-10. Particularly preferred hair treatment compositions according to the invention contain as cationic polysaccharide polymer (s) - based on the weight of the composition - 0.01 to 3 wt .-%, preferably 0.05 to 2 wt .-%, more preferably 0.1 to 1, 5 wt .-% and in particular 0.15 to 0.8 wt .-% Polyquaternium-10.
Geeignete kationische Guar-Derivate im Sinne der Erfindung sind kationische Hydroxyalkyl-Guar- Derivate, vorzugsweise kationisches Hydroxyethyltrimethylammonium-Guar und/oder kationisches Hydroxypropyltrimethylammonium-Guar mit mittleren Molekulargewichten zwischen 100.000 und 2.000.000 Dalton. Insbesondere bevorzugt sind die unter der INCI-Bezeichnung Guar Hydroxypropyltrimonium Chloride bekannten kationischen Guar-Polymere mit einem Molekulargewicht (Gewichtsmittel) zwischen 200.000 und 1 .600.000 Dalton. Die kationische Ladungsdichte dieser Guar-Polymere beträgt vorzugsweise mindestens 0,4 meq/g, bevorzugt mindestens 0,5 meq/g und insbesondere mindestens 0,6 meq/g. Ihr Stickstoffgehalt liegt vorzugsweise im Bereich von 1 , 1 bis 1 ,8 Gew.-% (bezogen auf ihr Gesamtgewicht). Suitable cationic guar derivatives in the context of the invention are cationic hydroxyalkyl guar derivatives, preferably cationic hydroxyethyltrimethylammonium guar and / or cationic hydroxypropyltrimethylammonium guar with average molecular weights between 100,000 and 2,000,000 daltons. Particularly preferred are the cationic guar polymers having a molecular weight (weight average) between 200,000 and 1,600,000 daltons known by the INCI name Guar Hydroxypropyltrimonium Chloride. The cationic charge density of these guar polymers is preferably at least 0.4 meq / g, preferably at least 0.5 meq / g and especially at least 0.6 meq / g. Their nitrogen content is preferably in the range of 1, 1 to 1, 8 wt .-% (based on their total weight).
Kationische Guar-Derivate, die unter der INCI-Bezeichnung Guar Hydroxypropyltrimonium Chloride bekannt sind, sind dem Fachmann bekannt und beispielsweise unter den Handelsnamen Cosmedia® Guar, N-Hance® und/oder Jaguar® von verschiedenen Anbietern erhältlich. Cationic guar derivatives, which are known under the INCI designation Guar Hydroxypropyltrimonium Chloride, are known in the art and available, for example under the trade name Cosmedia Guar ®, N-Hance ® and / or Jaguar ® from different vendors.
Besonders bevorzugte erfindungsgemäße Haarbehandlungsmittel enthalten als kationische(s) Polysaccharid-Polymer(e) - bezogen auf das Gewicht des Mittels - 0,01 bis 3 Gew.-%, vorzugsweise 0,05 bis 2 Gew.-%, weiter bevorzugt 0, 1 bis 1 ,5 Gew.-% und insbesondere 0, 15 bis 0,8 Gew.-% Guar Hydroxypropyltrimonium Chloride. Particularly preferred hair treatment compositions according to the invention contain as cationic polysaccharide polymer (s) - based on the weight of the composition - 0.01 to 3 wt .-%, preferably 0.05 to 2 wt .-%, more preferably 0, 1 to 1, 5 wt .-% and in particular 0, 15 to 0.8 wt .-% guar hydroxypropyltrimonium chlorides.
Zusammenfassend sind erfindungsgemäß bevorzugte Haarbehandlungsmittel dadurch gekennzeichnet, daß sie - bezogen auf das Gewicht des Mittels - 0,01 bis 3 Gew.-%, vorzugsweise 0,05 bis 2 Gew.-%, weiter bevorzugt 0,1 bis 1 ,5 Gew.-% und insbesondere 0,15 bis 0,8 Gew.-% kationische(s) Polymer(e), vorzugsweise 0,01 bis 3 Gew.-%, vorzugsweise 0,05 bis 2 Gew.-%, weiter bevorzugt 0, 1 bis 1 ,5 Gew.-% und insbesondere 0, 15 bis 0,8 Gew.-% mindestens eines Polymers aus der Gruppe der kationischen Cellulosepolymeren und/oder der kationischen Guarderivate enthalten. In summary, according to the invention preferred hair treatment compositions are characterized in that they - based on the weight of the composition - 0.01 to 3 wt .-%, preferably 0.05 to 2 wt .-%, more preferably 0.1 to 1, 5 wt. % and in particular 0.15 to 0.8% by weight of cationic polymer (s), preferably 0.01 to 3% by weight, preferably 0.05 to 2% by weight, more preferably 0, 1 to 1, 5 wt .-% and in particular 0, 15 to 0.8 wt .-% of at least one polymer from the group of cationic cellulose polymers and / or cationic guar derivatives.
Es hat sich gezeigt, daß alpha-substituierte Aldehyde die Wirkung der erfindungsgemäßen Mittel noch weiter verstärken können. Insbesondere im Hinblick auf die innerstrukturelle Stärkung der Keratinfasern und die Verhinderung des Auswaschens werden deutliche Leistungssteigerungen beobachtet. It has been shown that alpha-substituted aldehydes can further enhance the action of the compositions of the invention. In particular with regard to the inner structural strengthening of the keratin fibers and the prevention of leaching, significant increases in performance are observed.
Erfindungsgemäß bevorzugte Haarbehandlungsmittel sind daher dadurch gekennzeichnet, daß sie - bezogen auf das Gewicht des Mittels - zusätzlich 0,001 bis 20 Gew.-% mindestens eines alphasubstituierten Aldehyds enthalten.
Bevorzugte erfindungsgemäße Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie - bezogen auf ihr Gewicht - 0,01 bis 10 Gew.-%, vorzugsweise 0,05 bis 7,5 Gew.-%, weiter bevorzugt 0,1 bis 6 Gew.-% und insbesondere 0, 15 bis 5 Gew.-% alpha-substituierte Aldehyd(e) der Formel (I) Hair treatment compositions which are preferred according to the invention are therefore characterized in that, based on the weight of the composition, they additionally contain from 0.001 to 20% by weight of at least one alpha-substituted aldehyde. Preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.01 to 10% by weight, preferably from 0.05 to 7.5% by weight, more preferably from 0.1 to 6% by weight and in particular from 0.15 to 5% by weight of alpha-substituted aldehyde (s) of the formula (I)
Y-CH(X)-CHO Y-CH (X) -CHO
enthalten, in der included in the
X für -OH oder -Cl oder -Br oder -I oder -0-(CH2)n-CH3 mit n = 1 , 2, 3, 4 oderX is -OH or -Cl or -Br or -I or -0- (CH 2) n CH 3 with n = 1, 2, 3, 4, or
-0-(CH2)m-OH mit m = 1 , 2, 3 steht. -O- (CH 2 ) m -OH with m = 1, 2, 3 stands.
Y für -H oder -CH3 oder H3C-(CH2)k- mit k = 1 , 2, 3, 4, 5, 6, 7, 8 oder -OH oder -(CH2)P-OH mit p = 1 , 2, 3, 4 oder -CHO steht Y is -H or -CH 3 or H 3 C- (CH 2 ) k - with k = 1, 2, 3, 4, 5, 6, 7, 8 or -OH or - (CH 2 ) P -OH p = 1, 2, 3, 4 or -CHO
Erfindungsgemäß bevorzugt einzusetzende Aldehyde sind mit den Nummern 1 bis 176 auf den Seiten 38 bis 41 des Prioritätsdokuments beschrieben. Preferred aldehydes to be used according to the invention are described by the numbers 1 to 176 on pages 38 to 41 of the priority document.
Ganz besonders bevorzugte erfindungsgemäße Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie - bezogen auf ihr Gewicht - 0,01 bis 10 Gew.-%, vorzugsweise 0,05 bis 7,5 Gew.-%, weiter bevorzugt 0, 1 bis 6 Gew.-% und insbesondere 0, 15 bis 5 Gew.-% mindestens eines alpha-substituierten Aldehyds aus der Gruppe Very particularly preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.01 to 10% by weight, preferably from 0.05 to 7.5% by weight, more preferably from 0 to 1 to 6% by weight. % and in particular 0, 15 to 5 wt .-% of at least one alpha-substituted aldehyde from the group
- 2-Hydroxypropanal (X = -OH, Y = -CH3): 2-hydroxypropanal (X = -OH, Y = -CH 3 ):
- 2-Hydroxyhexanal (X = -OH, Y = H3C-(CH2)k- mit k = 3): 2-hydroxyhexanal (X = -OH, Y = H 3 C- (CH 2 ) k - with k = 3):
- 2-Hydroxyoctanal (X = -OH, Y = H3C-(CH2)k- mit k = 5): 2-hydroxyoctanal (X = -OH, Y = H 3 C- (CH 2 ) k - with k = 5):
Brommalonaldehyd (X = Br, Y = -CH=):
Bromomalonaldehyde (X = Br, Y = -CH =):
- 2-(2-Hydroxyethoxy)acetaldehyd (X = -0-(CH2)P-OH mit p = 2, Y = -H) 2- (2-hydroxyethoxy) acetaldehyde (X = -O- (CH 2 ) P -OH where p = 2, Y = -H)
Glycerinaldehyd (X = -OH, Y = -(CH2)P-OH mit p = 1 ) Glyceraldehyde (X = -OH, Y = - (CH 2 ) P -OH with p = 1)
enthalten. contain.
Es hat sich gezeigt, daß Succinimidylester die Wirkung der erfindungsgemäßen Mittel noch weiter verstärken können. Insbesondere im Hinblick auf die innerstrukturelle Stärkung der Keratinfasern und die Verhinderung des Auswaschens werden deutliche Leistungssteigerungen beobachtet. Erfindungsgemäß bevorzugte Haarbehandlungsmittel sind daher dadurch gekennzeichnet, daß sie - bezogen auf das Gewicht des Mittels - zusätzlich 0,001 bis 10 Gew.-% mindestens eines Succinimidylesters enthalten. It has been shown that succinimidyl esters can further enhance the effect of the agents according to the invention. In particular with regard to the inner structural strengthening of the keratin fibers and the prevention of leaching, significant increases in performance are observed. Hair treatment compositions which are preferred according to the invention are therefore characterized in that they contain, based on the weight of the composition, additionally from 0.001 to 10% by weight of at least one succinimidyl ester.
Succinimidylester sind Ester von Carbonsäuren mit (ggf. substituiertem) /V-Hydroxysuccinimid (NHS, IUPAC 1-Hydroxy-2,5-pyrrolidindion) und werden auch als NHS-Ester bezeichnet. Erfindungsgemäß bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie - bezogen auf das Gewicht des Mittels - zusätzlich 0,01 bis 10 Gew.-%, vorzugsweise 0,05 bis 7,5 Gew.-%, weiter bevorzugt 0,1 bis 6 Gew.-% und insbesondere 0,15 bis 5 Gew.-% (eines) Succinimidylester(s) der Formel (III)
Succinimidyl esters are esters of carboxylic acids with (optionally substituted) / V-hydroxysuccinimide (NHS, IUPAC 1-hydroxy-2,5-pyrrolidinedione) and are also referred to as NHS esters. Hair treatment compositions which are preferred according to the invention are characterized in that they additionally contain from 0.01 to 10% by weight, preferably from 0.05 to 7.5% by weight, more preferably from 0.1 to 6% by weight, based on the weight of the composition. % and in particular 0.15 to 5% by weight of (one) succinimidyl ester (s) of the formula (III)
enthalten, in der included in the
R1 für -H oder eine ionische Gruppe steht. R1 represents -H or an ionic group.
R für einen optional substituierten gesättigten oder ungesättigten, linearen, verzweigten oder cyclischen, aliphatischen oder aromatischen Kohlenwasserstoffrest mit mindestens 5 C-Atomen steht. R is an optionally substituted saturated or unsaturated, linear, branched or cyclic, aliphatic or aromatic hydrocarbon radical having at least 5 C atoms.
Als ionische Gruppe R1 kommen sowohl anionische Gruppen wie Phosphat-, Phosphonat-, Phosphinat-, Sulfat-, Sulfonat-, Sulfinat-, Sulfenat-, Oxysulfonat-, Carboxylat-Gruppen in Frage als auch kationische Gruppen wie substituierte oder unsubstituierte Ammoniumgruppen. Auch zwitterionische/betainische Gruppen wie Carboxybetain- oder Sulfobetaingruppen sind möglich. In erfindungsgemäß bevorzugten Succinimidylestern steht R1 für -H oder -OSO3" oder -SO3" oder -SO2- oder -COO" oder -NH3 + oder -N(CH3)H2 + oder -N(CH3)2H+ oder -N(CH3)3 + oder -N+(CH3)2(CH2)2-COO- oder -N+(CH3)2(CH2)3-S03-. Suitable ionic groups R1 include both anionic groups such as phosphate, phosphonate, phosphinate, sulfate, sulfonate, sulfinate, sulfenate, oxysulfonate, carboxylate groups and cationic groups such as substituted or unsubstituted ammonium groups. Zwitterionic / betainic groups such as carboxybetaine or sulfobetaine groups are also possible. In succinimidyl esters preferred according to the invention, R 1 is -H or -OSO 3 " or -SO 3 " or -SO 2 - or -COO " or -NH 3 + or -N (CH 3 ) H 2 + or -N (CH 3 ) 2 H + or -N (CH 3 ) 3 + or -N + (CH 3 ) 2 (CH 2 ) 2-COO- or -N + (CH 3 ) 2 (CH 2 ) 3 -SO 3 -.
Erfindungsgemäß bevorzugt einzusetzende Succinimidylester sind in Prioritätsdokument auf den Seiten 45 bis 47 mit den Nummern 1 bis 72 beschrieben. Preferred succinimidyl esters to be used according to the invention are described in the priority document on pages 45 to 47 with the numbers 1 to 72.
Ganz besonders bevorzugte erfindungsgemäße Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie - bezogen auf ihr Gewicht - 0,01 bis 10 Gew.-%, vorzugsweise 0,05 bis 7,5 Gew.-%, weiter bevorzugt 0, 1 bis 6 Gew.-% und insbesondere 0, 15 bis 5 Gew.-% mindestens eines Succinimidylesters aus der Gruppe Very particularly preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.01 to 10% by weight, preferably from 0.05 to 7.5% by weight, more preferably from 0 to 1 to 6% by weight. % and in particular 0, 15 to 5 wt .-% of at least one Succinimidylesters from the group
in der R für -Ph oder -(CH2)nCH3 mit n = 4, 5, 6, 7, 8, 9, 10 steht,
in which R stands for -Ph or - (CH 2 ) nCH 3 with n = 4, 5, 6, 7, 8, 9, 10,
enthalten. contain.
Komplexbildner können die Wirkung der erfindungsgemäßen Mittel noch weiter steigern, wobei sich insbesondere Komplexbildner bewährt haben, die sich von Polycarbonsäuren ableiten. Complexing agents can increase the effect of the agents according to the invention even further, in particular complexing agents which are derived from polycarboxylic acids have proved useful.
Erfindungsgemäß bevorzugte Haarbehandlungsmittel sind daher dadurch gekennzeichnet, daß sie - bezogen auf ihr Gewicht - 0,001 bis 20 Gew.-% Komplexbildner aus der Gruppe Tetranatrium- A/,A/-bis(carboxylatomethyl)-L-glutamat (Tetrasodium Glutamate Diacetate, GLDA), Pentasodium Diethylenetriaminepentaacetate (DTPA), Tetranatriumiminodisucciniat (IDS), Tetranatrium- Ethylendiamintetraacetat (EDTA), Tetranatrium-Ethylendiamindibernsteinsäure (EDDS), Trinatrium- Hydroxyethylethylendiamintriessigsäure (HEDTA) enthalten. Hair treatment compositions which are preferred according to the invention are therefore characterized in that they contain, based on their weight, from 0.001 to 20% by weight of complexing agents from the group consisting of tetrasodium A / A / bis (carboxylatomethyl) -L-glutamate (Tetrasodium glutamate diacetate, GLDA). , Pentasodium diethylenetriaminepentaacetate (DTPA), tetrasodiumiminodisuccinate (IDS), tetrasodium ethylenediaminetetraacetate (EDTA), tetrasodium ethylenediamine disuccinic acid (EDDS), trisodium hydroxyethylethylenediaminetriacetic acid (HEDTA).
Ganz besonders bevorzugt ist der Einsatz der drei erstgenannten Komplexbildner. Äußerst bevorzugte erfindungsgemäße Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie - bezogen auf ihr Gewicht - 0,001 bis 20 Gew.-%, vorzugsweise 0,005 bis 15 Gew.-%, bevorzugt 0,01 bis 10 Gew.-%, weiter bevorzugt 0,05 bis 7,5 Gew.-% und insbesondere 0, 1 bis 5 Gew.-% Komplexbildner aus der Gruppe
a. Tetranatrium-A/,A/-bis(carboxylatomethyl)-L-glutamat (Tetrasodium Glutamate Diacetate, GLDA), Very particularly preferred is the use of the first three complexing agents. Extremely preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.001 to 20% by weight, preferably from 0.005 to 15% by weight, preferably from 0.01 to 10% by weight, more preferably from 0.05 to 7.5 wt .-% and in particular 0, 1 to 5 wt .-% complexing agent from the group a. Tetrasodium A /, A / -bis (carboxylatomethyl) -L-glutamate (Tetrasodium Glutamate Diacetate, GLDA),
b. Pentasodium Diethylenetriaminepentaacetate (DTPA) b. Pentasodium diethylenetriamine pentaacetate (DTPA)
c. Tetranatriumiminodisucciniat (IDS) c. Tetrasodiumiminodisuccinate (IDS)
enthalten. contain.
Dabei können die erfindungsgemäßen Mittel nur einen der drei genannten Komplexbildner enthalten. Es ist aber ebenso möglich, daß die erfindungsgemäßen Mittel zwei oder alle drei der o.g. Komplexbildner enthalten, wobei die Mange aller in den Mitteln enthaltener Komplexbildner aus der o.g. Gruppe innerhalb des Mengenbereiches 0,01 bis 20 Gew.-% liegt. The agents according to the invention may contain only one of the three complexing agents mentioned. But it is also possible that the means according to the invention two or all three of the above. Complexing agents, the manganese of all the complexing agents contained in the agents from the o.g. Group within the quantitative range 0.01 to 20 wt .-% is.
Erfindungsgemäß bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie - bezogen auf ihr Gewicht - 0,005 bis 15 Gew.-%, vorzugsweise 0,01 bis 10 Gew.-%, weiter bevorzugt 0,05 bis 7,5 Gew.-% und insbesondere 0,1 bis 5 Gew.-% Tetranatrium-A/,A/-bis(carboxylatomethyl)- L-glutamat (Tetrasodium Glutamate Diacetate, GLDA) enthalten. Hair treatment compositions which are preferred according to the invention are characterized in that they contain, based on their weight, from 0.005 to 15% by weight, preferably from 0.01 to 10% by weight, more preferably from 0.05 to 7.5% by weight and in particular from 0 , 1 to 5 wt .-% tetrasodium A /, A / -bis (carboxylatomethyl) - L-glutamate (Tetrasodium Glutamate Diacetate, GLDA) included.
Erfindungsgemäß ebenfalls bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie - bezogen auf ihr Gewicht - 0,005 bis 15 Gew.-%, vorzugsweise 0,01 bis 10 Gew.-%, weiter bevorzugt 0,05 bis 7,5 Gew.-% und insbesondere 0, 1 bis 5 Gew.-% Pentasodium Diethylenetriaminepentaacetate (DTPA) enthalten. Hair treatment compositions which are likewise preferred according to the invention are characterized in that they contain, based on their weight, from 0.005 to 15% by weight, preferably from 0.01 to 10% by weight, more preferably from 0.05 to 7.5% by weight and in particular 0, 1 to 5 wt .-% pentasodium Diethylenetriaminepentaacetate (DTPA) included.
Erfindungsgemäß ebenfalls bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, daß sie - bezogen auf ihr Gewicht - 0,005 bis 15 Gew.-%, vorzugsweise 0,01 bis 10 Gew.-%, weiter bevorzugt 0,05 bis 7,5 Gew.-% und insbesondere 0,1 bis 5 Gew.-% Tetranatriumiminodisucciniat (IDS) enthalten.
Erfindungsgemäß ebenfalls bevorzugte Haarbehandlungsmittel enthalten - bezogen auf ihr GewichtHair treatment compositions which are likewise preferred according to the invention are characterized in that they contain, based on their weight, from 0.005 to 15% by weight, preferably from 0.01 to 10% by weight, more preferably from 0.05 to 7.5% by weight and in particular 0.1 to 5 wt .-% tetrasodium imino disuccinate (IDS) included. According to the invention also contain preferred hair treatment agent - based on their weight
- 0,01 bis 10 Gew.-%, weiter bevorzugt 0,05 bis 7,5 Gew.-% und insbesondere 0, 1 bis 5 Gew.-% Tetranatrium-A/,A/-bis(carboxylatomethyl)-L-glutamat (Tetrasodium Glutamate Diacetate, GLDA) und 0,01 bis 10 Gew.-%, weiter bevorzugt0,05 bis 7,5 Gew.-% und insbesondere 0, 1 bis 5 Gew.-% Pentasodium Diethylenetriaminepentaacetate (DTPA). From 0.01 to 10% by weight, more preferably from 0.05 to 7.5% by weight and in particular from 0.1 to 5% by weight of tetrasodium A /, A / -bis (carboxylatomethyl) -L- glutamate (Tetrasodium Glutamate Diacetate, GLDA) and 0.01 to 10% by weight, more preferably 0.05 to 7.5% by weight, and more preferably 0.1 to 5% by weight of pentasodium diethylenetriaminepentaacetate (DTPA).
Erfindungsgemäß ebenfalls bevorzugte Haarbehandlungsmittel enthalten - bezogen auf ihr Gewicht According to the invention also contain preferred hair treatment agent - based on their weight
- 0,01 bis 10 Gew.-%, weiter bevorzugt 0,05 bis 7,5 Gew.-% und insbesondere 0, 1 bis 5 Gew.-% Tetranatrium-A/,A/-bis(carboxylatomethyl)-L-glutamat (Tetrasodium Glutamate Diacetate, GLDA) und 0,01 bis 10 Gew.-%, weiter bevorzugt0,05 bis 7,5 Gew.-% und insbesondere 0, 1 bis 5 Gew.-% Tetranatriumiminodisucciniat (IDS). From 0.01 to 10% by weight, more preferably from 0.05 to 7.5% by weight and in particular from 0.1 to 5% by weight of tetrasodium A /, A / -bis (carboxylatomethyl) -L- glutamate (Tetrasodium Glutamate Diacetate, GLDA) and 0.01 to 10% by weight, more preferably 0.05 to 7.5% by weight and especially 0.1 to 5% by weight of tetrasodium imino disuccinate (IDS).
Erfindungsgemäß ebenfalls bevorzugte Haarbehandlungsmittel enthalten - bezogen auf ihr Gewicht According to the invention also contain preferred hair treatment agent - based on their weight
- 0,01 bis 10 Gew.-%, weiter bevorzugt 0,05 bis 7,5 Gew.-% und insbesondere 0, 1 bis 5 Gew.-% Pentasodium Diethylenetriaminepentaacetate (DTPA) und 0,01 bis 10 Gew.-%, weiter bevorzugt0,05 bis 7,5 Gew.-% und insbesondere 0,1 bis 5 Gew.-% Tetranatriumiminodisucciniat (IDS). 0.01 to 10% by weight, more preferably 0.05 to 7.5% by weight and in particular 0.1 to 5% by weight of pentasodium diethylenetriamine pentaacetate (DTPA) and 0.01 to 10% by weight , more preferably 0.05 to 7.5% by weight and especially 0.1 to 5% by weight of tetrasodium imino disuccinate (IDS).
Erfindungsgemäß ebenfalls bevorzugte Haarbehandlungsmittel enthalten - bezogen auf ihr Gewicht -0, 1 bis 5 Gew.-% Tetranatrium-A/,A/-bis(carboxylatomethyl)-L-glutamat (Tetrasodium Glutamate Diacetate, GLDA) und 0, 1 bis 5 Gew.-% Pentasodium Diethylenetriaminepentaacetate (DTPA) und 0,1 bis 5 Gew.-% Tetranatriumiminodisucciniat (IDS). According to the invention also preferred hair treatment compositions contain - based on their weight -0, 1 to 5 wt .-% tetrasodium A /, A / -bis (carboxylatomethyl) -L-glutamate (Tetrasodium glutamate diacetates, GLDA) and 0, 1 to 5 wt % Pentasodium diethylenetriaminepentaacetate (DTPA) and 0.1 to 5% by weight tetrasodiumiminodisuccinate (IDS).
Die Haarbehandlungsmittel können mindestens ein zwei- oder dreiwertiges Metallsalz enthalten. Diese führen zu einer verbesserten Auswaschverhinderung. Zur Erzielung einer optimalen Wirkung ist es von Vorteil, wenn die Metallsalze in den erfindungsgemäßen Mitteln in gelöster Form vorliegen. In einer bevorzugten Ausführungsform enthalten die erfindungsgemäßen Haarreinigungsund -Pflegemittel daher in Wasser lösliche zwei- oder dreiwertigen Metallsalze. Unter „wasserlöslich" wird dabei verstanden, daß sich bei 20°C mindestens 1 g des jeweiligen Salzes in 1 I Wasser vollständig lösen lassen. The hair treatment compositions may contain at least one divalent or trivalent metal salt. These lead to an improved washout prevention. To achieve an optimum effect, it is advantageous if the metal salts are present in dissolved form in the compositions according to the invention. In a preferred embodiment, the hair cleansing and care compositions according to the invention therefore contain water-soluble divalent or trivalent metal salts. The term "water-soluble" is understood to mean that at 20 ° C. at least 1 g of the respective salt can be completely dissolved in 1 l of water.
Geeignete zwei- oder dreiwertige Metallsalze können ausgewählt sein aus zwei- oder dreiwertigen organischen und/oder anorganischen Salzen. Suitable divalent or trivalent metal salts may be selected from divalent or trivalent organic and / or inorganic salts.
Besonders geeignete Kationen innerhalb dieser Salze können bevorzugt ausgewählt sein aus Erdalkalimetallkationen sowie aus Kupfer-, Zink-, Eisen(ll)-, Eisen(lll)- und/oder Aluminiumkationen. Ganz besonders bevorzugt sind Erdalkalimetallkationen und insbesondere bevorzugt Calcium- und Magnesiumkationen. Besonders geeignete organische Anionen innerhalb dieser Salze können bevorzugt ausgewählt sein aus Formiat-, Acetat-, Lactat-, Succinat-, Citrat-, Tartrat-, Malat-, Maleat-, Oxalat- und/oder Glycolationen. Ganz besonders bevorzugt sind Acetat-, Lactat- und/oder Citratsalze mit den zuvor genannten Kationen. Particularly suitable cations within these salts may preferably be selected from alkaline earth metal cations and from copper, zinc, iron (II), iron (III) and / or aluminum cations. Very particularly preferred are alkaline earth metal cations and particularly preferably calcium and magnesium cations. Particularly suitable organic anions within these salts may preferably be selected from formate, acetate, lactate, succinate, citrate, tartrate, malate, maleate, oxalate and / or glycolate ions. Very particular preference is given to acetate, lactate and / or citrate salts with the abovementioned cations.
Insbesondere bevorzugte organische Salze sind Calciumlactat, Calciumcitrat, Calciumacetat, Magnesiumlactat, Magnesiumeitrat und/oder Magnesiumacetat.
Besonders geeignete anorganische Anionen innerhalb dieser Salze können ausgewählt sein aus Halogenid-, Sulfat-, Phosphat- und/oder Carbonationen. Ganz besonders bevorzugt sind Sulfat- und/oder Halogenidionen wie Chlorid- und Bromidionen. Particularly preferred organic salts are calcium, calcium, calcium, magnesium, magnesium and / or magnesium acetate. Particularly suitable inorganic anions within these salts can be selected from halide, sulfate, phosphate and / or carbonate ions. Very particular preference is given to sulfate and / or halide ions, such as chloride and bromide ions.
Insbesondere bevorzugte anorganische Salze sind Calciumchlorid, Calciumsulfat, Magnesiumchlorid und/oder Magnesiumsulfat. Particularly preferred inorganic salts are calcium chloride, calcium sulfate, magnesium chloride and / or magnesium sulfate.
Der Gewichtsanteil des mindestens einen zwei- oder dreiwertigen Metallsalzes am Gesamtgewicht der erfindungsgemäßen Haarbehandlungsmittel beträgt bevorzugt 0,01 bis 10 Gew.-%, vorzugsweise 0,1 bis 7,5 Gew.-%, weiter bevorzugt 0,2 bis 5 Gew.-% und insbesondere 0,3 bis 3 Gew.-%. The proportion by weight of the at least one divalent or trivalent metal salt in the total weight of the hair treatment compositions according to the invention is preferably from 0.01 to 10% by weight, preferably from 0.1 to 7.5% by weight, more preferably from 0.2 to 5% by weight. % and in particular 0.3 to 3 wt .-%.
Erfindungsgemäß bevorzugte Haarbehandlungsmittel enthalten - bezogen auf ihr Gewicht - 0,01 bis 10 Gew.-%, vorzugsweise 0,1 bis 7,5 Gew.-%, weiter bevorzugt 0,2 bis 5 Gew.-% und insbesondere 0,3 bis 3 Gew.-% mindestens eines zwei- oder dreiwertige Metallsalzes aus der Gruppe der organischen oder anorganischen Kupfer-, Zink-, Eisen(ll)-, Calcium-, Magnesium-, Eisen(lll)- und/oder Aluminiumsalze. According to the invention preferred hair treatment compositions contain - based on their weight - 0.01 to 10 wt .-%, preferably 0.1 to 7.5 wt .-%, more preferably 0.2 to 5 wt .-% and in particular 0.3 to 3 wt .-% of at least one divalent or trivalent metal salt from the group of organic or inorganic copper, zinc, iron (II), calcium, magnesium, iron (III) and / or aluminum salts.
Innerhalb dieser Ausführungsform sind die wasserlöslichen Salze besonders bevorzugt. Ganz besonders bevorzugt innerhalb dieser Ausführungsform sind Calciumlactat, Calciumcitrat, Calciumacetat, Magnesiumlactat, Magnesiumeitrat, Magnesiumacetat, Calciumhalogenide, Calciumhydroxid, Magnesiumhalogenide und/oder Magnesiumhydroxid. Within this embodiment, the water-soluble salts are particularly preferred. Most particularly preferred within this embodiment are calcium lactate, calcium citrate, calcium acetate, magnesium lactate, magnesium citrate, magnesium acetate, calcium halides, calcium hydroxide, magnesium halides and / or magnesium hydroxide.
Die Haarbehandlungsmittel enthalten die vorstehend beschriebenen Wirkstoffe bevorzugt in einem kosmetisch akzeptablen Träger. Darunter wird im Rahmen der Erfindung bevorzugt ein wäßriger oder wäßrig-alkoholischer Träger verstanden. The hair treatment compositions preferably contain the active ingredients described above in a cosmetically acceptable carrier. For the purposes of the invention, this is preferably understood as meaning an aqueous or aqueous-alcoholic carrier.
Der kosmetische Träger enthält bevorzugt mindestens 50 Gew.-%, mehr bevorzugt mindestens 60 Gew.-%, besonders bevorzugt mindestens 70 Gew.-% und insbesondere bevorzugt mindestens 75 Gew.-% Wasser. The cosmetic carrier preferably contains at least 50% by weight, more preferably at least 60% by weight, particularly preferably at least 70% by weight and especially preferably at least 75% by weight of water.
Weiterhin kann der kosmetische Träger 0,01 bis 40 Gew.-%, bevorzugt 0,05 bis 30 Gew.-% und insbesondere 0, 1 bis 20 Gew.-% mindestens eines Alkohols enthalten. Furthermore, the cosmetic carrier may contain 0.01 to 40 wt .-%, preferably 0.05 to 30 wt .-% and in particular 0, 1 to 20 wt .-% of at least one alcohol.
Geeignete Alkohole sind beispielsweise Ethanol, Ethyldiglykol, 1-Propanol, 2-Propanol, Isopropanol, 1 ,2-Propylenglycol, Glycerin, Diglycerin, Triglycerin, 1 -Butanol, 2-Butanol, 1 ,2-Butandiol, 1 ,3- Butandiol, 1-Pentanol, 2-Pentanol, 1 ,2-Pentandiol, 1 ,5-Pentandiol, 1 , Hexanol, 2-Hexanol, 1 ,2- Hexandiol, 1 ,6-Hexandiol, Polyethylenglycolen, Sorbitol, Sorbitan, Benzylalkohol oder Mischungen dieser Alkohole. Suitable alcohols are, for example, ethanol, ethyl diglycol, 1-propanol, 2-propanol, isopropanol, 1,2-propylene glycol, glycerol, diglycerol, triglycerol, 1-butanol, 2-butanol, 1, 2-butanediol, 1, 3-butanediol, 1-pentanol, 2-pentanol, 1, 2-pentanediol, 1, 5-pentanediol, 1, hexanol, 2-hexanol, 1, 2-hexanediol, 1, 6-hexanediol, polyethylene glycols, sorbitol, sorbitan, benzyl alcohol or mixtures thereof alcohols.
Besonders bevorzugt sind die wasserlöslichen Alkohole. Insbesondere bevorzugt sind Ethanol, 1 ,2- Propylenglycol, Glycerin, Benzylalkohol sowie Mischungen dieser Alkohole. Particularly preferred are the water-soluble alcohols. Particularly preferred are ethanol, 1, 2-propylene glycol, glycerol, benzyl alcohol and mixtures of these alcohols.
Für eine sehr gute (Kopf)hautverträglichkeit der erfindungsgemäßen Haarbehandlungsmittel ist es von Vorteil, wenn diese einen leicht aciden pH-Wert aufweisen. For a very good (head) skin compatibility of the hair treatment compositions according to the invention, it is advantageous if they have a slightly acidic pH.
Es wurde gefunden, dass die erfindungsgemäßen Mittel in einem pH-Bereich von 4,2 bis 5,8 eine besonders gute Hautverträglichkeit und Milde aufweisen. It has been found that the compositions according to the invention in a pH range from 4.2 to 5.8 have a particularly good skin tolerance and mildness.
In einer ersten bevorzugten Ausführungsform weisen die erfindungsgemäßen Haarbehandlungsmittel daher bevorzugt einen pH-Wert im Bereich von 4,2 bis 5,8, mehr bevorzugt
von 4,3 bis 5,6, besonders bevorzugt von 4,4 bis 5,5, außerordentlich bevorzugt von 4,5 bis 5,4 und insbesondere bevorzugt von 4,7 bis 5,3 auf. Therefore, in a first preferred embodiment, the hair treatment compositions of the invention preferably have a pH in the range of 4.2 to 5.8, more preferably from 4.3 to 5.6, more preferably from 4.4 to 5.5, most preferably from 4.5 to 5.4, and most preferably from 4.7 to 5.3.
Die erfindungsgemäßen Haarbehandlungsmittel können pflanzliche Öle, pflanzliche Buttern und/oder pflanzliche Wachse enthalten. Diese pflanzlichen Ölkomponenten verleihen den Haaren eine verbesserte Kämmbarkeit und Frisierbarkeit und erhöhen den Haarglanz. The hair treatment compositions according to the invention may contain vegetable oils, vegetable butters and / or vegetable waxes. These vegetable oil components give the hair improved combability and manageability and increase hair shine.
Zu den geeigneten pflanzlichen Ölkomponenten zählen natürliche (pflanzliche) Öle und/oder Buttern, die üblicherweise Triglyceride und Mischungen von Triglyceriden enthalten. Suitable vegetable oil components include natural (vegetable) oils and / or butters, which commonly contain triglycerides and mixtures of triglycerides.
Bevorzugte natürliche Öle sind Kokosnussöl, (süßes) Mandelöl, Walnussöl, Pfirsichkernöl, Aprikosenkernöl, Arganöl, Avocadoöl, Teebaumöl (Tea Tree Oil), Sojaöl, Sesamöl, Sonnenblumenöl, Tsubakiöl, Nachtkerzenöl, Reiskleieöl, Palmkernöl, Mangokernöl, Marulaöl, Wiesenschaumkrautöl, Distelöl, Macadamianussöl, Traubenkernöl, Amaranthsamenöl, Bambusöl, Olivenöl, Weizenkeimöl, Kürbiskernöl, Malvenöl, Haselnussöl, Safloröl, Canolaöl, Sasanquaöl, Jojobaöl, Rambutanöl, Kakaobutter und/oder Shea-Butter. Preferred natural oils are coconut oil, (sweet) almond oil, walnut oil, peach kernel oil, apricot kernel oil, argan oil, avocado oil, tea tree oil, soybean oil, sesame oil, sunflower oil, tsubaki oil, evening primrose oil, rice bran oil, palm kernel oil, mango seed oil, marula oil, meadowfoam oil, thistle oil, Macadamia nut oil, grape seed oil, amaranth seed oil, bamboo oil, olive oil, wheat germ oil, pumpkin seed oil, mallow oil, hazelnut oil, safflower oil, canola oil, sasanqua oil, jojoba oil, rambutan oil, cocoa butter and / or shea butter.
Als geeignete natürliche oder pflanzliche Wachse können bevorzugt Carnaubawachse, Bienenwachse und/oder Candelillawachse eingesetzt werden. Carnauba waxes, beeswaxes and / or candelilla waxes may be used as suitable natural or vegetable waxes.
Besonders bevorzugte pflanzliche Ölkomponenten sind (süßes) Mandelöl, Pfirsichkernöl, Aprikosenkernöl, Amaranthsamenöl, Arganöl, Olivenöl, Jojobaöl, Kakaobutter und/oder Shea-Butter. Insbesondere bevorzugt sind Aprikosenkernöl, Arganöl, Olivenöl und/oder Jojobaöl. Particularly preferred vegetable oil components are (sweet) almond oil, peach kernel oil, apricot kernel oil, amaranth seed oil, argan oil, olive oil, jojoba oil, cocoa butter and / or shea butter. Apricot kernel oil, argan oil, olive oil and / or jojoba oil are particularly preferred.
In einer bevorzugten Ausführungsform enthalten die erfindungsgemäßen Haarbehandlungsmittel bevorzugt Kokosnussöl, (süßes) Mandelöl, Walnussöl, Pfirsichkernöl, Aprikosenkernöl, Arganöl, Avocadoöl, Teebaumöl (Tea Tree Oil), Sojaöl, Sesamöl, Sonnenblumenöl, Tsubakiöl, Nachtkerzenöl, Reiskleieöl, Palmkernöl, Mangokernöl, Marulaöl, Wiesenschaumkrautöl, Distelöl, Macadamianussöl, Traubenkernöl, Amaranthsamenöl, Bambusöl, Olivenöl, Weizenkeimöl, Kürbiskernöl, Malvenöl, Haselnussöl, Safloröl, Canolaöl, Sasanquaöl, Jojobaöl, Rambutanöl, Kakaobutter und/oder Shea-Butter. In a preferred embodiment, the hair treatment compositions according to the invention preferably contain coconut oil, (sweet) almond oil, walnut oil, peach kernel oil, apricot kernel oil, argan oil, avocado oil, tea tree oil, soybean oil, sesame oil, sunflower oil, tsubaki oil, evening primrose oil, rice bran oil, palm kernel oil, mango seed oil, marula oil , Meadowfoam seed oil, thistle oil, macadamia nut oil, grape seed oil, amaranth seed oil, bamboo oil, olive oil, wheat germ oil, pumpkin seed oil, mallow oil, hazelnut oil, safflower oil, canola oil, sasanqua oil, jojoba oil, rambutan oil, cocoa butter and / or shea butter.
Innerhalb dieser Ausführungsform ist es besonders bevorzugt, wenn die erfindungsgemäßen Haarbehandlungsmittel (süßes) Mandelöl, Pfirsichkernöl, Aprikosenkernöl, Amaranthsamenöl, Arganöl, Olivenöl, Jojobaöl, Kakaobutter und/oder Shea-Butter enthalten. Within this embodiment it is particularly preferred if the hair treatment compositions according to the invention contain (sweet) almond oil, peach kernel oil, apricot kernel oil, amaranth seed oil, argan oil, olive oil, jojoba oil, cocoa butter and / or shea butter.
Der Gewichtsanteil des mindestens einen pflanzlichen Öls, der pflanzlichen Butter und/oder des pflanzlichen Wachses am Gesamtgewicht der erfindungsgemäßen Haarbehandlungsmittel beträgt bevorzugt 0,02 bis 2,50 Gew.-%, mehr bevorzugt von 0,03 bis 2,00 Gew.-%, besonders bevorzugt 0,04 bis 1 ,50 Gew.-% und insbesondere 0,05 bis 1 ,00 Gew.-%. The proportion by weight of the at least one vegetable oil, the vegetable butter and / or the vegetable wax in the total weight of the hair treatment compositions according to the invention is preferably 0.02 to 2.50 wt .-%, more preferably from 0.03 to 2.00 wt .-% , Particularly preferably 0.04 to 1, 50 wt .-% and in particular 0.05 to 1, 00 wt .-%.
Neben den zuvor genannten wesentlichen und fakultativen Bestandteilen können die erfindungsgemäßen Haarbehandlungsmittel in einer weiteren bevorzugten Ausführungsform zur weiteren Steigerung der pflegenden Eigenschaften der Mittel mindestens einen weiteren haarkonditionierenden Wirkstoff enthalten, der ausgewählt sein kann aus der Gruppe der In a further preferred embodiment, in addition to the abovementioned essential and optional constituents, the hair treatment compositions according to the invention may contain at least one further hair-conditioning active agent, which may be selected from the group of US Pat
Vitamine, vitamins,
Pflanzenextrakte und/oder Plant extracts and / or
Glycerin.
Besonders bevorzugt sind Vitamine, Provitamine und Vitaminvorstufen aus den Gruppen A, B, E und H. Insbesondere bevorzugt sind Nicotinsäureamid, Biotin, Pantolacton und/oder Panthenol. Glycerol. Particular preference is given to vitamins, provitamins and vitamin precursors from groups A, B, E and H. Particular preference is given to nicotinamide, biotin, pantolactone and / or panthenol.
Der Gewichtsanteil des oder der Vitamins(e), Vitaminderivats(e), und/oder der Vitaminvorstufe(n) am Gesamtgewicht der Haarbehandlungsmittel beträgt bevorzugt 0,001 bis 2 Gew.-%, besonders bevorzugt 0,005 bis 1 Gew.-% und insbesondere 0,01 bis 0,5 Gew.-%. The proportion by weight of the vitamin (s), vitamin derivative (s), and / or the vitamin precursor (s) in the total weight of the hair treatment agent is preferably from 0.001 to 2% by weight, particularly preferably from 0.005 to 1% by weight and in particular 0, 01 to 0.5 wt .-%.
Unter geeigneten Pflanzenextrakten sind Extrakte zu verstehen, die aus allen Teilen einer Pflanze hergestellt werden können. Üblicherweise werden diese Extrakte durch Extraktion der gesamten Pflanze hergestellt. Es kann aber in einzelnen Fällen auch bevorzugt sein, die Extrakte ausschließlich aus Blüten und/oder Blättern der Pflanze herzustellen. Geeignet sind vor allem die Extrakte aus Grünem Tee, Eichenrinde, Brennessel, Hamamelis, Hopfen, Kamille, Klettenwurzel, Schachtelhalm, Weißdorn, Lindenblüten, Litschi, Mandel, Aloe Vera, Fichtennadel, Roßkastanie, Sandelholz, Wacholder, Kokosnuß, Mango, Aprikose, Limone, Weizen, Kiwi, Melone, Orange, Grapefruit, Salbei, Rosmarin, Birke, Malve, Wiesenschaumkraut, Quendel, Schafgarbe, Thymian, Melisse, Hauhechel, Huflattich, Eibisch, Ginseng, Ingwerwurzel, Echinacea purpurea, Olea europea, Boerhavia Diffusa-Wurzeln, Foeniculum vulgaris und Apim graveolens. Suitable plant extracts are extracts that can be made from any part of a plant. Usually these extracts are produced by extraction of the whole plant. However, in individual cases it may also be preferred to prepare the extracts exclusively from flowers and / or leaves of the plant. Particularly suitable are the extracts of green tea, oak bark, stinging nettle, witch hazel, hops, chamomile, burdock root, horsetail, linden, lychee, almond, aloe vera, spruce needle, horse chestnut, sandalwood, juniper, coconut, mango, apricot, lime , Wheat, Kiwi, Melon, Orange, Grapefruit, Sage, Rosemary, Birch, Mallow, Meadowfoam, Quendel, Yarrow, Thyme, Melissa, Hominy, Coltsfoot, Marshmallow, Ginseng, Ginger root, Echinacea purpurea, Olea europea, Boerhavia diffusa roots, Foeniculum vulgaris and Apim graveolens.
Besonders bevorzugt für die Verwendung in den erfindungsgemäßen Zusammensetzungen sind die Extrakte aus Grünem Tee, Brennessel, Hamamelis, Kamille, Aloe Vera, Ginseng, Echinacea purpurea, Olea europea und/oder Boerhavia Diffusa-Wurzeln. Particularly preferred for use in the compositions of the invention are the extracts of green tea, stinging nettle, witch hazel, chamomile, aloe vera, ginseng, echinacea purpurea, olea europea and / or Boerhavia diffusa roots.
Die Pflanzenextrakte können in den erfindungsgemäßen Haarbehandlungsmitteln (bezogen auf das Gesamtgewicht der Mittel) bevorzugt in einer Menge von 0,01 bis 10 Gew.-%, mehr bevorzugt von 0,05 bis 7,5 Gew.-% und insbesondere von 0, 1 bis 5 Gew.-% eingesetzt werden. The plant extracts may in the hair treatment compositions according to the invention (based on the total weight of the compositions) preferably in an amount of 0.01 to 10 wt .-%, more preferably from 0.05 to 7.5 wt .-% and in particular from 0, 1 be used to 5 wt .-%.
Glycerin kann den Haarreinigungs- und -Pflegemitteln separat in einer Menge von bis zu 10 Gew.-% (bezogen auf das Gesamtgewicht des Mittels) zugegeben werden. Es kann aber auch Bestandteil des zuvor genannten wäßrig-alkoholischen Trägers sein. Glycerin may be added to the hair cleansing and care products separately in an amount of up to 10% by weight (based on the total weight of the composition). However, it may also be part of the aforementioned aqueous-alcoholic carrier.
Es wurde festgestellt, daß die erfindungsgemäßen Haarbehandlungsmittel auch für eine Anwendung als Antischuppenzubereitung geeignet sind. It has been found that the hair treatment compositions according to the invention are also suitable for use as antidandruff preparation.
Das Gesamtgewicht an Antischuppenmitteln am Gesamtgewicht der Haarbehandlungsmittel kann bevorzugt 0,01 bis 10 Gew.-%, mehr bevorzugt 0,025 bis 7,5 Gew.-%, besonders bevorzugt 0,05 bis 5 Gew.-% und insbesondere 0,075 bis 3 Gew.-% betragen. The total weight of anti-dandruff agents in the total weight of the hair treatment agent may preferably 0.01 to 10 wt .-%, more preferably 0.025 to 7.5 wt .-%, particularly preferably 0.05 to 5 wt .-% and in particular 0.075 to 3 wt. -%.
Geeignete Antischuppenwirkstoffe können ausgewählt sein aus Piroctone Olamine, Climbazol, Zink Pyrithion, Ketoconazole, Salicylsäure, Schwefel, Selensulfid, Teerpräparaten, Undecensäurederivaten, Klettenwurzelextrakten, Pappelextrakten, Brennesselextrakten, Walnussschalenextrakten, Birkenextrakten, Weidenrindenextrakten, Rosmarinextrakten und/oder Arnika extra kten. Suitable antidandruff active ingredients may be selected from piroctone olamine, climbazole, zinc pyrithione, ketoconazole, salicylic acid, sulfur, selenium sulfide, tar preparations, undecenoic acid derivatives, burdock root extracts, poplar extracts, nettle extracts, walnut shell extracts, birch extracts, willow bark extracts, rosemary extracts and / or arnica extracts.
Bevorzugt sind Climbazol, Zink Pyrithion und Piroctone Olamine. Preferred are climbazole, zinc pyrithione and piroctone olamine.
Weitere Wirk-, Hilfs- und Zusatzstoffe, die in den erfindungsgemäßen Haarbehandlungsmitteln bevorzugt enthalten sein können, sind beispielsweise: Further active ingredients, auxiliaries and additives which may preferably be present in the hair treatment compositions according to the invention are, for example:
Feuchthaltemittel, Humectants,
Parfüms,
- UV-Filter, perfumes, - UV filters,
Verdickungsmittel wie Gelatine oder Pflanzengumme, beispielsweise Agar-Agar, Guar- Gum, Alginate, Xanthan-Gum, Gummi arabicum, Karaya-Gummi, Johannisbrotkernmehl, Leinsamengummen, Dextrane, Cellulose-Derivate, z. B. Methylcellulose, Hydroxyalkyl- cellulose und Carboxymethylcellulose, Stärke-Fraktionen und Derivate wie Amylose, Amylopektin und Dextrine, Tone und Schichtsilikate wie z. B. Bentonit oder vollsynthetische Hydrokolloide wie z. B. Polyvinylalkohol, die Ca-, Mg- oder Zn - Seifen, Thickening agents such as gelatin or vegetable gums, for example agar-agar, guar gum, alginates, xanthan gum, gum arabic, karaya gum, locust bean gum, linseed gums, dextrans, cellulose derivatives, e.g. As methyl cellulose, hydroxyalkyl cellulose and carboxymethyl cellulose, starch fractions and derivatives such as amylose, amylopectin and dextrins, clays and phyllosilicates such. As bentonite or fully synthetic hydrocolloids such. As polyvinyl alcohol, the Ca, Mg or Zn - soaps,
Strukturanten wie Maleinsäure und Milchsäure, Structurants such as maleic acid and lactic acid,
Dimethylisosorbid, dimethyl isosorbide,
Cyclodextrine, cyclodextrins
faserstrukturverbessernde Wirkstoffe, insbesondere Mono-, Di- und Oligosaccharide wie beispielsweise Glucose, Galactose, Fructose, Fruchtzucker und Lactose, fiber-structure-improving active ingredients, in particular mono-, di- and oligosaccharides such as, for example, glucose, galactose, fructose, fructose and lactose,
Farbstoffe zum Anfärben des Mittels, Dyes for staining the agent,
Wirkstoffe wie Bisabolol und/oder Allantoin, Active ingredients such as bisabolol and / or allantoin,
Komplexbildner wie EDTA, NTA, ß-Alanindiess ig säure und Phosphonsäuren, Complexing agents such as EDTA, NTA, β-alaninedic acid and phosphonic acids,
Ceramide. Unter Ceramiden werden N-Acylsphingosin (Fettsäureamide des Sphingosins) oder synthetische Analogen solcher Lipide (sogenannte Pseudo-Ceramide) verstanden, Treibmittel wie Propan-Butan-Gemische, N2O, Dimethylether, CO2 und Luft, Ceramides. Ceramides are understood as meaning N-acylsphingosine (fatty acid amides of sphingosine) or synthetic analogues of such lipids (so-called pseudo-ceramides), propellants such as propane-butane mixtures, N 2 O, dimethyl ether, CO 2 and air,
Antioxidantien, antioxidants
Zusätzliche Viskositätsregler wie Salze (NaCI). Additional viscosity regulators, such as salts (NaCl).
Die erfindungsgemäßen Mittel können als sogenannte rinse-off-Produkte formuliert werden, d.h. werden nach einer bestimmten Einwirkzeit wieder aus dem Haar ausgespült. Diese Einwirkzeit beträgt vorzugsweise weniger als eine Stunde, d.h. der Verbraucher beläßt die Produkte vorzugsweise nicht bis zur nächsten Haarwäsche im Haar. The agents of the invention can be formulated as so-called rinse-off products, i. are rinsed out of the hair after a certain exposure time. This exposure time is preferably less than one hour, i. the consumer preferably does not leave the products until the next hair wash in the hair.
Ein weiterer Gegenstand der vorliegenden Erfindung ist daher ein Verfahren zur Haarbehandlung, bei dem ein erfindungsgemäßes Mittel auf trockenes oder feuchtes Haar aufgebracht, dort für einen Zeitraum von 10 bis 300 Sekunden belassen und danach ausgespült wird. Another object of the present invention is therefore a method for hair treatment in which an agent according to the invention is applied to dry or damp hair, left there for a period of 10 to 300 seconds and then rinsed out.
Die erfindungsgemäßen Mittel können auch als sogenannte leave-on-Produkte formuliert werden, d.h. werden nicht aus dem Haar ausgespült, sondern dort bis zur nächsten Haarwäsche belassen. Ein weiterer Gegenstand der vorliegenden Erfindung ist daher ein Verfahren zur Haarbehandlung, bei dem ein erfindungsgemäßes Mittel auf trockenes oder feuchtes Haar aufgebracht und dort bis zur nächsten Haarwäsche belassen wird. The agents of the invention may also be formulated as so-called leave-on products, i. are not rinsed out of the hair, but left there until the next hair wash. Another object of the present invention is therefore a method for hair treatment, in which an agent according to the invention is applied to dry or damp hair and left there until the next hair wash.
Die erfindungsgemäßen Mittel führen zu einer deutlich erhöhten Stärkung der inneren und äußeren Haarstruktur. Ein weiterer Gegenstand der vorliegenden Erfindung ist daher die Verwendung von erfindungsgemäßen Mitteln zur Stärkung der Haarstruktur, insbesondere der inneren Haarstruktur. Unter Strukturstärkung im Sinne der Erfindung, ist eine Verringerung der durch verschiedenartigste Einflüsse entstandenen Schädigungen keratinischer Fasern zu verstehen. Hierbei spielt beispielsweise die Wiederherstellung der natürlichen Festigkeit eine wesentliche Rolle. Restrukturierte Fasern zeichnen sich beispielsweise durch einen verbesserten Glanz, durch einen
verbesserten Griff und durch eine leichtere Kämmbarkeit aus. Zusätzlich weisen sie eine optimierte Festigkeit und Elastizität auf. Eine erfolgreiche Strukturstärkung oder Restrukturierung läßt sich physikalisch als Schmelzpunkterhöhung im Vergleich zur geschädigten Faser nachweisen. The agents according to the invention lead to a significantly increased strengthening of the inner and outer hair structure. Another object of the present invention is therefore the use of agents according to the invention for strengthening the hair structure, in particular the inner hair structure. Structural strengthening in the sense of the invention is to be understood as meaning a reduction in the damage of keratinic fibers which has arisen due to the most diverse influences. Here, for example, the restoration of natural strength plays an essential role. Restrukturierte fibers are characterized for example by an improved gloss, by a improved grip and easier combing. In addition, they have an optimized strength and elasticity. Successful structural reinforcement or restructuring can be physically detected as a melting point increase compared to the damaged fiber.
Die erfindungsgemäßen Mittel führen auch zu einer deutlich erhöhten Stabilität künstlicher Färbungen gegen das Auswaschen von Farbe. So können chemisch gefärbte Haare mit den erfindungsgemäßen Mitteln deutlich häufiger gewaschen werden, ohne daß es zu dem unerwünschten Ausbluten oder einem Verblassen der Farbe kommt. The compositions of the invention also lead to a significantly increased stability of artificial dyeings against the washing out of paint. Thus, chemically dyed hairs can be washed significantly more frequently with the compositions according to the invention, without the undesired bleeding or color fading occurring.
Ein weiterer Gegenstand der vorliegenden Erfindung ist daher die Verwendung von erfindungsgemäßen Mitteln zur Verringerung des Auswaschens von Farbe aus chemisch gefärbten Haaren. Another object of the present invention is therefore the use of agents according to the invention for reducing the washout of color from chemically colored hair.
Bezüglich bevorzugter Ausführungsformen der erfindungsgemäßen Verfahren und der erfindungsgemäßen Verwendungen gilt mutatis mutandis das zu den erfindungsgemäßen Mitteln Gesagte.
With regard to preferred embodiments of the method according to the invention and the uses according to the invention, what has been said about the agents according to the invention applies mutatis mutandis.
Beispiele: Examples:
Alle Angaben in Gew.-%. All data in% by weight.
Haarshampoo: Shampoo:
7 8 9 10 11 127 8 9 10 11 12
Sodium Laureth Sulfate 10 10 10 10 10 10Sodium Laureth Sulfate 10 10 10 10 10 10
Cocoamidopropyl Betaine 4,0 4,0 4,0 4,0 4,0 4,0Cocoamidopropyl Betaine 4.0 4.0 4.0 4.0 4.0 4.0
Ammonium Lauryl Sulfate 4,0 4,0 4,0 4,0 4,0 4,0Ammonium Lauryl Sulfate 4.0 4.0 4.0 4.0 4.0 4.0
Polyquaternium-10 0,3 0,3 0,3 0,3 0,3 0,3Polyquaternium-10 0.3 0.3 0.3 0.3 0.3 0.3
Cocamide MEA 0,8 0,8 0,8 0,8 0,8 0,8Cocamide MEA 0.8 0.8 0.8 0.8 0.8 0.8
PEG-7 Glyceryl Cocoate 1,0 1,0 1,0 1,0 1,0 1,0PEG-7 Glyceryl Cocoate 1.0 1.0 1.0 1.0 1.0 1.0
Nicotinsäureamid 0,3 0,3 0,3 0,3 0,3 0,3Nicotinic acid amide 0.3 0.3 0.3 0.3 0.3 0.3
Citronensäure 0,8 0,8 0,8 0,8 0,8 0,8Citric acid 0.8 0.8 0.8 0.8 0.8 0.8
Monoethanolammoniumhexanoat 0,1 0,5 0,2 0,1 0,2 0,15Monoethanol ammonium hexanoate 0.1 0.5 0.2 0.1 0.2 0.15
Glycerinaldehyd 0,10 - - - - -Glyceraldehyde 0,10 - - - - -
2-Hydroxypropanal - 0,12 - - - -2-hydroxypropanal - 0.12 - - - -
2-Hydroxyhexanal - - 0,15 - - -2-hydroxyhexanal - - 0.15 - - -
2-Hydroxyoctanal - - - 0,10 - -2-hydroxyoctanal - - - 0.10 - -
2-(2-Hydroxyethoxy)acetaldehyd - - - - 0,12 -2- (2-hydroxyethoxy) acetaldehyde - - - - 0.12 -
Brommalonaldehyd - - - - - 0,10Bromomalonaldehyde - - - - - 0.10
Panthenol 0,5 0,5 0,5 0,5 0,5 0,5Panthenol 0,5 0,5 0,5 0,5 0,5 0,5
2-Hydroxyoctanal 1,0 1,0 1,0 1,0 1,0 1,02-hydroxyoctanal 1.0 1.0 1.0 1.0 1.0 1.0
Hydrolyzed Wheat Protein 1,0 2,0 3,5 1,0 0,8 1,0Hydrolyzed Wheat Protein 1.0 2.0 3.5 1.0 0.8 1.0
Laureth-2 1,2 1,2 1,2 1,2 1,2 1,2Laureth-2 1.2 1.2 1.2 1.2 1.2 1.2
Natriumchlorid 1,3 1,0 1,0 1,2 1,1 1,3Sodium chloride 1.3 1.0 1.0 1.2 1.1 1.3
Wasser, Konservierung Parfümöle ad 100 ad 100 ad 100 ad 100 ad 100 ad 100
Haars ülun : Water, preservation Perfume oils ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 Hair ülun:
7 8 9 10 11 12 7 8 9 10 11 12
Quaternium-87 0,75 0,75 0,75 0,75 0,75 0,75Quaternium-87 0.75 0.75 0.75 0.75 0.75 0.75
Glycol Distearate 1,0 1,0 1,0 1,0 1,0 1,0Glycol Distearate 1.0 1.0 1.0 1.0 1.0 1.0
Cetearyl Alcohol 5,0 5,0 5,0 5,0 5,0 5,0Cetearyl Alcohol 5.0 5.0 5.0 5.0 5.0 5.0
Guar Hydroxypropyltrimonium 0,2 0,2 0,2 0,2 0,2 0,2 Chloride Guar Hydroxypropyltrimonium 0.2 0.2 0.2 0.2 0.2 0.2 Chlorides
Polyquaternium-37 0,4 0,4 0,4 0,4 0,4 0,4 Polyquaternium-37 0.4 0.4 0.4 0.4 0.4 0.4
Hydrolyzed Keratin 0,1 0,1 0,1 0,1 0,1 0,1Hydrolyzed keratin 0.1 0.1 0.1 0.1 0.1 0.1
Shea Butter 1,5 1,5 1,5 1,5 1,5 1,5Shea Butter 1.5 1.5 1.5 1.5 1.5 1.5
Behenoyl PG -Trimoniumchloride 1,5 1,5 1,5 1,5 1,5 1,5Behenoyl PG -Trimonium Chloride 1.5 1.5 1.5 1.5 1.5 1.5
Distearoylethyl 0,3 0,3 0,3 0,3 0,3 0,3Distearoylethyl 0.3 0.3 0.3 0.3 0.3 0.3
Hydroxyethylmonium Methosulfate Hydroxyethylmonium Methosulfate
Behentrimonium Chloride 0,4 0,4 0,4 0,4 0,4 0,4 Behentrimonium chlorides 0.4 0.4 0.4 0.4 0.4 0.4
Milchsäure 0,1 0,1 0,1 0,1 0,1 0,1Lactic acid 0.1 0.1 0.1 0.1 0.1 0.1
Trimethylammoniumoctanoat 0,2 0,5 1,0 1,2 0,8 0,6Trimethylammonium octanoate 0.2 0.5 1.0 1.2 0.8 0.6
Glycerinaldehyd 1,2 - - - - -Glyceraldehyde 1,2 - - - - -
2-Hydroxypropanal - 1,0 - - - -2-hydroxypropanal - 1.0 - - - -
2-Hydroxyhexanal - - 2,0 - - -2-hydroxyhexanal - - 2.0 - - -
2-Hydroxyoctanal - - - 1,5 - -2-hydroxyoctanal - - - 1.5 - -
2-(2-Hydroxyethoxy)acetaldehyd - - - - 1,2 -2- (2-hydroxyethoxy) acetaldehyde - - - - 1,2 -
Brommalonaldehyd - - - - - 1,5Bromomalonaldehyde - - - - - 1,5
Amodimethicone 0,8 0,8 0,8 0,8 0,8 0,8Amodimethicones 0.8 0.8 0.8 0.8 0.8 0.8
Wasser, Konservierung, Parfümöle ad 100 ad 100 ad 100 ad 100 ad 100 ad 100
Water, preservation, perfume oils ad 100 ad 100 ad 100 ad 100 ad 100 ad 100
ingesetzte Succinimidyleester: Succinimidyl ester used:
Haarshampoo: Shampoo:
13 14 15 16 17 18 13 14 15 16 17 18
Sodium Laureth Sulfate 10 10 10 10 10 10Sodium Laureth Sulfate 10 10 10 10 10 10
Cocoamidopropyl Betaine 4,0 4,0 4,0 4,0 4,0 4,0Cocoamidopropyl Betaine 4.0 4.0 4.0 4.0 4.0 4.0
Ammonium Lauryl Sulfate 4,0 4,0 4,0 4,0 4,0 4,0Ammonium Lauryl Sulfate 4.0 4.0 4.0 4.0 4.0 4.0
Polyquaternium-10 0,3 0,3 0,3 0,3 0,3 0,3Polyquaternium-10 0.3 0.3 0.3 0.3 0.3 0.3
Cocamide MEA 0,8 0,8 0,8 0,8 0,8 0,8Cocamide MEA 0.8 0.8 0.8 0.8 0.8 0.8
PEG-7 Glyceryl Cocoate 1,0 1,0 1,0 1,0 1,0 1,0PEG-7 Glyceryl Cocoate 1.0 1.0 1.0 1.0 1.0 1.0
Nicotinsäureamid 0,3 0,3 0,3 0,3 0,3 0,3Nicotinic acid amide 0.3 0.3 0.3 0.3 0.3 0.3
Citronensäure 0,8 0,8 0,8 0,8 0,8 0,8Citric acid 0.8 0.8 0.8 0.8 0.8 0.8
Succinimidylester Nr.1 0,1 - - - 0,1 -Succinimidyl ester No.1 0.1 - - - 0.1 -
Succinimidylester Nr.2 - 0,15 - - - -Succinimidyl ester No.2 - 0.15 - - - -
Succinimidylester Nr.3 - - 0,1 - - 0,1Succinimidyl ester No.3 - - 0.1 - - 0.1
Succinimidylester Nr.4 - - - 0,15 - -Succinimidyl ester No.4 - - - 0.15 - -
Glycerinaldehyd — - - - 0,1 -Glyceraldehyde - - - - 0.1 -
Brommalonaldehyd - - - - - 0,2Bromomalonaldehyde - - - - - 0.2
Panthenol 0,5 0,5 0,5 0,5 0,5 0,5Panthenol 0,5 0,5 0,5 0,5 0,5 0,5
2-Hydroxyoctanal 1,0 1,0 1,0 1,0 1,0 1,02-hydroxyoctanal 1.0 1.0 1.0 1.0 1.0 1.0
Trimethylammoniumoctanoat 0,2 0,5 1,0 1,2 0,8 0,6Trimethylammonium octanoate 0.2 0.5 1.0 1.2 0.8 0.6
Hydrolyzed Wheat Protein 1,0 2,0 3,5 1,0 0,8 1,0Hydrolyzed Wheat Protein 1.0 2.0 3.5 1.0 0.8 1.0
Laureth-2 1,2 1,2 1,2 1,2 1,2 1,2Laureth-2 1.2 1.2 1.2 1.2 1.2 1.2
Natriumchlorid 1,3 1,0 1,0 1,2 1,1 1,3Sodium chloride 1.3 1.0 1.0 1.2 1.1 1.3
Wasser, Konservierung Parfümöle ad 100 ad 100 ad 100 ad 100 ad 100 ad 100
Haarspülung: Water, preservation Perfume oils ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 Hair conditioner:
13 14 15 16 17 18 13 14 15 16 17 18
Quaternium-87 0,75 0,75 0,75 0,75 0,75 0,75Quaternium-87 0.75 0.75 0.75 0.75 0.75 0.75
Glycol Distearate 1,0 1,0 1,0 1,0 1,0 1,0Glycol Distearate 1.0 1.0 1.0 1.0 1.0 1.0
Cetearyl Alcohol 5,0 5,0 5,0 5,0 5,0 5,0Cetearyl Alcohol 5.0 5.0 5.0 5.0 5.0 5.0
Guar Hydroxypropyltrimonium 0,2 0,2 0,2 0,2 0,2 0,2 Chloride Guar Hydroxypropyltrimonium 0.2 0.2 0.2 0.2 0.2 0.2 Chlorides
Polyquaternium-37 0,4 0,4 0,4 0,4 0,4 0,4 Polyquaternium-37 0.4 0.4 0.4 0.4 0.4 0.4
Hydrolyzed Keratin 0,1 0,1 0,1 0,1 0,1 0,1Hydrolyzed keratin 0.1 0.1 0.1 0.1 0.1 0.1
Shea Butter 1,5 1,5 1,5 1,5 1,5 1,5Shea Butter 1.5 1.5 1.5 1.5 1.5 1.5
Behenoyl PG -Trimoniumchloride 1,5 1,5 1,5 1,5 1,5 1,5Behenoyl PG -Trimonium Chloride 1.5 1.5 1.5 1.5 1.5 1.5
Distearoylethyl 0,3 0,3 0,3 0,3 0,3 0,3Distearoylethyl 0.3 0.3 0.3 0.3 0.3 0.3
Hydroxyethylmonium Methosulfate Hydroxyethylmonium Methosulfate
Behentrimonium Chloride 0,4 0,4 0,4 0,4 0,4 0,4 Behentrimonium chlorides 0.4 0.4 0.4 0.4 0.4 0.4
Monoethanolammoniumhexanoat 0,1 0,5 0,2 0,1 0,2 0,15Monoethanol ammonium hexanoate 0.1 0.5 0.2 0.1 0.2 0.15
Milchsäure 0,1 0,1 0,1 0,1 0,1 0,1Lactic acid 0.1 0.1 0.1 0.1 0.1 0.1
Succinimidylester Nr.1 0,1 - - - - -Succinimidyl ester No.1 0,1 - - - - -
Succinimidylester Nr.2 - 0,15 - - 0,1 -Succinimidyl ester No.2 - 0.15 - - 0.1 -
Succinimidylester Nr.3 - - 0,1 - - -Succinimidyl ester No.3 - - 0.1 - - -
Succinimidylester Nr.4 - - - 0,15 - 0,1Succinimidyl ester No.4 - - - 0.15 - 0.1
2-Hydroxyhexanal — - - - 0,1 -2-hydroxyhexanal - - - - 0.1 -
2-Hydroxyoctanal - - - - - 0,22-hydroxyoctanal - - - - - 0.2
Amodimethicone 0,8 0,8 0,8 0,8 0,8 0,8Amodimethicones 0.8 0.8 0.8 0.8 0.8 0.8
Wasser, Konservierung, Parfümöle ad 100 ad 100 ad 100 ad 100 ad 100 ad 100
Water, preservation, perfume oils ad 100 ad 100 ad 100 ad 100 ad 100 ad 100
Claims
Patentansprüche: claims:
1. Haarbehandlungsmittel, enthaltend bezogen auf sein Gewicht 1. hair treatment compositions containing based on its weight
a) 0,001 bis 10 Gew.-% mindestens eines Aminsalzes einer Carbonsäure; a) 0.001 to 10 wt .-% of at least one amine salt of a carboxylic acid;
b) 0,001 bis 20 Gew.-% mindestens eines Proteinhydrolysats. b) 0.001 to 20 wt .-% of at least one protein hydrolyzate.
2. Haarbehandlungsmittel nach Anspruch 1 , dadurch gekennzeichnet, daß es - bezogen auf sein Gewicht - 0,01 bis 10 Gew.-%, vorzugsweise 0,05 bis 7,5 Gew.-%, weiter bevorzugt 0, 1 bis 6 Gew.-% und insbesondere 0, 15 bis 5 Gew.-% Aminsalz(e) von Carbonsäure(n) der Formel (I) 2. hair treatment composition according to claim 1, characterized in that it - based on its weight - 0.01 to 10 wt .-%, preferably 0.05 to 7.5 wt .-%, more preferably 0, 1 to 6 wt. % and in particular 0, 15 to 5% by weight of amine salt (s) of carboxylic acid (s) of the formula (I)
(i) (I)
enthält, in der contains, in the
R1 , R2 und R3 unabhängig voneinander ausgewählt sind aus -H, -CH3, -CH2CH3,-CH2CH2OH, R 1, R 2 and R 3 are independently selected from -H, -CH 3 , -CH 2 CH 3 , -CH 2 CH 2 OH,
R für einen optional substituierten gesättigten oder ungesättigten, linearen, verzweigten oder cyclischen, aliphatischen oder aromatischen Kohlenwasserstoffrest mit mindestens 2 C-Atomen steht. R is an optionally substituted saturated or unsaturated, linear, branched or cyclic, aliphatic or aromatic hydrocarbon radical having at least 2 C atoms.
Haarbehandlungsmittel nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß es - bezogen auf sein Gewicht - 0,01 bis 10 Gew.-%, vorzugsweise 0,05 bis 7,5 Gew.-%, weiter bevorzugt 0, 1 bis 6 Gew.-% und insbesondere 0, 15 bis 5 Gew.-% mindestens eines Aminsalzes aus der Gruppe
Hair treatment composition according to one of the preceding claims, characterized in that it contains - based on its weight - 0.01 to 10 wt .-%, preferably 0.05 to 7.5 wt .-%, more preferably 0, 1 to 6 wt. -% and in particular 0, 15 to 5 wt .-% of at least one amine salt from the group
(la) (La)
in der R für -Ph oder -(CH2)nCH3 mit n = 4, 5, 6, 7, 8, 9, 10, insbesondere für 5 oder 7, steht,
in which R is -Ph or - (CH 2 ) n CH 3 where n = 4, 5, 6, 7, 8, 9, 10, in particular 5 or 7,
(Ib) (Ib)
in der R für -Ph oder -(CH2)nCH3 mit n = 4, 5, 6, 7, 8, 9, 10, insbesondere für 5 oder 7, steht,
in which R is -Ph or - (CH 2 ) n CH 3 where n = 4, 5, 6, 7, 8, 9, 10, in particular 5 or 7,
in der R für -Ph oder -(CH2)nCH3 mit n = 4, 5, 6, 7, 8, 9, 10, insbesondere für 5 oder 7, steht
in which R is -Ph or - (CH 2) n CH 3 where n = 4, 5, 6, 7, 8, 9, 10, in particular 5 or 7
(Id) (Id)
in der R und R' unabhängig voneinander für -Ph oder -(CH2)nCH3 mit n = 4, 5, 6, 7, 8, 9, 10, insbesondere für 5 oder 7, stehen, in which R and R ', independently of one another, are -Ph or - (CH 2) n CH 3 where n = 4, 5, 6, 7, 8, 9, 10, in particular 5 or 7,
enthält. contains.
Haarbehandlungsmittel nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß es - bezogen auf sein Gewicht -0,01 bis 15 Gew.-%, vorzugsweise 0,05 bis 10 Gew.-%, weiter bevorzugt 0, 1 bis 7,5 Gew.-% und insbesondere 0,15 bis 5 Gew.- % Proteinhydrolysat(e) aus der Gruppe Elastin-, Kollagen-, Keratin-, Seiden- und Milchei- weiß-Proteinhydrolysat, Soja-, Mandel-, Erbsen-, Moringa-, Kartoffel- und Weizenproteinhydrolysat enthält. Hair treatment composition according to one of the preceding claims, characterized in that it contains - based on its weight -0.01 to 15 wt .-%, preferably 0.05 to 10 wt .-%, more preferably 0, 1 to 7.5 wt. % and in particular 0.15 to 5% by weight of protein hydrolyzate (s) from the group of elastin, collagen, keratin, silk and milk protein hydrolysates, soybean, almond, pea, moringa, Potato and wheat protein hydrolyzate contains.
Haarbehandlungsmittel nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß es mindestens ein Oligopeptid mit einer Aminosäuresequenz Tyr-Glu- Glu-Glu-Ile Hair treatment composition according to one of the preceding claims, characterized in that it comprises at least one oligopeptide having an amino acid sequence Tyr-Glu-Glu-Glu-Ile
enthält, wobei die Amino-Gruppe frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können. wherein the amino group is free or protonated and the carboxy groups may be free or deprotonated.
Haarbehandlungsmittel nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß es - bezogen auf sein Gewicht - 0,3 bis 10 Gew.-%, vorzugsweise 0,5 bis 8 Gew.-%, weiter bevorzugt 0,75 bis 6 Gew.-% und insbesondere 1 bis 5 Gew.-% amphotere(s) Tensid(e) enthält. Hair treatment composition according to one of the preceding claims, characterized in that it contains, based on its weight, from 0.3 to 10% by weight, preferably from 0.5 to 8% by weight, more preferably from 0.75 to 6% by weight. and in particular from 1 to 5% by weight of amphoteric surfactant (s).
Haarbehandlungsmittel nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß es - bezogen auf das Gewicht des Mittels - 0,01 bis 3 Gew.-%, vorzugsweise 0,05 bis 2 Gew.-%, weiter bevorzugt 0,1 bis 1 ,5 Gew.-% und insbesondere
0, 15 bis 0,8 Gew.-% kationische(s) Polymer(e), vorzugsweise 0,01 bis 3 Gew.-%, vorzugsweise 0,05 bis 2 Gew.-%, weiter bevorzugt 0,1 bis 1 ,5 Gew.-% und insbesondere 0, 15 bis 0,8 Gew.-% mindestens eines Polymers aus der Gruppe der kationischen Cellulosepolymeren und/oder der kationischen Guarderivate enthält. Hair treatment composition according to one of the preceding claims, characterized in that it contains, based on the weight of the composition, from 0.01 to 3% by weight, preferably from 0.05 to 2% by weight, more preferably from 0.1 to 1.5 Wt .-% and in particular 0.15 to 0.8% by weight of cationic polymer (s), preferably 0.01 to 3% by weight, preferably 0.05 to 2% by weight, more preferably 0.1 to 1, 5 wt .-% and in particular 0, 15 to 0.8 wt .-% of at least one polymer from the group of cationic cellulose polymers and / or cationic guar derivatives.
8. Haarbehandlungsmittel nach einem der vorhergehenden Ansprüche, 8. hair treatment composition according to any one of the preceding claims,
gekennzeichnet, daß es - bezogen auf das Gewicht des Mittels -0,05 bis 20 Gew.-%, vorzugsweise 0, 1 bis 10 Gew.-%, weiter bevorzugt 0,25 bis 8 Gew.-% und insbesondere 0,5 bis 7 Gew.-% kationische(s) Tensid(e), vorzugsweise 0,05 bis 20 Gew.-%, vorzugsweise 0, 1 bis 10 Gew.-%, weiter bevorzugt 0,25 bis 8 Gew.-% und insbesondere 0,5 bis 7 Gew.-% Behenyltrimethyl-ammoniumchlorid enthält. in that, based on the weight of the composition, it is -0.05 to 20% by weight, preferably 0.1 to 10% by weight, more preferably 0.25 to 8% by weight and in particular 0.5 to 7% by weight of cationic surfactant (s), preferably 0.05 to 20% by weight, preferably 0, 1 to 10% by weight, more preferably 0.25 to 8% by weight and in particular 0 , 5 to 7 wt .-% behenyl trimethyl ammonium chloride.
9. Haarbehandlungsmittel nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß es - bezogen auf das Gewicht des Mittels - zusätzlich 0,001 bis 20 Gew.-% mindestens eines alpha-substituierten Aldehyds enthält. 9. hair treatment composition according to any one of the preceding claims, characterized in that it contains - based on the weight of the composition - additionally 0.001 to 20 wt .-% of at least one alpha-substituted aldehyde.
10. Haarbehandlungsmittel nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß es - bezogen auf das Gewicht des Mittels - zusätzlich 0,01 bis 10 Gew.-%, vorzugsweise 0,05 bis 7,5 Gew.-%, weiter bevorzugt 0,1 bis 6 Gew.-% und insbesondere 0, 15 bis 5 Gew.-% alpha-substituierte Aldehyd(e) der Formel (III) 10. hair treatment composition according to any one of the preceding claims, characterized in that it - based on the weight of the composition - additionally 0.01 to 10 wt .-%, preferably 0.05 to 7.5 wt .-%, more preferably 0, 1 to 6 wt .-% and in particular 0, 15 to 5 wt .-% alpha-substituted aldehyde (s) of the formula (III)
Y-CH(X)-CHO (III) Y-CH (X) -CHO (III)
enthält, in der contains, in the
X für -OH oder -Cl oder -Br oder -I oder -0-(CH2)n- mit n = 1 , 2, 3, 4 oderX is -OH or -Cl or -Br or -I or -O- (CH 2 ) n- where n is 1, 2, 3, 4 or
-0-(CH2)m-OH mit m = 1 , 2, 3 steht. -O- (CH 2 ) m -OH with m = 1, 2, 3 stands.
Y für -H oder -CH3 oder H3C-(CH2)k- mit k = 1 , 2, 3, 4, 5, 6, 7, 8 oder -OH oder -(CH2)P-OH mit p = 1 , 2, 3, 4 oder -CHO steht. Y is -H or -CH 3 or H 3 C- (CH 2 ) k - with k = 1, 2, 3, 4, 5, 6, 7, 8 or -OH or - (CH 2 ) P -OH p = 1, 2, 3, 4 or -CHO.
1 1. Haarbehandlungsmittel nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß es - bezogen auf sein Gewicht - 0,01 bis 10 Gew.-%, vorzugsweise 0,05 bis 7,5 Gew.-%, weiter bevorzugt 0, 1 bis 6 Gew.-% und insbesondere 0, 15 bis 5 Gew.- % mindestens eines alpha-substituierten Aldehyds aus der Gruppe 1 1. hair treatment composition according to any one of the preceding claims, characterized in that it - based on its weight - 0.01 to 10 wt .-%, preferably 0.05 to 7.5 wt .-%, more preferably 0, 1 to 6 wt .-% and in particular 0, 15 to 5% by weight of at least one alpha-substituted aldehyde from the group
- 2-Hydroxypropanal (X = -OH, Y = -CH3): 2-hydroxypropanal (X = -OH, Y = -CH 3 ):
2-Hydroxyhexanal (X = -OH, Y = H3C-(CH2)k- mit k = 3):
2-hydroxyhexanal (X = -OH, Y = H 3 C- (CH 2 ) k - with k = 3):
2-Hydroxyoctanal (X = -OH, Y = H3C-(CH2)k- mit k = 5): 2-hydroxyoctanal (X = -OH, Y = H 3 C- (CH 2 ) k- with k = 5):
Brommalonaldehyd (X = Br, Y = -CH=): Bromomalonaldehyde (X = Br, Y = -CH =):
2-(2-Hydroxyethoxy)acetaldehyd (X = -0-(CH2)P-OH mit p 2- (2-hydroxyethoxy) acetaldehyde (X = -O- (CH 2 ) P -OH with p
Glycerinaldehyd (X Glyceraldehyde (X
enthält. contains.
12. Haarbehandlungsmittel nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß es - bezogen auf das Gewicht des Mittels - zusätzlich 0,001 bis 10 Gew.-% mindestens eines Succinimidylesters enthält. 12. hair treatment composition according to any one of the preceding claims, characterized in that it contains - based on the weight of the composition - additionally 0.001 to 10 wt .-% of at least one Succinimidylesters.
13. Haarbehandlungsmittel nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß es - bezogen auf das Gewicht des Mittels - zusätzlich 0,01 bis 10
Gew.-%, vorzugsweise 0,05 bis 7,5 Gew.-%, weiter bevorzugt 0,1 bis 6 Gew.-% und insbeso -% (eines) Succinimidylester(s) der Formel (II) 13. hair treatment composition according to any one of the preceding claims, characterized in that it - based on the weight of the composition - additionally 0.01 to 10 % By weight, preferably 0.05 to 7.5% by weight, more preferably 0.1 to 6% by weight and in particular (a) succinimidyl ester (s) of the formula (II)
enthält, in der contains, in the
R1 für -H oder eine ionische Gruppe steht. R1 represents -H or an ionic group.
R für einen optional substituierten gesättigten oder ungesättigten, linearen, verzweigten oder cyclischen, aliphatischen oder aromatischen Kohlenwasserstoffrest mit mindestens 5 C-Atomen steht. R is an optionally substituted saturated or unsaturated, linear, branched or cyclic, aliphatic or aromatic hydrocarbon radical having at least 5 C atoms.
Haarbehandlungsmittel nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß es - bezogen auf sein Gewicht - 0,01 bis 10 Gew.-%, vorzugsweise 0,05 bis 7,5 Gew.-%, weiter bevorzugt 0, 1 bis 6 Gew.-% und insbesondere 0, 15 bis 5 Gew.-% mindestens eines Succinimidylesters aus der Gruppe Hair treatment composition according to one of the preceding claims, characterized in that it contains - based on its weight - 0.01 to 10 wt .-%, preferably 0.05 to 7.5 wt .-%, more preferably 0, 1 to 6 wt. -% and in particular 0, 15 to 5 wt .-% of at least one Succinimidylesters from the group
in der R für -Ph oder -(CH2)nCH3 mit n = 4, 5, 6, 7, 8, 9, 10 und in the R for -Ph or - (CH2) nCH3 with n = 4, 5, 6, 7, 8, 9, 10 and
X für H, ein einwertiges Kation oder den n-ten Teil eines n-wertigen Kations steht,
X is H, a monovalent cation or the nth part of an n-valent cation,
enthält. contains.
15. Haarbehandlungsmittel nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß es - bezogen auf sein Gewicht - 0,001 bis 20 Gew.-% Komplexbildner aus der Gruppe Tetranatrium-A/,A/-bis(carboxylatomethyl)-L-glutamat (Tetrasodium Glutamate Diacetate, GLDA), Pentasodium Diethylenetriaminepentaacetate (DTPA), Tetranatriumiminodisucciniat (IDS), Tetranatrium-Ethylendiamintetraacetat (EDTA), Tetranatrium-Ethylendiamindibernsteinsäure (EDDS), Trinatrium- Hydroxyethylethylendiamintriessigsäure (HEDTA) enthält. 15. hair treatment composition according to any one of the preceding claims, characterized in that it - based on its weight - 0.001 to 20 wt .-% complexing agent from the group tetrasodium A /, A / -bis (carboxylatomethyl) -L-glutamate (Tetrasodium glutamate Diacetates, GLDA), pentasodium diethylenetriaminepentaacetate (DTPA), tetrasodiumiminodisuccinate (IDS), tetrasodium ethylenediaminetetraacetate (EDTA), tetrasodium ethylenediamine disuccinic acid (EDDS), trisodium hydroxyethylethylenediaminetriacetic acid (HEDTA).
16. Haarbehandlungsmittel nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß es - bezogen auf sein Gewicht - 0,001 bis 20 Gew.-%, vorzugsweise 0,005 bis 15 Gew.-%, bevorzugt 0,01 bis 10 Gew.-%, weiter bevorzugt 0,05 bis 7,5 Gew.-% und insbesondere 0, 1 bis 5 Gew.-% Komplexbildner aus der Gruppe 16. hair treatment composition according to any one of the preceding claims, characterized in that it - based on its weight - 0.001 to 20 wt .-%, preferably 0.005 to 15 wt .-%, preferably 0.01 to 10 wt .-%, more preferably 0.05 to 7.5 wt .-% and in particular 0, 1 to 5 wt .-% complexing agent from the group
d. Tetranatrium-A/,A/-bis(carboxylatomethyl)-L-glutamat (Tetrasodium Glutamate d. Tetrasodium A /, A / -bis (carboxylatomethyl) -L-glutamate (Tetrasodium glutamate
Diacetate, GLDA), Diacetates, GLDA),
e. Pentasodium Diethylenetriaminepentaacetate (DTPA)
e. Pentasodium diethylenetriamine pentaacetate (DTPA)
Tetranatriumiminodisucciniat (IDS) Tetrasodiumiminodisuccinate (IDS)
enthält. contains.
17. Verfahren zur Haarbehandlung, dadurch gekennzeichnet, daß ein Mittel nach einem der Ansprüche 1 bis 16 auf trockenes oder feuchtes Haar aufgebracht, dort für einen Zeitraum von 10 bis 300 Sekunden belassen und danach ausgespült wird. 17. A method of hair treatment, characterized in that an agent according to any one of claims 1 to 16 applied to dry or wet hair, left there for a period of 10 to 300 seconds and then rinsed.
18. Verfahren zur Haarbehandlung, dadurch gekennzeichnet, daß ein Mittel nach einem der Ansprüche 1 bis 16 auf trockenes oder feuchtes Haar aufgebracht und dort bis zur nächsten Haarwäsche belassen wird.
18. A method for hair treatment, characterized in that an agent according to any one of claims 1 to 16 is applied to dry or damp hair and left there until the next hair wash.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102016219001.6A DE102016219001A1 (en) | 2016-09-30 | 2016-09-30 | improves conditioner hair care products with washout protection |
| PCT/EP2017/068351 WO2018059778A1 (en) | 2016-09-30 | 2017-07-20 | Improved conditioning hair treatment product with washout protection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP3518881A1 true EP3518881A1 (en) | 2019-08-07 |
Family
ID=59381296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP17742246.6A Withdrawn EP3518881A1 (en) | 2016-09-30 | 2017-07-20 | Improved conditioning hair treatment product with washout protection |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20190240129A1 (en) |
| EP (1) | EP3518881A1 (en) |
| DE (1) | DE102016219001A1 (en) |
| WO (1) | WO2018059778A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3518875T3 (en) * | 2016-09-30 | 2025-04-22 | Innospec Limited | Cosmetic compositions for combatting colour loss from a dyed material |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU49208A1 (en) * | 1965-07-29 | 1967-01-30 | ||
| ZA837627B (en) * | 1982-10-15 | 1984-06-27 | Procter & Gamble | Storage stable topical pharmaceutical composition containing low dielectric solvents |
| DE3725030A1 (en) | 1987-07-29 | 1989-02-09 | Henkel Kgaa | SURFACE ACTIVE HYDROXYSULFONATE |
| JP3391403B2 (en) * | 1995-06-30 | 2003-03-31 | 株式会社ピーアンドピーエフ | Antibacterial antiseptic preservative, skin external preparation and cleaning composition |
| US20040234489A1 (en) * | 2003-03-25 | 2004-11-25 | L'oreal S.A. | Use of a particular carboxylic acid or salts thereof as agents for conditioning keratin materials |
| DE10335659A1 (en) * | 2003-08-04 | 2005-03-03 | Sonomed Gmbh | Suspensions for use in production of silicon-free skin protectants which can be used with latex gloves contain stearic acid, stearyl alcohol and metal stearates |
| US20050113268A1 (en) * | 2003-11-26 | 2005-05-26 | Landa Peter A. | Increased moisturization efficacy using hydroxyalkylurea |
| GB0718269D0 (en) * | 2007-09-12 | 2007-10-31 | Bioniqs Ltd | Purification of organic compounds |
| CN102549034B (en) * | 2009-07-31 | 2014-12-10 | 阿克佐诺贝尔股份有限公司 | Hybrid copolymer compositions for personal care applications |
| DE102010062612A1 (en) * | 2010-12-08 | 2012-06-14 | Henkel Ag & Co. Kgaa | Hair treatment agents |
| DE102011088929A1 (en) * | 2011-12-19 | 2013-06-20 | Henkel Ag & Co. Kgaa | Hair treatment with a special emulsifier and protein hydrolysates |
| DE102012214040A1 (en) * | 2012-08-08 | 2014-02-13 | Henkel Ag & Co. Kgaa | Hair care preparations containing selected fatty acid amides and selected protein hydrolysates |
| DE102014225218A1 (en) * | 2014-12-09 | 2016-06-09 | Henkel Ag & Co. Kgaa | Powerful color protection hair treatment products with a dipetid |
-
2016
- 2016-09-30 DE DE102016219001.6A patent/DE102016219001A1/en not_active Withdrawn
-
2017
- 2017-07-20 US US16/336,592 patent/US20190240129A1/en not_active Abandoned
- 2017-07-20 WO PCT/EP2017/068351 patent/WO2018059778A1/en not_active Ceased
- 2017-07-20 EP EP17742246.6A patent/EP3518881A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US20190240129A1 (en) | 2019-08-08 |
| WO2018059778A1 (en) | 2018-04-05 |
| DE102016219001A1 (en) | 2018-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE102015223828A1 (en) | Powerful hair treatment with anti-washout effect | |
| DE102015223817A1 (en) | Powerful hair treatment agent with structure-strengthening effect | |
| EP3519054A1 (en) | Conditioning hair treatment product with washout protection comprising an alpha substituted aldehyde | |
| WO2018059766A1 (en) | Improved conditioning hair treatment product with washout protection | |
| EP3522987A1 (en) | Improved conditioning hair treatment product with washout protection | |
| WO2018059777A1 (en) | Improved conditioning hair treatment product with washout protection | |
| EP3518879A1 (en) | Improved conditioning hair treatment product with washout protection | |
| EP3519059A1 (en) | Improved conditioning hair treatment product with washout protection | |
| EP3518878A1 (en) | Improved conditioning hair treatment product with washout protection | |
| EP3518881A1 (en) | Improved conditioning hair treatment product with washout protection | |
| WO2018059779A1 (en) | Improved conditioning hair treatment product with washout protection | |
| WO2018059767A1 (en) | Improved conditioning hair treatment product with washout protection | |
| EP3518872A1 (en) | Improved conditioning hair treatment product with washout protection | |
| DE102015223835A1 (en) | Powerful hair treatment with anti-washout effect | |
| EP3518884A1 (en) | Improved conditioning hair treatment product with washout protection | |
| EP3518890A1 (en) | Improved conditioning hair treatment product with washout protection | |
| EP3519053A1 (en) | Improved conditioning hair treatment product with washout protection | |
| EP3518887A1 (en) | Improved conditioning hair treatment product with washout protection | |
| DE102015223816A1 (en) | Powerful hair treatment agent with structure-strengthening effect | |
| EP3518871A1 (en) | Improved conditioning hair treatment product with washout protection | |
| DE102015223819A1 (en) | "Powerful hair treatment products with anti-washout effect" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20190114 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| 17Q | First examination report despatched |
Effective date: 20200409 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20200820 |